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Abstract 
This thesis describes the results of experiments into the intra and inter-molecular binding of 
various ligands with dsDNA via the mechanism of intercalation, principally using the 
technique of atomic force microscopy (AFM). Since the description of the first AFM in the 
mid 1980’s, AFM has emerged as a sensitive and versatile analytical tool, capable both of 
detecting and manipulating artefacts at picometer resolutions. 
 
In these studies, AFM imaging, supported by circular dichroism, reveals unusual 
conformational changes in DNA that occur as a result of the binding of ligands that 
incorporate the acridine chromophore. These changes are distinct from those observed 
following the binding of other intercalators such as doxorubicin and echinomycin. Direct 
measurement of the length of linear DNA strands bound to acridine based ligands reveals a 
shortening of the DNA at very low ligand concentrations. This observation suggests that the 
structural changes that occur in DNA following the intercalation of the acridine 
chromophore are more wide ranging than previously thought and support molecular 
modeling studies that have proposed that the intercalated DNA duplex exhibits 
characteristics of both B and A form DNA. Variations in the conformational changes that 
occur in DNA as a result of intercalation may have implications for the application of new 
intercalating ligands as chemotherapeutic agents. 
 
In addition, single molecule force spectroscopy has been used to examine the capacity of 
bisintercalators to bind to DNA in an inter-molecular fashion. By stretching individual 
strands of dsDNA, acridine dimers are shown to bind to separate strands of DNA. Inter-
molecular binding of this kind remains an unexplored cytotoxic mechanism that may yet find 
an application in vivo. This observation is supported by a novel assay that utilises the 
controlled aggregation of gold nanoparticles. These nanoparticles, functionalised with DNA, 
are shown to aggregate on addition of a bisintercalator. The aggregation is fully reversible 
with the addition of sodium dodecylsulphate.  
 
These force spectroscopy experiments have also uncovered a previously unobserved, inter-
molecular binding mode of the peptide antibiotics echinomycin and TANDEM. In certain 
circumstances, these ligands are revealed to bind exclusively to the termini of separate DNA 
strands in a sequence dependent fashion. This finding may have implications for the 
employment of these ligands in the nanosciences, as a tool for joining short pieces of DNA 
or improving the efficiency of the enzymatic, blunt-end ligation of DNA.  
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Background 
Despite significant advances in the understanding of cancer as a disease state, it remains one 
of the leading global causes of death in the human population. Essentially, cancers constitute 
a malfunction of endogenous biological mechanisms, whereby cell division proceeds 
unchecked, leading to the growth of a tumour. In the initial stages of tumour development, a 
tumour may be localised, or one of several spread through an area of tissue. Unresolved, the 
majority of tumours will eventually metastasize, spreading to other tissues and organs within 
the body. The development of cancers in this fashion is classified according to the particular 
developmental stage, from stage I, where a tumour is localized, to stage IV, where metastasis 
occurs. 
 
Early identification of the disease is essential to successful resolution. A national screening 
programme in the UK for breast cancer has been successful in signposting women with the 
early signs of tumour development for treatment.
1
 In stage I cancers, surgery is usually the 
most effective option, with removal of cancerous tissue often sufficient to prevent relapse. 
During the later stages of cancer, where tumour development is sufficiently advanced to 
prohibit surgery, techniques are employed to either destroy the cancer or reduce it in size 
sufficiently for surgery to proceed.  
 
Non-surgical options for treating cancer typically fall into one of two categories, those being 
either radiotherapy or chemotherapy. Significant technological advances in the controlled 
administration of radiotherapeutics, and sophisticated, non-invasive imaging technologies 
such as magnetic resonance imaging, have ensured that radiotherapy may be administered 
with a high degree of precision to a tumour.
2-3
 Although multiple treatments are generally 
required before a cancer can be said to be in remission, the technique is associated with a 
high degree of patient compliance, since administration is controlled exclusively by a 
medical practitioner.  
 
Chemotherapy remains an important treatment option, especially in those cases where 
neither surgery nor radiotherapy are viable options.
4-5
 Many chemotherapeutic agents are 
employed in an adjunctive fashion, improving patient outcomes even where surgery or 
radiotherapy have also been employed. This is particularly true in later stage cancers, where 
the controlled administration of cytotoxics such as methotrexate and vincristine may slow 
the progression of metastasis and prolong a patient’s life, if only for a short period of time. 
 
Existing chemotherapies employ many different mechanisms of action. The anti-metabolite 
methotrexate inhibits the enzyme dihydrofolate reductase, preventing the synthesis of the 
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nucleoside thymidine and thereby inducing cellular apoptosis. By contrast, the monoclonal 
antibody, trastuzumab, binds to an extracellular portion of the HER2 receptor, a cell-
regulatory protein that is overexpressed in some breast cancers.
6-7
 
 
Compounds that bind to DNA have been of interest for a considerable period of time, 
primarily due to their application as chemotherapeutic agents. Two commonly used anti-
cancer agents, amsacrine and cisplatin (Figure 1), both exert a cytotoxic effect on dividing 
cells by binding directly to DNA in the nucleus. Compounds that share this fundamental 
mechanism of action have been extensively studied,
8-11
 and new agents have been subjected 
to clinical trials.
12
 However, for a variety of reasons, few new agents of this kind have been 
employed in a clinical environment since the introduction of amsacrine (Figure 1) in the 
early 1980s. 
 
 
Figure 1 Structural formulae of the DNA platinating agent cisplatin (left) and the DNA 
intercalator amsacrine (right). 
 
Amsacrine belongs to a class of DNA binding ligands referred to as intercalators. First 
described by Lerman in 1961,
13-14
 these compounds bind directly to DNA. Despite having 
been in clinical use for several decades, amsacrine and other intercalating agents, such as 
doxorubicin and actinomycin, remain important adjunctive therapies, especially where other 
treatment options have failed. 
 
At present, all clinically utilised intercalating agents are monointercalators. Derivatives of 
these compounds that incorporate multiple intercalating moieties have been shown in vitro to 
afford a greater degree of cytotoxicity. Attempts to introduce a bisintercalator into the clinic 
have not proved successful. The peptide antibiotic, echinomycin, did not deliver any 
improvement in patient outcomes in vivo relative to existing treatment options.
15-16
 
 
Despite this, efforts to rationalise intercalator design have continued.
10, 17-19
 In theory at least, 
an improved understanding of the molecular mechanics that surround the intercalation of 
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DNA with certain compounds may facilitate the design of new DNA-intercalators that find 
clinical application. 
 
The structure of DNA 
First described in the 1950s by James Watson and Frances Crick,
20
 the helical structure of 
DNA is widely understood and accepted. Not only the structure, but the processes with 
which DNA is involved have also been extensively studied. Essentially a repository for 
genetic information, the successful transcription of DNA is essential to successful cell 
division. As such, DNA constitutes a viable target for disrupting the kinds of uncontrolled 
cell-division that are associated with tumour development. 
 
DNA consists of a linear series of deoxyribonucleotides each coupled to another by a 
phosphodiester linkage. The basic repeating unit of DNA, -2’-deoxy-D-ribofuranose, is 
illustrated in Figure 2. 
 
Figure 2 The chemical structure of -2’-deoxy-D-ribofuranose. The numerals, from 1 to 5, 
refer to the carbon atoms at those positions. 
 
Each preceding and subsequent ribose is connected at the 5’ and 3’ positions respectively. 
This arrangement is illustrated in Figure 3. Due to the constraints imposed by the cyclic 
ribose group, the bond between positions 3’ and 4’ of the ribose is not free to rotate in the 
same manner as the other components of the phosphodiester linkage. As such, the ribose 
group may exist in any of four different conformations, a phenomenon known as sugar 
pucker (Figure 4). Structural variations of this kind have important implications for the 
overall conformation of the DNA molecule. 
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Figure 3 An illustration of the coupling of the structure of the DNA phosphate backbone. 
Adjoining ribose groups are coupled via a phosphodiester linkage at the 5’ and 3’ positions 
of the sugar. DNA sequences of this kind can contain many thousands of bases in such a 
linear sequence. 
 
 
Figure 4 A Schematic illustration of the different conformations of the ribose ring that are 
observed in DNA. The red circle denotes the oxygen atom. Both the 2’ and the 3’ position 
may be in the same plane as the 5’ position (endo) or in the opposite plane (exo).21 
 
Original work on the structure of DNA utilised X-ray crystallography to define the spatial 
arrangement of the nucleobases and the phosphate/deoxyribose backbone of the molecule.
22
 
The primary structure of DNA consists of four distinct nucleobases, the purines adenine and 
guanine, and the pyrimidines, cytosine and thymine.  
Chapter 1 
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Figure 5 Chemical formulae of the four common nucleobases present in DNA, from left to 
right, adenine, guanine, cytosine and thymine. 
 
In the classic Watson-Crick arrangement (referred to as the B form), these bases form pairs 
within the duplex, adenine to thymine and guanine to cytosine. Each base pair within the 
DNA primary sequence forms a step, separated from the next pair of nucleobases by a 
distance of 3.4 Å (0.34 nm).  
 
 
Figure 6 An illustration of the Hydrogen bonding arrangements of the two DNA base pairs, 
guanine and cytosine (left) and adenine and thymine (right). 
 
Table 1 The common physical characteristics of the three most commonly known DNA 
conformations.
21
  
Parameter A Form B Form Z Form 
Helical sense Right Right Left 
Diameter / nm 2.6  2.0 1.8 
Base pairs / turn 11 10.5 12 
Helical rise / nm 0.24 0.34 0.37 
Sugar pucker C3’-endo C2’-endo C2’-endo / C2’-exo 
Tilt v. helix axis / ° 20 6 7 
 
Continued research into DNA structure revealed the existence of another form of DNA, that 
of the A form, often associated with DNA outside of an aqueous environment.
23
 Although in 
this arrangement the pairing of the nucleobases is maintained, the distance between each 
base pair (helical rise) is reduced to only 2.4 Å. Another form of DNA that has been 
identified is that of the Z form.
24
 While A and B form DNA maintain a right handed spiral, in 
Z-DNA the duplex is orientated in the other direction, a left hand spiral, while the bases are 
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separated by a rise of. 3.7 Å. These three forms of DNA, A, B and Z, are frequently referred 
to in the literature (Table 1 and Figure 7). 
 
 
Figure 7 Graphical illustrations of the three common forms of DNA; from left to right, A, B, 
and Z forms.
21
 The phosphate backbones of each of the two strands of DNA in the duplex are 
highlighted in blue. The scale bar represents one helical turn of A form DNA, approximately 
2.6 nm. The models highlight two important features of the DNA helix, the major and minor 
grooves, coloured in grey. The major groove is shown to be wider in the B form model than 
the more compact A form. 
 
However, numerous conformational isomers of the basic DNA duplex are now known to 
exist and the classical description of DNA constitutes something of an over-simplification. 
25
 
Subtypes of the B conformation, referred to as B-I and B-II have been isolated, along with an 
alternative conformation, that of the C form that is structurally very similar to that of the B-II 
subtype. These isomers vary not only in the direction of the helix spiral, or sugar pucker, but 
also in the spatial positioning of the base pairs relative to one another. Subtle variations in 
the degree of tilting, or twist, between each base pair relative to the perpendicular helix axis 
can induce significant changes in the physical characteristics of the DNA helix as a whole. 
 
Arguably, the picture that has emerged is that, far from adopting a particular, rigid, 
conformation, the DNA duplex demonstrates a high degree of conformational versatility, 
switching between conformations according to its environment. Such transitions need not 
affect the entire length of the DNA duplex, and may be localized while other regions remain 
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in a different conformation altogether. Importantly, it has been suggested that both A and Z 
form DNA are associated with the regulation of gene expression and DNA transcription, 
disruption of which may offer a means of controlling cell division.
21
 
 
Intercalation of DNA 
Originally defined by Lerman in 1961
13
, intercalation involves the insertion of a planar, 
aromatic moiety into the space between the base pairs in the DNA duplex. Typically, the 
intercalating ligand approaches the DNA from the minor groove, forming several short-range 
interactions that widen the inter-base pair spacing sufficiently for intercalation to occur. Base 
stacking of this kind is a non-covalent interaction, distinct from the binding mechanism of 
other small DNA binding ligands such as nitrogen mustards and cisplatin where the process 
of attachment is irreversible. An illustration of this mechanism is provided in Figure 8. 
 
 
Figure 8 Graphical illustration of the binding of a bisacridine to a strand of DNA. The red 
sections denote the location of the ligand’s chromophores between the DNA base pairs after 
binding. 
 
The clinically employed DNA intercalators exert their cytotoxic effects in two different 
ways. The anthracycline doxorubicin and the acridine derivative amsacrine (Figure 1) 
incorporate additional chemical functionalities. Once the molecule is anchored in the DNA, 
these additional groups bind to the enzyme topoisomerase II during intra-cellular processing 
of the DNA, trapping the enzyme/DNA complex.
26
 This enzyme relaxes DNA prior to 
transcription by inducing double strand breaks in the DNA duplex. Trapped in the 
intercalator/DNA/enzyme complex, usual re-attachment of the separated DNA strands by 
topoisomerase II is not possible, leading to cellular apoptosis. 
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Another clinically employed intercalator, actinomycin-D, employs a different mechanism of 
action to the anthracyclines. In this case, the ligand interferes with the activity of the enzyme 
RNA-polymerase, preventing the elongation of the RNA chain along the DNA template and 
thereby causing cell death.  
 
Studies of the intercalation of a variety of ligands have suggested that the process of 
intercalation may distort the duplex to a greater degree than was originally supposed.
27
 
Separation of the base pairs in the duplex by an intercalator causes an unwinding of the DNA 
helix and a lengthening of the DNA strand.
14
 This has been observed using a number of 
techniques, notably flow viscometry with intercalated DNA rods.
14, 28
 Substantial amounts of 
data, such as the helix unwinding angle, have been published for an array of intercalating 
agents, including ethidium bromide, proflavin and YOYO-1.
9
 Despite some similarities, 
these studies reveal that the precise nature of any structural changes in the DNA is unique to 
any given ligand. 
 
Separation of the base pairs in the DNA sequence may also be accompanied by a 
reorientation of the base pairs relative to one another. In both A and B form DNA, the base 
pairs are arranged, relative to the phosphate backbone, according to the anti-configuration 
(Figure 9).  
 
 
Figure 9 An illustration of the anti-configuration of the nucleobase adenine, left, and the 
alternative syn-configuration, right. 
 
Rotation of the base about the glycosidic bond between itself and the ribose sugar causes a 
conformational change referred to as the syn-configuration, illustrated in Figure 9. The latter 
is characteristic of Z form DNA, but does not usually appear in A or B forms of DNA. 
However, some studies of intercalation have suggested that a distortion of this kind is 
induced by ligand binding, leading to a non Watson-Crick arrangement of the base pairs 
referred to as Hoogsteen base pairing (Figure 10).
29-31
 The biological significance of this 
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change (if any) is not yet understood, but it has been suggested that this arrangement may 
occur during the binding of some intracellular enzymes to DNA. 
 
 
Figure 10 Illustrations of the alternative Hoogsteen arrangement of CG (left) and AT (right) 
base pairs that are observed in DNA. The red lines denote the hydrogen bonds between each 
base. The Hoogsteen arrangement requires the protonation of the cytosine base (left). 
 
The existence of another class of intercalating agents, the bisintercalators, has already been 
discussed. In essence, a bisintercalator consists of two monointercalators that have been 
linked together. The synthesis of even larger compounds (even an octakis intercalator) has 
also been reported, but none of these compounds have been suggested for clinical use.
32
 In 
the simple example of two acridine chromophores joined by a methylene chain, early studies 
revealed a transition from mono to bisintercalation when the length of the alkyl chain 
exceeded six methylene groups.
9
 On average, both the helix unwinding angles of these 
bisintercalators and their helix extension parameters are roughly double those of the parent 
monomers.
9
  
 
Bisintercalators are known to demonstrate greater cytotoxicity than monointercalators, even 
where the binding chromophores are structurally identical. However, the reasons behind this 
greater degree of cytotoxicity are complex. To an extent, the binding of each chromophore 
within the bisintercalator is synergistic, with binding of the first chromophore facilitating 
that of the second. However, equilibrium dialysis studies of the binding of bisacridines to 
CT-DNA revealed only a 10 to 15-fold increase in the binding affinities of bisacridines 
relative to 9-aminoacridine, as opposed to an expected increase of 10
4
.
9
 This discrepancy 
was attributed to unfavourable enthalpies and entropies associated with solvent 
rearrangements and distortions to the DNA duplex that occur with intercalation of an 
acridine.
9
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Figure 11 Graphical illustration of a bisacridine binding to two separate DNA strands (Type 
II intercalation). The red sections in the DNA strands demonstrate the position of the ligand 
chromophores. 
 
As well as binding to the same strand of DNA, in the manner of a monointercalator, 
bisintercalators, notably luzopeptin
33
 and some acridine analogues
34-35
, have been observed 
to bind to separate DNA strands in an inter-molecular fashion (Figure 11). Though not 
commonly utilised, a nomenclature for these different modes of intercalation has been 
previously suggested, with Type I intercalation referring to intra-molecular binding, and 
Type II intercalation referring to inter-molecular binding.
33
 
 
9-aminoacridine, doxorubicin and ethidium bromide 
The chemical structures of the three monointercalators that were utilised during the course of 
these studies are provided below (Figure 12). For reference, the chemical structures of all 
ligands used during these studies are provided in Appendix 2 (insert). 
 
 
Figure 12 Chemical structures of the three monointercalators from left to right, ethidium 
bromide, 9-aminoacridine and doxorubicin. 
 
 
Doxorubicin is commonly used in the treatment of many cancers, including acute 
leukaemias, Hodgkin’s lymphoma and some breast cancers. The compound is administered 
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via infusion. Side effects are common with doxorubicin, and range from diarrhoea to 
permanent kidney damage. Higher doses are associated with an increased risk of heart 
failure, limiting the courses of treatment that may be administered and reducing the potential 
range of patients by excluding those with pre-existing cardiac disorders.
36
 Like amsacrine, 
doxorubicin does not exert its cytotoxic effects via intercalation but by interaction with the 
enzyme topoisomerase II. The aglycone portion of the ligand stacks between nucleotides in 
the primary DNA sequence, the daunosamine residue remaining in the minor groove of the 
DNA. Doxorubicin is commonly believed to have a slight preference for intercalating into 
5’-CpG steps,37 although it has been suggested that the ligand exhibits a greater affinity for 
AT rich regions, specifically ApA.
38
 Doxorubicin utilised in these studies was purchased 
from Sigma (UK). Solutions of this ligand (aqueous solubility 50 mg/ml) were prepared as 
required and stored at -20°C until use. 
 
9-aminoacridine is an important precursor to many acridine based compounds that 
incorporate the acridine chromophore. The compound itself is a known cytotoxic and 
mutagen, and the potential utilization of this compound as a chemotherapeutic was suggested 
as early as 1948,
39
 before its mode of action had been characterised. Despite the simplicity 
and small size of this ligand, sequence specificity has been suggested, the ligand appearing 
to bind more tightly to regions of high GC content, especially the GpC step.
40
 Although 9-
aminoacridine itself is not clinically utilised, the monointercalator amsacrine that 
incorporates the acridine chromophore is successfully used in vivo. 9-aminoacridine used in 
these studies was purchased from Sigma (UK). The compound is water soluble, and stocks 
were prepared as required and stored at -20°C until use. 
 
Another DNA monointercalator, ethidium bromide is used as a dye, fluorescing when bound 
to DNA. This compound is commonly used as a DNA marker, especially in gel 
electrophoresis, and, like 9-aminoacridine, is a known mutagen. The compound was 
synthesized specifically to function as an anti-trypanosomal agent,
41
 but has never been 
employed in humans due to concerns about carcinogenicity. As may be discerned from 
Figure 12, the arrangement of the intercalating moiety within ethidium bromide is slightly 
different from the linear arrangement of the aromatic groups within doxorubicin and 9-
aminoacridine, the central aromatic ring being offset from the flanking pairs. Like 
doxorubicin and 9-aminoacridine, ethidium bromide is believed to exhibit a preference for 
GC rich regions of DNA.
42
 Ethidium bromide was purchased from Fisher Scientific (UK), 
and used as received.  
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Echinomycin and TANDEM 
Echinomycin (Figure 13) was, and so far remains, the only bisintercalator to enter phase II 
clinical trials.
12
 To date there is no published synthesis of this compound. The sequence 
specificities, and precise mechanism of action of this compound, have been studied 
extensively in the literature. The ligand is known to bind preferentially to regions of high GC 
content, although binding has been observed to occur in areas of AT sequences.
43
 DNAse 
footprinting and NMR have identified that echinomycin binds with the greatest degree of 
affinity to 5’-CpG steps within the DNA duplex,44-45 hydrogen bonding between the 2-amino 
group of guanine and the peptide component of the bisintercalator essential to the 
stabilisation of the complex.
46
 Precisely, the quinoxaline rings of the ligand flank the 2 
nucleotide base pairs, whilst the peptide ring remains in the minor grove of the DNA. Three 
hydrogen bonds are formed between the alanine groups of the peptide ring and the bases of 
the minor groove at CpG steps; the N3’s of both of the guanines at the binding site and the 2-
amino group of one of the guanines.
46
  
 
Echinomycin was purchased from Sigma (UK), and stock solutions in DMSO were prepared 
and stored at -20°C until use. The aqueous solubility of echinomycin is poor (approximately 
5 µM), and solutions were prepared freshly in aqueous media when required. 
 
 
Figure 13 The structure of the peptide antibiotic echinomycin.  
 
TANDEM (Figure 14), a synthetic analogue of Triostin-A, has also been extensively studied 
in vitro.
47
 Triostin-A is a bisintercalator with similar binding behaviour to echinomycin, 
favouring GC rich regions of DNA. By contrast, TANDEM favours AT rich regions of 
DNA, attributed to the removal of the methyl groups from the inter-chromophore linker and 
the disulfide bridge.
48
 These structural modifications disrupt the usual binding of the ligand 
to GC areas within the minor groove of the DNA strand. This is due to the formation of 
intra-molecular hydrogen bonds between the alanine residues of the peptide ring, prohibiting 
the formation of the necessary hydrogen bonds with the 2-amino group of guanine, the 
interaction that affords the specificity of echinomycin for CpG steps. By contrast, TANDEM 
has been shown to bind with high affinity to 5’-TpA steps.49 However, binding of the 
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compound is strongly dependent not only on the base pairs sandwiched by the quinoxaline 
chromophores, but also the composition of the flanking base pairs, since binding does not 
always occur even at the preferred 5’-TpA steps.48 
 
 
Figure 14 The chemical structure of the triostin-A analogue, TANDEM.  
 
The complete solid-phase synthesis of TANDEM was published in 2005.
47
 A supply of this 
compound was provided by Prof. M. Searcey (University of East Anglia). Stock solutions 
were prepared in DMSO, and diluted in aqueous media as required. 
 
Bisacridines with flexible linkers 
A simple acridine dimer (Figure 15), comprised of an alkyl linker between two acridine 
chromophores, was synthesized as part of this project. The other three bisacridines used in 
these studies were provided by Dr. L. A. Howell (University of East Anglia).
50
 All were 
stored at -20°C in aqueous media until used.  
 
Many similar linked acridines have been synthesized and biologically evaluated as anti-
tumour agents. 
51
 Although the individual specificity of bisacridine 1 for DNA sequences has 
not been determined, it has been suggested that bisacridines have a slight preference for GC 
regions of DNA.
52-53
 However, the reasons for this slight selectivity are not immediately 
clear, and importantly 9-aminoacridine is not known to exhibit any such preference. 
Incorporation of basic nitrogen atoms into the linker of bisacridines has been shown to either 
enhance or eliminate the alternative preference for ApT steps in DNA, suggesting that slight 
variations in sequence selectivity between different bisacridines are dictated by the chemistry 
of the linker and not the intercalating chromophore. 
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Figure 15 The chemical structure of the bisacridine, bis(acridine) N-(6-(acridin-9-
ylamino)hexyl)acridine-9-amine (bisacridine 1) 
  
Though structurally very similar, bisacridine 2 (Figure 16) incorporates additional 
functionalities that enhance the affinity of this compound for DNA.
54
 While the inter-
chromophore linker resides in the minor groove of the DNA, the carboxamide side-chains 
form hydrogen bond contacts with the O6 and N7 atoms of guanine in the major-groove, 
reducing dissociation of the ligand from the DNA and thereby enhancing its cytotoxic 
potential.  
 
This variation on classical intercalation is referred to as ‘threading’, since it necessitates the 
insertion of the carboxamide substituent through the DNA duplex from the minor groove, 
between the base pairs and into the major groove. This mode of action is very sensitive to the 
precise arrangement of the carboxamide substituent on the chromophore, and may be 
prevented at a pH greater than 9. Under physiological conditions at pH 7, the nitrogen of the 
central aromatic group of the acridine chromophore is protonated, forming a hydrogen bond 
with the carbonyl of the carboxamide that maintains a planar arrangement between the 
acridine and the 4’ substituent.  
 
 
Figure 16 The chemical structure of a derivative of bis(acridine) N-(6-(acridin-9-
ylamino)hexyl)acridine-9-amine, incorporating two carboxamide substituents at the 4’ 
position of each acridine chromophore (bisacridine 2) 
 
Both of these compounds bind to DNA via bisintercalation in a manner similar to 
echinomycin and TANDEM. The length of the flexible alkyl chain between the 
chromophores of 11.3 Å is sufficient to accommodate the required two base pairs, forming a 
sandwich between the acridine chromophores.
19
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Bisacridines with rigid linkers 
By varying the structure of the inter-chromophore linker, some degree of control over the 
binding activity of a bisacridine may be afforded. While the flexible, alkyl linked 
bisacridines are ideal Type I bisintercalators, compounds comprising a rigid inter-
chromophore linker are less able to bind to DNA in an intra-molecular fashion. Rigidly 
linked bisacridines, such as those illustrated in Figure 17 and Figure 18, have been evaluated 
for their capacity to adopt the Type II, inter-molecular mechanism of intercalation.
35
 It has 
been suggested that cross-linking strands of DNA in this fashion offers another means of 
inducing cellular apoptosis.
34, 55
 
 
 
Figure 17 The chemical structure of N-(2-(dimethylamino)ethyl)-9-(3-(1-(2-(4-(2-
(dimethylamino)ethylcarbamoyl)acridin-9-ylamino)ethyl)-1H-1,2,3-triazol-4-
yl)phenylamino)acridine-4-carboxamide, a bisacridine incorporating a rigid linker 
(bisacridine 3) 
 
 
Figure 18 The chemical structure of N-(2-(dimethylamino)ethyl)-9-(2-(4-(3-(4-(2-
(dimethylamino)ethylcarbamoyl)acridin-9-ylamino)ethyl)-1H-1,2,3-triazol-4-
yl)phenylamino)acridine-4-carboxamide (bisacridine 4) 
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Chapter 2 – The method and application of atomic force microscopy 
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The method and application of atomic force microscopy 
These studies make extensive use of two experimental techniques: intermittent contact mode 
atomic force microscopy; and single molecule force spectroscopy. Both of these techniques 
may be conducted using the same apparatus, commonly referred to as an atomic force 
microscope.  
 
Techniques for obtaining information at near atomic resolution have been in existence for 
some time. The first studies using electron microscopy were reported during the 1930’s, and 
demonstrated resolutions as high as 10 nm.
56
 The technology of electron microscopy has 
developed considerably in this time, giving way to systems that permit not only the 
observation of artefacts at picometer resolutions, but even their manipulation. Using the 
concept of quantum tunneling, the scanning tunneling microscope was the first such 
instrument to permit analysis of this kind.
57
 However, experimentation using this apparatus is 
restricted to conductive substrates.  
 
Effectively a combination of the principles of the scanning tunneling microscope and the 
stylus profilometer, atomic force microscopy permits the analysis and manipulation of non-
conductive substrates at very high resolutions (Figure 19). Early studies indicated that such 
apparatus was capable of demonstrating a lateral resolution of 3 nm and a vertical resolution 
of 0.1 nm.
58
 Instrumental sensitivity of this kind permits the analysis of individual molecules 
at an atomic level comparable to that established by STM, and even the testing of individual 
chemical bonds.
59
 
 
 
Figure 19 A Photograph of a JPK NanoWizard II™ atomic force microscope. Visible, from 
top to bottom, are the optical microscope, AFM scanning head, and the sample stage. 
 
Chapter 2 
27 
 
The concept of imaging a surface using the principles of AFM is relatively straightforward. 
A probe (Figure 20), typically made of silicon, is placed in contact with the surface to be 
analysed. As the probe is moved across the surface of the substrate, changes in the forces 
required to maintain a consistent contact between the probe and the substrate are monitored 
by the AFM instrumentation. These changes in force are translated into a digital computer 
image, representative of the topography of the region over which the AFM probe has passed. 
 
 
Figure 20 A SEM picture of a typical silicon AFM cantilever of the kind used in imaging 
experiments.
60
 The schematic, top right, shows the length of the cantilever to which the 
probe is attached. The AFM probe is mounted within the scanning head of the apparatus. 
 
Although an AFM image reflects the physical topography of the sample beneath the AFM 
cantilever, the AFM instrumentation itself actually measures changes in the electrical signal 
within a closed feedback loop. The position of the cantilever is controlled electrically via 
three piezo crystals, one each for the x, y and z axes. Piezoelectric material deforms in a 
reproducible manner proportional to the strength of an applied electric current. This permits 
the physical degree of movement of the cantilever to be controlled by varying the applied 
electrical force. Movement of the cantilever in the x and y axes can be carefully controlled in 
this way.  
 
Unlike scanning electron, or even optical microscopy, where pictures of whole regions may 
be obtained immediately, AFM images are assembled from a series of lines across the x axis 
of the scanning region, the probe moving sequentially through the y axis until the entire 
region has been analysed. AFM imaging can therefore be slow, with a typical scan of a 5 x 5 
micron region at a rate of 2 Hz typically taking several minutes. Technological developments 
are permitting faster scan rates, but this is often dependent on the nature of the sample that is 
being imaged.
61
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Image contrast, changes in surface topography, is provided by the movement of the AFM 
cantilever in the z axis. The precise deflection of the cantilever is determined by following 
the movement of a laser that is deflected from the back of the AFM cantilever onto a 
photodiode (Figure 21). The position of the reflected laser beam on the photodiode is 
transduced into an electrical signal. By measuring the changes in voltage required to 
maintain a constant degree of deflection in the cantilever (a concept referred to as the ‘set-
point’) a representation of the surface topography may be determined.  
 
Figure 21 An illustration of the movement of the AFM cantilever in the z axis and how this 
is translated into the movement of the reflected laser beam on the photodiode.
60
 The 
deflection signal is determined by measuring the differences in the electrical signal produced 
by each quadrant of the photodiode relative to one another. 
 
One of the particular advantages with respect to AFM imaging is that, provided a sample is 
flat, any material may be analysed (Figure 22). Cantilevers are available in a number of 
different shapes and cover a range of different mechanical stiffness. While hard, well defined 
material such as silicon can be imaged at very high resolutions using a stiffer cantilever, 
images of softer material are best obtained using a more flexible cantilever that will follow 
the surface topography more closely. This is particularly useful for the analysis of biological 
material. AFM images of individual strands of DNA were first published in the early 
1990’s.62 
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Figure 22 A typical AFM image, taken in contact mode, of a test grid (Bruker APCS-0099). 
The image is 72 x 72 µm in the x and y axes and the pitch of each repeating unit in the image 
is 9 µm. The scale bar to the right of the image denotes the z axis, indicating that the darker 
areas of the scan represent the higher regions. 
 
Hitherto, the discussion has described a form of AFM imaging referred to as ‘contact mode’, 
where the AFM probe is held in continuous contact with the substrate (Figure 23). This form 
of imaging is ideal for hard samples, and has been used to analyse the surface of electrical 
components and solid-dose pharmaceutical products such as tablets.
63-64
  However, initial 
efforts to obtain images of biological materials via AFM were hampered, despite the 
availability of softer cantilevers, by the delicacy of these substrates.
65
 Given the constant 
force between the AFM probe and the cantilever, questions remained as to whether or not the 
AFM probe was distorting the substrate, yielding a defective image.
62
  
 
Figure 23 An illustration of two different types of AFM imaging, contact mode (left) and 
intermittent-contact (IC) mode (right).
60
 In contact mode the cantilever remains on the 
surface of the sample, whereas in IC mode the cantilever oscillates above the sample. 
 
The solution to this problem is to reduce the force applied by the cantilever to the substrate, 
and even minimize physical contact between the surface and the probe. In ‘tapping mode’ (or 
intermittent contact mode), an oscillating AFM cantilever is held above the surface of the 
substrate.
66
 Changes in the amplitude of the oscillation of the cantilever are monitored as the 
cantilever moves across the surface of a sample, yielding a representation of the sample in 
the same manner as ‘contact mode’. Not only, given the reduced contact between the AFM 
probe and the sample’, is such an approach non-destructive, but other problems associated 
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with contact mode imaging, such as ‘drag’ (where the probe adheres to the substrate), are 
eliminated.
67
 
 
Recent studies have highlighted the capacity of what is essentially a physical analytical 
technique to deliver remarkable insights into molecular interactions at an atomic scale. The 
publication of an AFM image of a series of benzene rings has been followed by work that 
provides images of the various stages of a chemical reaction at a molecular level.
68-69
  
 
Studies that utilize AFM imaging are not limited, however, simply to obtaining pictures of a 
given sample. Quantitative information may also be obtained. With the assistance of 
appropriate computer software, the physical dimensions of features that appear within an 
image may be measured in a number of different ways. For example, by knowing the 
physical dimensions of a particular AFM image, it is possible to determine the area of that 
region that is occupied by an object of interest (Figure 24). By analyzing the relative 
fractions of protein monomers and dimers that were apparent in a series of AFM images, 
Ratcliff et al. were able to determine a dissociation constant for the DNA helicase UvrD.
70
 
 
Figure 24 AFM image, taken in intermittent contact mode, of 33 base pair fragments of DNA 
that have been deposited on mica. The scale bar denotes 500 nm. The histogram provides the 
size distribution of the dark features, in nm
2
, collected from a series of similar images. Each 
individual piece of DNA would have a theoretical area of approximately 22 nm
2
. The area of 
the total AFM scan of 2 x 2 µm is 4 million nm
2
. 
 
The activity of a helicase enzyme, and of DNA intercalators, has also been investigated by 
observing the capacity of these agents to unwind supercoiled plasmid DNA. Agarose gel 
electrophoresis has been used for some time to demonstrate the unwinding of a plasmid, and 
can reveal information about the helix unwinding parameters of a ligand.
19
 The same 
information may be taken from AFM images that also provide a direct visualization of the 
process itself, as the DNA progresses from a compact to a relaxed state.
71-72
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Not only may changes in the tertiary structure of DNA be observed, but also the physical 
dimensions of the secondary structure may be measured. By measuring linear sections of 
DNA (Figure 25), Coury et al. suggested that a diamidine, 2,5-bis(4-amidinophenyl) furan 
(APF), did not bind to DNA via an intercalative mechanism since no increase in the length of 
the DNA strands, a classical indication of intercalation, could be identified.
73
 More recently, 
the activity of luzopeptin and echinomycin have also been studied in the same manner.
74
 
Using measurements of DNA contour lengths, Tseng et al. examined the sequence 
specificities of the DNA bisintercalator echinomycin.
75
 This study confirmed the preference 
of this ligand for CpG steps in DNA by measuring the changes in the length of DNA strands 
relative to the adenine/thymine and guanine/cytosine composition of the DNA.
12, 46
 Similar 
experiments with the bisintercalator luzopeptin also confirmed that AFM was capable of 
distinguishing between DNA before and after binding of a known intercalator.
74
 The study 
with luzopeptin also revealed the formation of complex DNA morphologies at higher 
concentrations of the ligand. The authors attributed these structures to inter-molecular 
binding of the bisintercalator between adjacent DNA strands (Type II intercalation).
33
  
 
Figure 25 AFM image, taken in intermittent contact mode, of 1341 base pair, linear 
fragments of DNA deposited on mica. The scale bar denotes 500 nm. The histogram 
demonstrates the lengths of 9 fragments within the image that have been measured, yielding 
an experimental contour length of 447.9 nm (SE 0.95 nm). The theoretical length of these 
fragments, assuming 0.34 nm per base pair, is 455.9 nm.  
 
Data derived from AFM images of a material are not restricted to the physical dimensions of 
features within the x and y axes of the scan region. The AFM cantilever may also be used to 
provide information about the nature of the material that is being examined. By pressing the 
AFM cantilever into an article of interest within a scan region, it is possible to determine the 
mechanical stiffness of the artefact as a function of the degree to which it resists the applied 
force.
76
 Since an AFM cantilever is effectively a spring, there is a relationship between the 
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force (F) applied to it and the degree to which the spring will extend (x). According to 
Hooke’s law, where k is the spring constant of the cantilever: 
 
F = k * x 
 
This technique has been applied to cancerous cell lines, providing information about the 
structure of cells in a diseased state relative to healthy tissue.
77
 Such information provides 
not only a means of distinguishing between cancerous and healthy cell lines, but also informs 
research into how changes in the regulation of processes within a cell may affect cellular 
structure at a global level. Colonies of bacteria have also been studied in this fashion, 
providing information that may be of use in the development of new antibiotics.
78-79
  
 
Technological developments are now permitting data collected in this fashion to be 
incorporated into the imaging mode of the AFM, a technique referred to as quantitative 
imaging.
80
 By controlling the movement of the AFM in the x and y axes, multiple 
depressions of the cantilever, conducted in series, can be assembled into an image. This 
technique provides a more comprehensive view of the mechanical properties of an entire 
region of a sample, as opposed to the area immediately beneath the AFM probe alone. A 
recent study has utilised this particular form of AFM imaging to study living cells in aqueous 
conditions resembling the cells’ natural environment.81 
 
Modification of the AFM probe permits different kinds of information to be analysed, not 
only the physical topography of a sample. Essentially a refinement of scanning tunnelling 
microscopy, the use of conductive AFM probes can be used to explore the electrical 
characteristics of a material. Using a gold coated cantilever, differences in the electrical 
conductivity of ferritin proteins have been explored, revealing holoferritin, where the protein 
is bound to high levels of iron, to be 5 to 10 times more conductive than apoferritin, the 
protein in its unbound state.
82
  
 
Cantilevers may also be modified to conduct thermal energy. By measuring the energy 
required to maintain a constant temperature within the cantilever, the thermal conductivity of 
a material may be ascertained, although this technique requires careful maintenance of the 
environment surrounding the cantilever.
83
 By applying an increasing temperature to the AFM 
probe, the melting temperature of a material may also be defined.
84
 This technique is 
particularly useful for studying distinct regions within supposedly homogenous materials, 
and has been used to identify different crystalline states of pharmaceutical reagents.
85
 This 
would not be possible, even with sensitive thermal analysis techniques such as modulated 
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differential scanning calorimetry, since information applies to all the material within a bulk 
sample.  
 
 
Figure 26 Typical force extension curve from a force spectroscopy experiment, representing 
the distance of the cantilever from the substrate (x axis) against any applied force (y axis). 
The extend portion (black line) represents the initial approach of the cantilever towards the 
substrate. The negative deflection in this line between 0 and 25 nm illustrates the force 
exerted on the cantilever as it strikes the opposing surface of the substrate. The retract 
portion (red line) represents the withdrawal of the cantilever from the substrate. The 
deflection between 25 and 75 nm is attributable to the stretching of an artefact that has 
adhered itself to the cantilever. This resistance is overcome at a force of c. 300 pN, 
whereupon the cantilever returns to its normal retract cycle. The gradient of the retract curve 
at the point of rupture is proportional to the rate at which the rupture force was applied 
(critical loading rate). 
 
The deflection of the cantilever in the z axis can provide a great deal of information about the 
forces applied to the cantilever (Figure 26). Knowing the mechanical properties of the 
cantilever, it becomes possible to examine the kinetic properties of the interaction to which a 
force is applied by the cantilever.
86
 Conceptually, understanding the relationships between 
bond strength and loading rates is not straightforward. In simple terms, the lifetime of a 
chemical bond is reduced when a force is applied directly to it, in this case the pulling force 
of the AFM cantilever. Higher forces reduce the thermal activation energy required to break 
the bond, accelerating the rate of bond dissociation. Over a range of loading rates, a 
relationship may be discerned between the force required to break the bond that is being 
stretched, and the rate at which that force was applied. This concept has been described in 
detail by various authors, but is commonly referred to as the Bell-Evans model.
87-88
 Typical 
force spectra are divided into two primary regimes, at low rates an equilibrium regime 
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characterised by a finite force and at higher rates a kinetic regime where the force increases 
in a linear fashion relative to the logarithm of the rate.
89
 
 
This concept was first demonstrated in a paper published by Merkel et al., where the authors 
investigated the interaction between streptavidin and biotin.
90
 By varying the rate at which a 
force was applied to the bonds formed between these two molecules, the authors were able to 
deduce parameters such as the thermal off rate, koff, and the distance to the energy barrier, xt, 
from an understanding of the kinetic landscape of the interaction provided by the deflection 
of the AFM cantilever.  
 
Dynamic force spectroscopy, utilising the apparatus of the AFM instrument, has been 
utilised to investigate many other binding mechanisms.
91-95
 The elasticity of DNA has been 
studied extensively using this technique.
96-97
 A common experiment, where a ssDNA 
anchored to a substrate is annealed in situ with its complementary strand attached to the 
AFM cantilever, has been used to follow the stretching and final separation of the two 
annealed strands of DNA.
98
 Studies of this kind have revealed stages in this process, with 
DNA now known to undergo a transition from the canonical B form to an overstretched state 
approximately twice the length of the original molecule. It has even been possible to deduce 
an energy cost for this process, typically estimated to be in the region of 14 kcal / mol.
98
 
 
A similar experiment, of particular interest to this study, investigated the binding of 9-
aminoacridine to dsDNA.
99
 By attaching the amine functionality of the ligand to the AFM 
prove via a PEG tether, the authors were able to measure the force required to remove the 
monointercalator from DNA attached to the opposing substrate. The authors of this study 
postulated that two separate mechanisms were occurring during the process of intercalation, 
attributable to different regimes within the kinetic landscape of the dynamic force spectrum 
that they obtained. 
 
By attaching DNA to both the AFM probe and the substrate, Lyubchenko et al. were able to 
eliminate the effects that directly anchoring the ligand may have on its binding behaviour.
100
 
This study provided information about the binding preferences of the restriction enzyme SfiI. 
By introducing the enzyme, freely in solution, into the liquid cell of the AFM, the authors 
monitored the behaviour of the enzyme where binding had coterminously occurred to DNA 
strands on the cantilever and the substrate. This revealed differences in the forces required to 
separate the enzyme/DNA complex relative to the known binding preferences of the enzyme 
for different nucleotide sequences. 
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An understanding of the forces required to overcome certain interactions may permit 
characterisation of these interactions relative to known standards. It has been suggested that 
force spectroscopy could be used as a method for sequencing peptides.
101-102
 If the forces 
required to move a cyclodextrin ring attached to the cantilever along a peptide chain are 
known, fluctuations in these forces may be attributed to known variations in the resistance 
provided by different regions within the peptide sequence. 
 
The sensitivity of the AFM, in its ability to visualise molecular structures at an atomic 
resolution and directly manipulate single chemical bonds, makes this technique a valuable 
tool for any researcher. Similarly, the versatility of the AFM apparatus, with modification of 
the AFM probe relatively straightforward and with an array of different functionalities, 
means that the principles behind AFM may be readily applied to many different 
experimental scenarios. This does not mean to say that AFM precludes other analytical 
techniques. However, the volume of published research that incorporates AFM, alongside 
data from other methods, indicates that it is an increasingly important tool in scientific 
research.  
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Chapter 3 – Intra-molecular intercalation 
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Introduction 
As discussed in Chapter 1, the mechanism of DNA intercalation by a variety of ligands has 
been investigated in considerable detail. Using the imaging facilities of AFM, supported by 
several other techniques, the intention of this Chapter is to investigate the DNA binding 
behaviour of the acridine compounds described in Chapter 1, with a view to enhancing our 
understanding of their mode of action. Full methods for each of the experiments described in 
this Chapter are provided in Chapter 7. 
 
These particular experiments will concentrate on intramolecular mechanisms of intercalation 
(Type I), using well defined intercalators such as echinomycin, doxorubicin and 9-
aminoacridine as models with which to compare the activity of the bisacridines. Data 
indicative of inter-molecular binding (Type II) will be considered briefly but examined in 
more detail in Chapter 4. 
 
Despite the potent cytotoxicity of bisacridines in vivo, these compounds are not utilised 
clinically. Recently, an acridine based poison of the enzymes topoisomerase I and II was 
withdrawn from phase II clinical trials due to a lack of efficacy.
103-104
 Greater understanding 
of the binding mechanism of these ligands, at the individual molecule resolution afforded by 
AFM, may facilitate the development of new bisacridines that find employment in vivo.  
 
Agarose gel electrophoresis plasmid DNA unwinding assays 
DNA intercalation is commonly associated with two changes in the physical characteristics 
of DNA. First, a DNA duplex is assumed to lengthen in order to accommodate the binding 
chromophore. Second, the separation of two base pairs, necessary to provide a hydrophobic 
pocket into which an intercalating chromophore might bind, results in an unwinding of the 
DNA helix.
28
 In the case of a plasmid DNA, such a change in torsional stress is evidenced by 
an unwinding of the supercoiled plasmid into a fully relaxed state. Using agarose gel 
electrophoresis, the capacity of several intercalators to unwind a plasmid DNA was tested. 
 
A 5386 base pair plasmid DNA (2 µl), φX174 RFI, was diluted in 70 µl of tris buffer. Eight, 
9 µl aliquots were taken from this solution, to seven of which were added 1 µl of relevant 
concentrations of a particular ligand and to the eighth 1 µl of DMSO or water as a control. 
This yielded a final volume per sample of 10 µl and a DNA concentration of 7.1 nM. After 
an incubation period of 1 hour at room temperature, samples were transferred to a 1% 
agarose gel and separated via electrophoresis. The gel was stained with ethidium bromide 
and visualised under UV light.  
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Figure 27 Agarose gel plasmid DNA unwinding assay (DNA concentration 7.1 nM), 
showing the unwinding of the plasmid DNA as the concentration of the ligand is increased. 
From lanes 1 to 8, stock concentrations of echinomycin (µM) are 0, 0.01, 0.1, 1, 10, 100, 500 
and 1000. This corresponds to a ligand to base pair ratio of 0, 0.00003, 0.0003, 0.0026, 
0.026, 0.26, 1.3 and 2.6. 
 
Gel electrophoresis has been utilised to visualise the unwinding process with a large number 
of compounds.
105-106
 Due to the topological characteristics of DNA, unwinding of the duplex 
at each intercalation site progressively induces left-handed supercoiling as the binding 
density increases, reflected in the reduced electrophoretic mobility of a plasmid DNA.
9
 At a 
binding level where the number of right-handed supercoils is balanced by the number of left-
handed supercoils, the superhelix density is considered to be at equivalence between the two 
species. Since the degree of helical unwinding required to reach this point of equivalence is a 
constant value, the helix unwinding parameter of any ligand may be determined relevant to 
that of the known monointercalator ethidium bromide, the helix unwinding angle of which is 
known independently to be 26°.
9
 
 
Figure 27 shows a typical assay of this kind, illustrating the effects of the bisintercalator, 
echinomycin on supercoiled, plasmid DNA. At low concentrations, from lanes 2 to 4 of the 
gel, little change is observed in the electrophoretic mobility of the DNA (negative 
supercoiling). Between lanes 4 and 5, at ligand to base pair ratios between 0.0026 and 0.026 
(or 1:384 and 1:38.4) the DNA is observed to enter a relaxed state, where the supercoiling 
has been removed. From lanes 5 to 6, the relaxed DNA undergoes positive supercoiling at 
ligand to DNA ratios between 0.026 and 0.26, at which point no further changes in the 
mobility of the DNA are observed.  
 
An identical experiment was conducted with the monointercalator doxorubicin (Figure 28). 
In this case, unwinding of the DNA is not discernible until ligand to base pair ratios of 
between 0.026 and 0.26. Although the range of concentrations utilised in this assay prohibits 
any definitive conclusions being drawn from such an observation, this may be explained in a 
number of ways. First, the degree of unwinding per molecule of echinomycin is twice that of 
a monointercalator such as doxorubicin, with reported helix unwinding angles for 
quinoxaline antibiotics being in the range of 44 to 50°. Second, during the process of 
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electrophoresis a proportion of the bound ligand will dissociate from the DNA. Since the 
affinity of echinomycin for DNA is greater than that of doxorubicin, this may lead to 
unwinding apparently occurring at lower ligand to base pair ratios for echinomycin than for 
doxorubicin. Thirdly, apparent ligand to base pair ratios at which unwinding is evident may 
reflect the DNA sequence specificities of each ligand. The plasmid φX174 contains 5386 
base pairs (2693 potential intercalation sites), and its GC content is approximately 44 %. 
 
 
Figure 28 Agarose gel plasmid DNA unwinding assay of doxorubicin (DNA concentration 
7.1 nM) showing the unwinding of the plasmid DNA as the concentration of the ligand is 
increased. From lanes 1 to 8, stock ligand concentrations (µM) are 0, 0.01, 0.1, 1, 10, 100, 
500 and 1000. This corresponds to a ligand to base pair ratio of 0, 0, 0.0003, 0.0026, 0.026, 
0.26, 1.3 and 2.6. The secondary band apparent in lanes 2 to 4 is a small amount of nicked 
plasmid DNA that was known to be present in the stock solution that was used for all these 
experiments. 
 
Although increased ligand concentrations result in reversed supercoiling, and therefore a 
higher electrophoretic mobility, movement of the DNA through the gel remains less than that 
of the untreated DNA (see Figure 27, lanes 6 to 8). This is due to the increased contour 
length of the intercalated DNA, and reaches a plateau, suggesting saturation of the DNA 
with the ligand.  
 
Figure 29 shows a typical unwinding assay of an acridine bisintercalator, bisacridine 2. The 
appearance of the gel is very similar to that obtained using echinomycin. The DNA may be 
observed to reach a relaxed state at concentrations of bisacridine 2 between 20 and 50 µM, 
corresponding to ligand to base pair ratios between 0.052 and 0.13. Saturation of the DNA 
with the ligand subsequently occurs at ratios between 0.13 and 0.26. A study by Wakelin et 
al. using the same ligand but a different plasmid DNA found that the DNA entered a relaxed 
state at ligand to base pair ratios of between 0.08 and 0.13, consistent with these results.
19
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Figure 29 An agarose gel plasmid DNA unwinding assay, illustrating the binding of 
bisacridine 2 (DNA concentration 7.1 nM). From lanes 1 to 8 concentrations of the 
bisacridine are (µM) 0, 10, 20, 50, 100, 200, 500, and 1000. This corresponds to ligand to 
base pair ratios of 0, 0.026, 0.052, 0.13, 0.26, 0.52, 1.3 and 2.6. 
 
Bisacridine 3 was also assessed for its capacity to unwind supercoiling in plasmid DNA 
(Figure 30). Given the rigidity of the inter-chromophore linker in this compound, there has 
been speculation as to whether the compound is able to adopt a bisintercalative Type I 
binding arrangement, or simply functions as a monointercalator, with one chromophore 
either binding to an adjacent DNA strand or remaining unbound. As may be discerned from 
Figure 30, the behaviour of this compound with respect to the unwinding of DNA 
supercoiling is very similar to that of bisacridine 2, a known Type I bisintercalator. However, 
at high concentrations of bisacridine 3 (exceeding ligand to base pair ratios of 1:4), there was 
a noticeable reduction in the intensity of the DNA bands. This is conceivably due to a degree 
of inter-molecular binding, causing some of the DNA to precipitate during sample 
incubation. 
 
 
Figure 30 Plasmid unwinding assay of bisacridine 3 (DNA concentration 7.1 nM) showing 
the unwinding of the plasmid DNA as the concentration of the ligand is increased. From 
lanes 1 to 8 concentrations of the bisacridine are (µM) 0, 10, 20, 50, 100, 200, 500, and 
1000. This corresponds to ligand to base pair ratios of 0, 0.026, 0.052, 0.13, 0.26, 0.52, 1.3 
and 2.6. 
 
Imaging single molecules of DNA using AFM 
As discussed, two common indicators of DNA intercalation are the unwinding of DNA 
supercoiling, and the extension in length of the DNA strands themselves. Having ascertained 
the ability of bisacridines 2 and 3 to unwind the supercoiling of plasmid DNA, it remained 
necessary to test whether or not these compounds also cause a lengthening in DNA 
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sequences. Figure 31 shows the appearance of a single molecule of the plasmid DNA φX174 
RF I that was utilised in the gel unwinding assays. This image was obtained via AFM 
imaging in air using tapping-mode. Although theoretically the length of this plasmid may be 
determined, it is far more straightforward, and accurate, to measure shorter, linear sections of 
DNA. 
 
 
Figure 31 AFM image of the plasmid DNA, φX174 RF I, utilised in the previous gel 
unwinding assays. The scan size is 1 x 1 microns. 
 
Restriction of φX174 RFI with the enzyme BfaI yielded a 771 base pair fragment of linear 
DNA, approximately 262 nm in length, which was ideal for obtaining reliable contour 
lengths. An AFM image of these linear fragments is provided in Figure 32, along with 
measurements of the length of these strands. To provide samples for AFM imaging, the 
solution of 771 base pair DNA was diluted to a concentration of 4.7 ng/µl. A volume of 5 µl 
of this solution was added to 5 µl of Nanopure™ water. A further 15 µl of water, or the same 
volume of a ligand, was then added to the DNA solution yielding a final volume of 25 µl, in 
which the concentration of the DNA was 1.9 nM. 25 µl of 10 mM MgCl2 were subsequently 
added (to provide a positive counterion between the negatively charged DNA and the 
negatively charged surface of the mica substrate) and the complete volume of 50 µl was 
deposited on freshly cleaved mica and air dried under nitrogen. The mica, mounted on steel 
pucks, was mounted in the AFM ready for imaging. 
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Figure 32 AFM image of the linear, 771 base pair fragment of DNA used in these 
experiments. The bar denotes the scale (500 nm). A mean average of 257.8 nm and standard 
error of 1.6 nm were derived from fitting of a gaussian distribution to the histogram (n 119). 
 
The data presented in Figure 32 were compiled using two separate sets of data, obtained 
from different AFM samples of the DNA. Table 2 and Figure 33 illustrate the reproducibility 
of this technique, with the mean contour length of the different samples differing by only 3 
nm.   
 
Table 2 Measurements of DNA lengths, taken from various AFM images. Irrespective of the 
different number of measurements taken from each sample, the average length of the DNA 
strands was in good agreement with one another. 
Sample Mean contour length / nm (SE) n (number of strands) 
Mica sample 1 255.4 (2.2) 70 
Mica sample 2 258.4 (2.6) 49 
 
 
Figure 33 Histograms of contour lengths for each of the two DNA samples reported in Table 
2, showing sample 1 (left) and sample 2 (right). Despite the lower number of measurements 
in the second histogram (right) the central tendency of each population is the same. 
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Although each sample had been prepared at a different time, and measurements taken 
independently, there was a good correlation between the mean contour lengths of each 
sample. Typical standard error for each sample was approximately 1% of the measured 
strand length.  
 
Interpretation of histograms such as these is not always straightforward. Parametric testing of 
data assumes a normal, or gaussian, distribution of the data points. In the case of the second 
DNA control, illustrated by the right hand histogram in Figure 33, it could be argued that the 
distribution is in fact bimodal, that is to say that the data contains two overlapping 
populations, each with its own central tendency. Although a bimodal distribution may be 
described, there is no mathematical test to determine whether or not a distribution of data is 
in fact bimodal.
107
 However, a data set may be tested to ascertain whether the distribution is 
either unimodal (i.e. normal) or multimodal.
108
 Two tests for normality in a data set are the 
Shapiro-Wilk test and a modified version of the Kolmogorov-Smirnov test. Applying these 
tests to the histograms in Figure 34 using Origin Pro™ (OriginLab, ver. 8.0724) leads to the 
conclusion that both data sets are normally distributed (i.e. p > 0.05). 
 
An important factor in the appearance of a histogram is the chosen bin width, into which the 
data are subdivided. A typical formula for suggesting the appropriate bin widths (k) 
expresses this as a function of the number of data points within a sample (n): 
 
k =  n 
 
Unfortunately, even where the bin widths of individual histograms are adjusted in this 
fashion, the elucidation of quantitative information from any histogram remains subjective. 
Certainly, it is difficult to draw meaningful conclusions about differences between different 
sets of data on the basis of their respective histograms alone.  
 
A more reliable and consistent technique, for expressing the central tendency and standard 
deviation of data points within a data set is that of non-linear regression. The computer 
software used in these studies for statistical analysis, Origin Pro™ (OriginLab, ver. 8.0724), 
uses the Levenberg-Marquardt algorithm in curve fitting, also referred to as the damped 
least-squares method.
109
 Simply, this algorithm estimates those parameters (such as the width 
of the gaussian peak) that would minimize the deviation of the theoretical gaussian curve 
from the experimental data. Adjusted R
2
 values for the two gaussian fits presented in Figure 
33 were 0.89 and 0.83, theoretically indicating that between 80 and 90 % of the data could 
be explained by the gaussian model. 
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However, the value of adjusted R
2
 values in non-linear regression has recently been 
questioned.
110
 In the context of these experiments, it should be noted that the R
2
 value of the 
gaussian fitting in Figure 32 (n 119) was 0.89, whilst that of the distribution in Figure 25 (n 
9) was 0.88. A more practical means of assessing the validity of the mean averages derived 
from gaussian fitting of these populations may be conducted by comparing these values to 
the median and arithmetic mean (sum total / n) averages of each population. 
 
Table 3 Comparison of the gaussian mean (derived from fitting of gaussian curves to the 
data) and arithmetic mean (the sum total of the data divided by n) with the median average of 
the data presented in Figure 33. IQ stands for interquartile. The close correlation of all these 
averages (all within the SE) demonstrates that the data is normally distributed. 
Sample Gaussian mean (SE) Arithmetic mean (SE) Median (IQ range) 
Mica sample 1 255.4 (2.2) 255.4 (2.2) 253.7 (24.5) 
Mica sample 2 258.4 (2.6) 258.4 (2.6) 258.8 (23.5) 
 
The excellent correlation of the gaussian mean with the arithmetic mean in the case of each 
separate mica sample demonstrates both the robustness and the appropriateness of the 
statistical analyses applied to these data sets despite the 6 % difference in their respective R
2
 
values of 0.89 and 0.83. The close correlation of the median with the arithmetic mean 
(within the standard error of the mean) provides further evidence that the data is normally 
distributed and not skewed. 
 
A similar experiment was conducted to ascertain the reproducibility of measurements 
derived from DNA fragments treated with a ligand, the monointercalator 9-aminoacridine, at 
a concentration of 2 µM. After the addition of the ligand, the aqueous sample was allowed to 
incubate for one hour at room temperature. As for the DNA control, measurements were 
obtained from two separately prepared mica samples. Table 4 and Figure 34 provide a 
summary of these measurements, and as for the DNA controls, both measurements are 
virtually identical to one another and show a slight increase in the length of the strands 
relative to control (257.8 nm), as may be expected following binding of the intercalator. 
 
Table 4 A comparison of the measured lengths of two separate samples of the linear DNA 
fragment after the addition of 2 µM 9-aminoacridine. There is a slight increase in DNA 
length relative to the control (257.8 nm). 
Sample Mean contour length / nm (SE) n (number of strands) 
Mica sample 1 269.5 (2.9) 66 
Mica sample 2 267.0 (3.1) 37 
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Figure 34 Histograms of contour lengths for the two DNA samples bound to 2 µM 9-
aminoacridine reported in Table 4 (DNA concentration 1.9 nM), showing sample 1 (left) and 
sample 2 (right). Despite the larger number of measurements taken for sample 1, there is no 
significant change in the central tendency or distribution of measurements between the two 
samples. 
 
Overall, these initial imaging experiments confirm the ability of AFM to resolve individual 
molecules of DNA at nanometer resolutions. Measurements derived from this technique are 
reproducible, demonstrated by the excellent correlation between sets of measurements 
derived from separately prepared samples of the same materials. This technique will be 
exploited further to follow the changes that occur in the physical characteristics of DNA 
following ligand binding over a range of ligand concentrations. 
 
Studying ligand induced changes in DNA structure using AFM 
As discussed in Chapter 2, AFM has already been utilised to investigate any changes that 
occur in the physical characteristics of individual DNA strands following ligand binding. 
The activity of several DNA intercalators, such as echinomycin and luzopeptin, has been 
studied using this technique.
73, 75
  
 
Our preliminary studies focused on two well characterised intercalating agents, the 
bisintercalator echinomycin and the monointercalator doxorubicin. The purpose of these 
experiments was twofold. First, to ascertain whether or not the AFM protocol that had been 
adopted was sufficiently sensitive to measure the kinds of change in DNA contour length 
that might accompany binding of these ligands. Second, to establish if data derived from 
these experiments were sufficient to distinguish between the behaviors of two different 
ligands.  
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Figure 35 An AFM image of linear DNA fragments treated with 0.1% DMSO, and the 
corresponding histogram showing the lengths of these fragments. The scale bar denotes 500 
nm. This reflects a very slight contraction relative to the aqueous control, but this is not 
statistically significant since each value is within the SE. 
 
Although a control population of DNA had been defined in aqueous solution, the poor 
solubility of echinomycin in water necessitated the preparation of another control solution 
which included a small amount of DMSO (Figure 35).
75
 DMSO is known to cause a slight 
shortening of DNA, even at low concentrations. This process was not necessary for 
doxorubicin, due to its greater solubility in aqueous media. To prepare this particular sample, 
15 µl of an aqueous solution of 0.1% DMSO was added to the 10 µl solution of 771 base 
pair DNA (2.35 ng/µl), and the sample imaged via AFM as previously described. 
 
Table 5 Comparison of DNA in aqueous solution and an aqueous solution of 0.1% DMSO. 
Although there is no significant difference between the mean values, changes in DNA length 
observed with echinomycin were considered relative to the value of 255.6 nm, and 256.9 nm 
for doxorubicin. 
Sample Mean contour length / nm (SE) n (number of measured strands) 
DNA (aqueous) 256.9 (2.6) 119 
DNA (0.1% DMSO) 255.6 (2.6) 48 
 
Table 5 shows the different lengths of DNA in an aqueous environment and in a solution of 
0.1% DMSO. An expected shortening of the DNA in the presence of DMSO was not 
observed, likely due to the very low concentration of DMSO. Nevertheless, measurements 
for DNA bound to echinomycin will be considered relative to the DNA solution containing 
0.1% DMSO, while aqueous ligands such as doxorubicin will be considered relative to the 
DNA in aqueous solution. 
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The contour length of linear DNA fragments has been shown to increase on the addition of 
echinomycin and doxorubicin, not only using AFM but other techniques such as gel 
electrophoresis and solution viscometry.
28, 111
 Ideally, similar changes in DNA contour length 
would be observed when following our own AFM protocol. Both ligands share a preference 
for GC rich regions of DNA,
8
 and as such the number of available binding sites within the 
DNA strand should be similar for each compound. Theoretically, saturation of the available 
binding sites should occur at a lower ratio of ligand to base pairs in the case of the 
bisintercalator than that of the monointercalator. 
 
In order to preserve the same ratio of ligand to base pair ratios that were used during the 
plasmid unwinding assays, it was necessary to reduce the absolute concentration of the 
ligands since the concentration of the DNA utilised for the AFM experiments was lower than 
that used for gel electrophoresis (1.9 nM versus 7.1 nM). The affinity of any ligand for a 
receptor is defined by the dissociation constant (Kd) of that ligand, typically expressed as the 
concentration of the ligand at which 50 % of the ligand is bound to available binding sites. 
The lower the concentration at which this equilibrium occurs, the greater the affinity of the 
ligand for the receptor. The monointercalator 9-amino acridine has a dissociation constant in 
the region of 5 µM, whilst values for echinomycin and TANDEM range from 100 nM to 5 
µM depending on the DNA sequence to which they are binding.
9
 Dissociation constants for 
bisacridines are typically 10 to 15 times lower than 9-amino acridine, at approximately 100 
nM. Theoretically, at ligand concentrations less than the corresponding Kd of the ligand, 
binding will be occurring at less than 50 % of the available binding sites even where ligand 
to DNA base pair ratios are preserved, rendering analysis of any data difficult. However, the 
ligand concentrations used in these studies cover a similar range to those used elsewhere.
19
 
Moreover, the correlation between results of the plasmid unwinding assays and AFM 
contour length assay described below, both suggesting that bisintercalator binding peaks at 
ligand to base pair ratios in the region of 0.25, suggest that the low initial ligand 
concentrations were not adversely affected by the dissociation kinetics. This observation is 
supported by CD experiments described later in this chapter, where significantly higher 
ligand concentrations were used (c. 3 mM) over an identical range of ligand to base pair 
ratios. 
 
Data obtained for doxorubicin are presented in Figure 36 and Table 6, while data obtained 
for echinomycin are presented in Figure 37 and Table 7. Changes in the measured contour 
length of linear DNA fragments as a function of the increasing concentration of each 
intercalator are shown in Figure 38. For all the ligands studied herein, an exponential fit was 
applied to the data. There is a significant increase in DNA length on addition of either 
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ligand, which reaches a plateau where no further increase in the length of the DNA is 
observed. The change in contour length that may be derived from this plateau is 
approximately the same for both echinomycin and doxorubicin. However, saturation of the 
DNA occurs at a lower ratio of ligand to base pairs with the bisintercalator.  
 
 
Figure 36 (above) AFM images of DNA bound to doxorubicin (DNA concentration 1.9 nM). 
The concentration of the ligand is shown in the figure. Scale bars denote 500 nm (below) 
Histograms of the lengths of the DNA within each image, showing the distributions of 
measured lengths and the gaussian fitting of the data. 
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Table 6 Mean lengths of each population of DNA strands relative to the concentration of 
doxorubicin. These results indicate a progressive lengthening of the DNA when the ligand 
concentration is increased. 
Concentration / nM Ligand to BP ratio Mean length / nm SE / nm n 
0 0.000 257.8 1.6 119 
200 0.079 270.1 2.4 31 
500 0.197 276.6 2.0 48 
1000 0.394 292.7 1.0 33 
1500 0.591 290.7 2.7 32 
2000 0.789 287.3 1.0 53 
 
 
Figure 37 (above) AFM images of DNA bound to echinomycin (DNA concentration 1.9 
nM). The concentration of the ligand is shown in the figure. Scale bars denote 500 nm 
(below) Histograms of the lengths of the DNA within each image, showing the distributions 
of measured lengths and the gaussian fitting of the data. 
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Table 7 Mean lengths of each population of DNA strands relative to the concentration of 
echinomycin. These results indicate a progressive lengthening of the DNA when the ligand 
concentration is increased. 
Concentration / nM Ligand to BP ratio Mean length / nm SE / nm n 
0 0.000 256.4 1.6 48 
100 0.039 268.5 1.9 46 
250 0.099 271.3 1.4 41 
500 0.197 284.0 0.9 77 
750 0.296 291.1 2.4 50 
1500 0.591 295.0 1.3 61 
2000 0.789 287.7 1.6 48 
 
 
Figure 38 Plots of % change in DNA contour length versus ligand concentration (as a 
function of the ratio of ligand molecules to DNA base pairs) for echinomycin (left) and 
doxorubicin (right), using an exponential fit. The trend reflects a progressive increase in 
DNA length followed by a plateau. In both cases, increases in DNA length plateau at 
between 12 and 14%. 
 
The presentation of data of this kind has been examined in detail. Early studies of 
intercalation made extensive use of viscometry, where the intercalator was bound to 
sonicated DNA fragments.
112
 These experiments deduced a linear relationship between 
binding of an intercalator and the associated increase in the contour length of the DNA, 
accompanied by a slight curvature in the scatchard plots at high ligand concentrations.
28
 
Classically, non-linearity in Scatchard plots has been interpreted as being indicative of 
cooperative processes. After this initial increase in the length of the DNA, there is a plateau 
in the length of the DNA, despite further increases in ligand concentration. This suggests that 
at these higher ligand concentrations, the DNA is saturated with the ligand and no further 
binding is occurring. 
 
Unfortunately, the simple ligand receptor model on which these assumptions were originally 
based may not be suitable for the complexities of intercalation, especially in the case of a 
0.0 0.2 0.4 0.6 0.8 1.0
0
2
4
6
8
10
12
14
16
18
20
0.0 0.2 0.4 0.6 0.8 1.0
0
2
4
6
8
10
12
14
16
18
20
%
 c
h
a
n
g
e
 i
n
 D
N
A
 c
o
n
to
u
r 
le
n
g
th
Ratio (ligand / base pairs)
%
 c
h
a
n
g
e
 i
n
 D
N
A
 c
o
n
to
u
r 
le
n
g
th
Ratio (ligand / base pairs)
Chapter 3 
51 
 
bisintercalator where one molecule is, in effect, binding conterminously to two separate 
receptors.
113
 Although some recent studies have suggested a degree of cooperativity in some 
localized intercalation complexes, the consensus of opinion is that globally, intercalation is a 
non-cooperative process.
114
  As such, initial binding of echinomycin and doxorubicin to 
DNA may be considered to be a linear process, where saturation is governed by the 
availability of energetically favourable sites for intercalation. This is demonstrated in Figure 
39.  
 
Figure 39 Plots of % change in DNA contour length versus ligand concentration (as per 
Figure 38), showing the increase in DNA length up to the point at which saturation occurs. 
As may be expected, the gradient of the line of echinomycin is greater than that of 
doxorubicin, suggesting that bisintercalation is occurring.  
 
Linear regression was conducted using Origin Pro™, yielding a gradient for the slope where 
the intercept of the x and y axes was assumed to be zero. The gradient of the slope and the 
degree of confidence in the fitting of the linear model for each ligand are provided in Table 
8.  
 
Table 8 Values for the relationship between ligand concentration and the increase in DNA 
length for echinomycin and doxorubicin, showing that the trend for each ligand is 
significantly different to the other. 
 Ligand Gradient (x/y) SE  R
2
 
Echinomycin 55.4 3.3 0.99 
Doxorubicin 34.7 1.2 0.99 
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A comparison of the data derived from Figure 38 and Figure 39 is provided in Table 9. The 
ratio of ligand molecules to DNA base pairs at which saturation is reached was calculated by 
taking the gradient of the line for the appropriate compound from Figure 39 and the value of 
the y axis at saturation from Figure 38 where, 
 
y = mx + c 
 
Table 9 Comparison of the changes in DNA contour length observed with echinomycin and 
doxorubicin and the relative number of DNA base pairs per ligand molecule. Although this 
highlights a difference in the ligand to base pair ratio at which the DNA ceases to increase in 
length, this could reflect a number of factors, such as each ligand’s precise sequence 
selectivity and relative binding affinity for DNA. 
Ligand % change at 
saturation (SE) 
Ligand : BP ratio 
at saturation 
Base pairs per 
ligand molecule 
Echinomycin 14.20 (1.05) 0.26 3.85 
Doxorubicin 12.66 (1.24) 0.37 2.70 
 
Given the similar sequence selectivities of echinomycin and doxorubicin, it is not surprising 
that both compounds cause a similar degree of lengthening of the DNA. The GC content of 
the fragment of DNA utilised in these experiments was 44% of the total number of base 
pairs. Theoretically, this should yield a 22% increase in the length of a DNA strand, allowing 
for the neighbour exclusion principle, where binding may only occur between alternate base 
pairs. However, estimates of this kind are not particularly helpful. The precise nucleotide 
specificities of any intercalating ligand are very complicated, and the preference of 
echinomycin and doxorubicin for GC rich regions does not preclude binding within AT rich 
regions. Initial binding of an intercalator can occur randomly, and only after a period of 
incubation with the DNA does the intercalator find binding sites from which it dissociates at 
a slower rate.
8
 Intercalation is a reversible, non-covalent interaction between a ligand and 
DNA, and intercalators are known to move or ‘shuffle’ from one binding site to another.9 
Similarly, the arrangement of nucleotides within GC rich regions can also affect ligand 
binding. Echinomycin is known to bind preferentially to the nucleotide step 5’-CpG, 
especially where the flanking base pairs are AT.
45
 Above all, theoretical assumptions 
regarding the change in length of the DNA assume that each intercalation event induces the 
same degree of lengthening within the DNA strand. Although a helix extension of 0.34 nm 
per intercalation event is often assumed, experimentally determined values differ 
considerably
11
 and are strongly dependent on the characteristics of the particular ligand, the 
conformational arrangement of the DNA, and the conditions of the solution in which the 
DNA and the ligand are suspended.
115
 NMR and crystal structures of short DNA sequences 
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may provide precise values for this parameter, but it is likely that in longer DNA stretches, 
the lengthening of the DNA will depend strongly on the composition of the primary 
sequence at the site of intercalation and the degree of ligand binding preceding the point of 
measurement.  
 
Despite these considerations, some general conclusions may be drawn from this initial 
experiment. The overall change in the length of the DNA following intercalation is similar 
for both doxorubicin and echinomycin, but saturation of the DNA with each ligand occurs at 
different ratios of ligand to base pairs, approximately 0.26 for echinomycin and 0.37 for 
doxorubicin. These ratios reveal that the number of molecules in solution at the point at 
which saturation of the DNA is occurring is significantly higher than may be expected if 
binding is only occurring at GC regions, and is likely interpreted in one of two ways. First, 
binding is occurring at sites other than GC regions, in which case the expected rise of 0.34 
nm per intercalation event is not represented by the measured percentage change in the 
length of the DNA strands. Second, that the number of ligand molecules in solution, or rather 
present in the solution of DNA and ligand, is not representative of the concentration of 
ligand bound to the DNA. That a very similar value was obtained from the agarose gel 
unwinding assay with echinomycin (saturation occurring before 0.25 ligands per DNA base 
pair) suggests that the higher than expected ratios are a consequence of several different 
factors, and not due to an irregularity of the AFM imaging experiment itself. In terms of a 
simple equilibrium, the concentration of bound ligand will be determined to some extent by 
the concentration of free ligand that remains in solution. Although, as previously discussed, 
the intercalation of DNA at low ligand concentrations follows a non-cooperative process, at 
high ligand concentrations, where many binding sites are already occupied, competition 
between ligands for the remaining sites may yield a degree of negative cooperativity. This 
phenomenon is evident in Figure 38, where the increase in DNA length slows, relative to 
increases in ligand concentration, as available binding sites become saturated. 
 
Given the known preference of echinomycin for GC rich DNA, it was decided to conduct 
further experiments of this kind using the triostin-A analogue, TANDEM. Since this ligand 
has a preference for AT rich regions of DNA, parameters such as the overall change in the 
length of the DNA fragments observed with this ligand might be different to those observed 
with echinomycin. Like echinomycin, this ligand is also poorly water soluble and stock 
solutions were prepared in DMSO before diluting to an appropriate concentration in 0.1% 
DMSO. Data obtained for TANDEM via AFM imaging are provided in Figure 40. 
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Plots of the overall changes in DNA contour length that were observed at increasing 
concentrations of TANDEM are provided in Figure 41. Relative to echinomycin and 
doxorubicin, the value of the y axis as the change in DNA length reaches a plateau is 
noticeably higher in the case of TANDEM. Given the greater AT content of the DNA 
fragment (56%), this might suggest that the observed changes in DNA contour length for all 
three ligands reflect the sequence specificities of those compounds. A comparison of the 
changes observed for echinomycin and TANDEM is shown in Table 11. 
 
 
Figure 40 (above) AFM images of DNA bound to TANDEM (DNA concentration 1.9 nM). 
The concentration of the ligand is shown in the figure. Scale bars denote 500 nm (below) 
Histograms of the lengths of the DNA within each image, showing the distributions of 
measured lengths and the gaussian fitting of the data. 
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Table 10 Mean lengths of each population of DNA strands relative to the concentration of 
TANDEM. These results indicate a progressive lengthening of the DNA when the ligand 
concentration is increased. 
Concentration / nM Ligand to BP ratio Mean length / nm SE / nm n 
0 0.000 256.4 1.6 48 
100 0.039 261.4 1.6 45 
250 0.099 271.6 0.8 51 
500 0.197 293.7 0.9 51 
1000 0.394 310.0 1.1 50 
2000 0.789 302.8 2.0 60 
 
 
Figure 41 Changes observed in DNA contour length as a function of increasing ligand 
concentration for the bisintercalator TANDEM. An initial increase and subsequent plateau in 
the length of the DNA may be discerned (left) using an exponential fit, while non-
cooperative binding at lower ligand concentrations is demonstrated (right). The gradient of 
the linear portion is 70.5 (x/y), with a SE of 3.4 and an R
2
 value of 0.99. 
 
Table 11 Comparison of overall changes in DNA contour length, and ligand to DNA base 
pair ratios at saturation for echinomycin and TANDEM. The differences between each 
ligand, such as the overall change in the length of the DNA likely reflect several factors, not 
least the different sequence specificities of these ligands. 
Ligand % change at 
saturation (SE) 
Ligand : BP ratio 
at saturation 
Base pairs per 
ligand molecule 
Echinomycin 14.20 (1.05) 0.26 3.85 
TANDEM 22.71 (3.90) 0.32 3.11 
 
As with echinomycin, the expected increase in DNA contour length was not observed for 
TANDEM. Given an AT content of 56%, one could argue that an increase of 28% ought to 
be observed. However, the previous discussion of how the precise arrangement of GC base 
pairs could affect the number of available binding sites remains equally valid for the AT 
component of the DNA strand. Similarly, the slight difference in the ratio of ligand to DNA 
base pairs at saturation that may be discerned between echinomycin and TANDEM, 0.26 and 
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0.32 respectively, could be the consequence of many different factors, and cannot be 
considered to be significant in the context of this particular experiment. In fact, whether or 
not the differences between these two bisintercalators are attributable to their nucleotide 
preferences cannot be ascertained with the available data. Further experiments would need to 
be conducted, varying the nucleotide content of the DNA, before any definite conclusions 
may be drawn. 
 
Despite the limitations of this experiment, some general conclusions may be drawn from 
these initial AFM imaging experiments that apply to all of echinomycin, doxorubicin and 
TANDEM. First, binding of these ligands to DNA induces a lengthening in DNA that may 
be detected by AFM. Lengthening of the DNA was typically in the region of 15 to 20% at 
ligand to base pair ratios of approximately 0.25, after which a plateau was observed in the 
lengthening of the DNA fragments despite further increases in ligand concentration. Second, 
this lengthening process followed a broadly linear, positive regime. 
  
Investigating the binding of bisacridines to DNA using AFM 
The binding of bisacridines to DNA has yet to be thoroughly investigated using AFM. Given 
the findings of the initial experiments with echinomycin and doxorubicin, it was decided to 
examine the acridine compounds described in Chapter 1 in the same manner, in order to 
ascertain whether or not these ligands induce a similar kind of lengthening in the DNA 
fragments. 
 
Unlike echinomycin and TANDEM, where extensive studies have been conducted into their 
respective binding preferences, the specificities of acridine analogues have not been 
characterised definitively. Early studies have suggested that some bisacridines may 
demonstrate a preference for ApT steps under conditions of low ionic strength.
9
  However, 
small changes to the composition of the inter-chromophore linker, such as the addition of a 
nitrogen atom, have been demonstrated to eliminate this slight selectivity.
9
 Conversely, it has 
been suggested that some acridine ligands have a preference for GC rich DNA.
52
 
 
Despite the lack of definite information as to the sequence selectivities of acridine ligands, it 
is not unreasonable to assume that, like echinomycin and TANDEM, these compounds will 
cause a progressive lengthening of DNA strands to which they are bound. The behaviour of 
the acridine ligands as determined by the plasmid DNA unwinding assays conducted earlier 
was certainly very similar to that of echinomycin and TANDEM, the acridine 
bisintercalators also reversing the negative supercoiling of plasmid DNA up to a ligand to 
base pair ratio of approximately 0.25. 
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Figure 42 (above) AFM images of DNA bound to 9-aminoacridine (DNA concentration 1.9 
nM). The concentration of the ligand is shown in the figure. Scale bars denote 500 nm 
(below) Histograms of the lengths of the DNA within each image, showing the distributions 
of measured lengths and the gaussian fitting of the data. 
 
Table 12 Mean lengths of each population of DNA strands relative to the concentration of 9-
aminoacridine. These results show an unexpected contraction in DNA length at 500 nM. 
Concentration / nM Ligand to BP ratio Mean length / nm SE / nm n 
0 0.000 257.8 1.6 119 
200 0.079 251.8 0.7 113 
500 0.197 243.8 0.7 93 
1000 0.394 263.0 1.3 116 
1500 0.591 266.4 0.7 76 
2000 0.789 268.5 1.4 103 
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Figure 43 (above) AFM images of DNA bound to bisacridine 1 (DNA concentration 1.9 
nM). The concentration of the ligand is shown in the figure. Scale bars denote 500 nm 
(below) Histograms of the lengths of the DNA within each image, showing the distributions 
of measured lengths and the gaussian fitting of the data. 
 
Table 13 Mean lengths of each population of DNA strands relative to the concentration of 
bisacridine 1. These results show a similar contraction in DNA length to that observed with 
9-amino acridine. 
Concentration / nM Ligand to BP ratio Mean length / nm SE / nm n 
0 0.000 257.8 1.6 119 
100 0.039 246.8 0.8 99 
250 0.099 238.9 0.7 61 
500 0.197 274.8 1.3 28 
750 0.296 275.7 1.3 64 
1000 0.394 281.5 3.3 24 
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AFM imaging was first conducted using bisacridine 1 and 9-aminoacridine, a 
monointercalator. Data obtained for these two ligands are presented in Figure 42 and Table 
12 for 9-aminoacridine, and Figure 43 and Table 13 for bisacridine 1. The overall changes 
that were observed in the length of DNA bound to increasing concentrations of these two 
compounds are shown in Figure 44. These results are somewhat surprising and reveal a 
contraction in the length of the DNA at low ligand concentrations that precedes lengthening. 
 
 
Figure 44 Comparison of the changes in DNA length observed after addition of increasing 
concentrations of a Bisacridine 1 (left) and 9-aminoacridine (right). Both plots show the 
initial contraction in DNA length that is followed by a progressive lengthening and a plateau. 
 
As discerned from AFM imaging of experiments conducted with echinomycin and 
doxorubicin, there is a difference in the ratio of ligand to base pairs at which the lengthening 
of the DNA begins to plateau, approximately 0.2 for bisacridine 1, and 0.4 for the 
monointercalator. There is also a difference in the length of the DNA strands at which this 
plateau is observed, the length of the DNA strands bound to the bisintercalator being 
approximately 5% greater than those bound to the monointercalator. Given that the acridine 
chromophore in these compounds is identical, it may be that the inert alkyl linker of the 
bisacridine plays a role in determining the binding behaviour of the ligand. 
 
Further studies were conducted using the bisintercalators that incorporated a modification to 
the inter-chromophore linker and a carboxamide substituent at the 4’ position of the acridine. 
The proposed significance of these modifications to the binding mode of the ligand has been 
discussed in Chapter 1. Data for compounds bisacridine 2 and bisacridine 3 are presented in 
Figure 45 and Table 14, and Figure 46 and Table 15 respectively. 
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Figure 45 (above) AFM images of DNA bound to bisacridine 2 (DNA concentration 1.9 
nM). The concentration of the ligand is shown in the figure. Scale bars denote 500 nm 
(below) Histograms of the lengths of the DNA within each image, showing the distributions 
of measured lengths and the gaussian fitting of the data.  
 
Table 14 Mean lengths of each population of DNA strands relative to the concentration of 
bisacridine 2. Measurements were not taken at a concentration of 2500 nM. 
Concentration / nM Ligand to BP ratio Mean length / nm SE / nm n 
0 0.000 257.8 1.6 119 
100 0.039 243.7 1.1 92 
250 0.099 254.9 1.6 58 
500 0.197 269.1 1.3 49 
750 0.296 265.5 1.3 68 
1000 0.394 269.2 0.9 41 
2500 1.037 - - - 
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Figure 46 (above) AFM images of DNA bound to bisacridine 3 (DNA concentration 1.9 
nM). The concentration of the ligand is shown in the figure. Scale bars denote 500 nm 
(below) Histograms of the lengths of the DNA within each image, showing the distributions 
of measured lengths and the gaussian fitting of the data. 
 
Table 15 Mean lengths of each population of DNA strands relative to the concentration of 
bisacridine 3. Measurements were not taken at concentrations greater than 1000 nM. 
Concentration / nM Ligand to BP ratio Mean length / nm SE / nm n 
0 0.000 257.8 1.6 119 
100 0.039 255.2 1.9 34 
250 0.099 249.9 1.6 38 
500 0.197 283.0 3.5 42 
750 0.296 279.5 1.9 52 
1000 0.394 279.2 2.3 31 
5000 2.075 - - - 
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The results obtained with these acridines are provided in Figure 47. Addition of bisacridine 2 
resulted in a significant contraction of the DNA at very low concentrations of the ligand, 
whereas the addition of bisacridine 3 produced a less marked shortening of the DNA, 
followed by a degree of lengthening at higher concentrations. These findings were broadly 
comparable to those made with bisacridine 1 and 9-aminoacridine, with subtle variations in 
behaviour between each ligand likely reflecting the slightly different structural chemistry of 
each compound.  
 
 
Figure 47 Comparison of the changes in contour length of DNA observed on addition of 
increasing concentrations of bisacridine 2 (left) and bisacridine 3 (right). As with 9-amino 
acridine and bisacridine 1, the initial contraction in the DNA gives way to a progressive 
lengthening and a plateau. 
 
The changes observed with these acridine compounds are exceptionally difficult to compare, 
since there is no pharmacological model that describes the relationship between a contraction 
of the DNA and the corresponding increase in contour length due to intercalation of the 
acridine chromophore. Certainly the conventional approach of McGhee and von Hippel may 
not be applied directly to the data presented in Figure 44 and Figure 47. Although 
discrepancies between observed changes in DNA length and those calculated by theoretical 
approximation could be explained previously by differences in the helix extension 
parameters of echinomycin, doxorubicin and TANDEM from the classical value of 0.34 nm, 
the changes observed on binding of the acridines must incorporate a deformation of the DNA 
duplex. Localised changes in base stacking arrangements have been observed at intercalation 
sites with many different ligands.
8
 The existence of Hoogsteen base pairs at some 
echinomycin intercalation sites has already been discussed in Chapter 2. However, given the 
low ratio of ligand to base pairs at which the contraction is occurring, these changes, in the 
case of the acridines at least, must be far more long range than had previously been thought.  
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A crystal structure of 9-aminoacridine, bound to an ApU residue revealed significant 
distortion of the arrangement of the nucleotides.
116
 Although this structure may not be 
directly applicable to DNA since it contains a uracil nucleobase, the authors noted that the 
orientation of the intercalated bases did not conform to accepted structures of RNA. 
 
The first crystal structure of an intercalated DNA complex was published in 1978.
117
 
Although the ligand in this study was a platinum based compound and not an acridine, the 
authors observed that the sugar pucker of the intercalated DNA adopted a similar pattern to 
that of an intercalated RNA complex. A later study of the complex between an analogue of 
proflavin and DNA revealed that the structure of the intercalated DNA complex shared many 
features with A form DNA.
118-119
 
 
Molecular modeling studies have also suggested that acridine chromophores may induce A 
form character in DNA.
120
 The so called ICR model, describing the structure of DNA 
intercalated with proflavin, exhibits many similarities with A form DNA. Here, both major 
and minor grooves of the intercalated DNA are significantly wider than in classical B DNA, 
the minor groove extending from 6 Å in its B form to 9.1 Å when intercalated (11 Å in the A 
form).
121
 A change in the sugar pucker of the DNA was also observed, from C2’ to C3’-
endo, characteristic of A form DNA. Importantly, these changes occurred at low ligand 
concentrations, with the intercalator inducing deformations in the DNA some distance from 
the actual binding site. However, to date this binding model has not been corroborated by 
direct experimental data. 
 
More recently, the existence of DNA in a hybrid A/B form has been demonstrated by Kypr 
et al.
122
 Using a combination of CD and NMR, a DNA sequence where the duplex exhibited 
the physical characteristics of the A conformation was found to retain the C2’-endo pucker 
of the B conformation. Though an alternative arrangement to that described by the ICR 
model, both of these studies highlight the capacity of DNA to undergo transitions between 
conformations that are not described by the canonical categories of A, B and Z.  
 
While the question of DNA conformation cannot be definitively resolved via AFM imaging, 
assuming that the binding of bisacridines to DNA induces a change from a B to an A 
conformation permits the data from Figure 44 and Figure 47 to be presented in a different 
manner. Figure 48 and Table 16 shows a reassessment of Figure 44 and Figure 47 that 
assumes the DNA to be in the A, as opposed to the B, conformation. Obviously such an 
assumption is not without its limitations. Not least, during the process of contraction that 
occurs during binding of low concentrations of a ligand, the DNA is most likely in a range of 
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different conformations. However, at a ratio of 0.1 ligands to base pairs (or 0.2 in the case of 
9-aminoacridine), the extension of the DNA as a consequence of ongoing intercalation 
begins to outweigh any shortening of the DNA that may result from ligand induced 
deformation of the B-duplex.  
 
  
Figure 48 Comparison of changes in DNA length observed with the acridine compounds, 
assuming the DNA to be in the A conformation. Clockwise from top left, bisacridine 1, 9-
aminoacridine, bisacridine 3, bisacridine 2. The poor fit of points at low ligand to base pair 
ratios reflects the likelihood that during contraction, some portions of the DNA remain in a B 
form. The exponential fits suggests a linear increase in strand length followed by the plateau 
at higher ligand concentrations that has been observed for all the ligands in this study. 
 
Looking solely at the shape of the graphs in Figure 48, the assumed change in DNA 
conformation, and importantly, the change in spacing between the base pairs of the primary 
sequence from 0.34 nm to 0.24 nm would appear to resolve the problem of an observed 
contraction in the length of the DNA. However, as previously stated, a range of helix 
extension lengths have been reported for different compounds. That each different acridine 
should extend the DNA helix to the same degree, and bind to the DNA to the same extent, 
seems unlikely. At the same time, contraction of the DNA in itself does not necessarily 
constitute a change in conformation. The historical value of 0.34 nm for the distance 
between adjacent base pairs in the helix is an average value derived from measurements of 
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longer stretches of DNA, where this distance has been shown to range from 0.25 to 0.42 
nm.
8
  
 
Table 16 A comparison of the final observed increase in DNA contour length between the 
different acridines, highlighting the difference in these values when the DNA is assumed to 
enter a different configuration. Increases in strand length for the B form DNA were 
determined by taking a mean average of the length of the strands at ligand concentrations 
exceeding the point of saturation. 
Ligand % change in DNA contour length 
(B Form) (SE) 
% change in DNA contour length 
(A Form) (SE)  
9-aminoacridine 3.17 (0.62) 43.8 (0.9) 
Bisacridine 1 7.57 (0.81) 49.9 (1.1) 
Bisacridine 2 3.91 (0.47) 44.8 (0.7) 
Bisacridine 3 8.82 (0.48) 51.7 (0.7) 
 
Although unable to resolve precise helix extension parameters of individual compounds, 
these experiments have demonstrated AFM imaging to be sufficiently sensitive to distinguish 
between small changes in the length of individual molecules on a nanometer scale. This 
resolution has highlighted a distinction between the behaviour of sequence specific 
intercalators such as echinomycin and TANDEM, and a group of acridine based ligands. 
While echinomycin and TANDEM demonstrate a concentration dependent lengthening of 
the bound DNA that correlates with the particular sequence specificity of the ligand, the 
acridines are all observed to shorten the DNA before causing a slight lengthening at higher 
concentrations. Although this contraction may be explained by extensive deformation of the 
B duplex, leading to a reduction in the usual spacing between the base pairs, this 
interpretation is largely hypothetical and would need to be confirmed by further 
investigations.  
 
It should be noted that the AFM protocol itself is not without limitations. Deposition of DNA 
on mica may, in part, be responsible for a reduction in the expected contour length of DNA 
molecules, although initial experiments into the reproducibility of measurements from AFM 
images of the kind used here would seem to allay this concern. Moreover, no shrinking was 
seen with either echinomycin or doxorubicin, though these compounds were analysed using 
the same surface preparation techniques as the acridines. Previous studies have also observed 
a reduction in the number of DNA molecules that may adhere to mica following binding to a 
ligand.
75
 Although this would not explain a contraction in the length of the DNA, it would 
explain why DNA saturated with a ligand, and therefore (presumably) showing an extensive 
degree of lengthening, would not be observed during imaging since it would not have 
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adhered to the mica surface. The study by Tseng et al. attributed the reduction in DNA 
volume to variations in the GC/AT content of the particular DNA strands that they were 
studying, and in our case was not apparent with echinomycin or doxorubicin. However, there 
was a noticeable reduction in the amount of visible DNA at high concentrations of the 
bisacridines. This was almost certainly a consequence of inter-molecular binding activity 
(Figure 49), since it was not apparent with the monointercalator 9-aminoacridine or 
echinomycin, and may be discerned in the peculiar DNA aggregates observed at high 
concentrations of ligands such as bisacridine 3 (Figure 46). 
 
 
Figure 49 Comparison of the amount of DNA visible on mica at different concentrations of 
the two bisintercalators bisacridine 2 and echinomycin. While the average number of DNA 
strands per µm
2
 stays roughly the same with echinomycin, there is a noticeable drop with the 
bisacridine. 
 
Investigating conformational changes of DNA in air using FTIR 
Although the issue of DNA conformation under the conditions of AFM imaging has been 
extensively discussed,
123-124
 the conundrum of the observed shrinking that had been observed 
following binding of the DNA to acridine intercalators required further investigation. In 
order to ascertain whether or not a conformational change from the B to the A conformation 
could occur under normal laboratory conditions, experiments were conducted using FTIR. 
The change from B to A form DNA that occurs when DNA is allowed to dry has been 
followed at room temperature using FTIR and reported results would suggest that this 
change occurs rapidly.
125
 Using this existing protocol, spectra were obtained for a sample of 
DNA under the same atmospheric conditions as those samples analysed by AFM.  
 
Samples were prepared using CT-DNA (Sigma, UK), at a stock concentration of 1mg/ml. A 
5 µl aliquot of the DNA solution was deposited on the ATR crystal of the FTIR apparatus 
and gradually allowed to dry. Spectra were obtained at 60 second intervals under standard 
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conditions. The FTIR signal was monitored in this way for several hours, with changes in the 
DNA spectra readily apparent after approximately 40 minutes. 
 
Figure 50 FTIR spectra of CT-DNA for both the B-form and the A-form. Deposition of the 
DNA in aqueous solution was followed over a period of time and any peak shifts observed. 
The large band at approximately 3250 cm
-1
 is caused by water. 
 
Figure 50 shows the obtained spectra for CT-DNA. The spectrum of B form DNA 
constitutes the first in the dehydration series and that of the A form after a period of 59 
minutes has elapsed, when the sample has dehydrated to equilibrium with the ambient 
conditions of the laboratory. No further changes in the spectra were observed after this 
period of time. Both spectra closely resemble those reported in the literature, and bands were 
assigned accordingly.
125
 Figure 51 highlights the section of these spectra where differences 
between the A and B conformations are most readily discerned. There is a marked shift in 
the wavenumber of the signal at 1225cm
-1
, indicative of the antisymmetric phosphate group 
in DNA in a B conformation, towards 1238cm
-1
, typical of the A form. Similarly, the 
shoulder at 1185cm
-1
, indicative of the C3’ endo-sugar phosphate of A form DNA, is absent 
from the B form spectrum. As such, a conformational change of the DNA under standard 
laboratory conditions may occur.  
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Figure 51 Enlargement of selected wavenumbers from Figure 50, where differences in the 
FTIR spectra of A and B DNA may be discerned, particularly the position of the peak around 
1320 cm
-1
 and the shoulder at 1185cm
-1
. 
 
Although samples were freshly prepared and used immediately, the results of the FTIR 
measurements necessitated the further investigation of the stability of the DNA samples. 
Table 17 shows a comparison between the mean contour lengths of a freshly prepared DNA 
control sample of 771 base pair DNA, and the same sample after a period of twenty-four 
hours having been left in situ under the AFM head. As may be discerned from the table, the 
measured length of DNA strands from the same sample, taken after a twenty-four hour 
interval, is not significantly different. Both values correspond to the theoretical length of a 
771 base pair fragment of DNA in a B conformation, which is 262 nm. This result suggests 
that once adhered to the mica, the DNA is trapped in a stable complex with the substrate and 
that this complex is stable for extended periods of time. Given that typical experiments with 
the ligands took periods of a few hours, it is therefore highly unlikely that the process of 
sample preparation is responsible for any observed changes in the length of the DNA. 
 
Table 17 Comparison of the mean contour length of DNA strands taken from the same mica 
sample. One set of measurements were taken immediately, the other after 24 hours. There is 
no obvious difference in the length of either set of DNA strands. 
Sample Mean contour length / nm (SE) n (strands measured) 
DNA (t = 0) 257.8 (1.6) 119 
DNA (t = + 24 hours) 258.6 (2.6) 35 
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Notwithstanding the results of these particular experiments, that seem to confirm that the 
DNA does remain in a B conformation, this issue was never really in doubt.
124
 Numerous 
studies have confirmed that adsorption of DNA on mica does not induce a conformational 
change that is reflected by a shrinking of the physical length of the molecule. However, 
given the fact that the preparation of the DNA for AFM imaging does not appear to cause a 
contraction in the length of the DNA that may indicate a conformational change, and that 
experiments with echinomycin and TANDEM demonstrated a purely linear relationship 
between contour length and ligand concentration, the contraction observed with the acridine 
compounds would appear to be solely a consequence of the ligands themselves. In order to 
investigate the nature of these potential changes, further experiments were conducted using a 
solution based protocol. 
 
Following conformational changes of DNA in solution using CD 
One means of differentiating between the various DNA conformations is the technique of 
circular dichroism.
126
 Changes in DNA secondary structure may be discerned by their 
differing effects on the rotation of a beam of polarised light. CD spectra of A and B form 
DNA are significantly different, permitting straightforward comparison. The intercalation of 
DNA with various ligands has already been followed using this technique.
127
 
 
Experiments were conducted using the same ligands that had been analysed via AFM. 
Limitations to the sensitivity of the apparatus necessitated a higher concentration of DNA 
than had been used for the AFM imaging. Samples were prepared using CT- DNA (Sigma, 
UK) at a stock concentration of 1 mg/ml (3007 µM in DNA base pairs). The control was 
prepared by the addition of 20 µl of 200 µM NaCl to 20 µl of DNA. The volume was made 
up to 200 µl by the addition of tris buffer (pH 7.4). 1 µl of the appropriate concentration of 
each ligand was added to this volume and mixed. In the case of bisintercalators, a stock 
solution of 3 mM was used. To preserve the ligand to base pair ratios for direct comparison 
between bisintercalators and monointercalators, stock solutions of 6 mM were used for the 
monointercalators. The effect of the increase in volume (from 200 µl to 205 µl) on the 
concentrations of the DNA and the ligands was not considered to be significant. 
 
The A form of CT-DNA was induced by the substitution of the tris buffer with ethanol. 
Reference spectra were obtained for both the B and the A conformations of CT-DNA and 
these are shown in Figure 52. The spectra obtained corresponded well to those reported in 
the literature.
128
 The broad positive peak between 240 and 280 nm is typical of DNA in its B 
form, while the A form is distinguished by the larger positive peak at these wavelengths and 
a distinct negative peak at 210 nm. 
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Figure 52 CD spectra of the A and B conformations of CT-DNA, showing the large negative 
peak at 210 nm that is typical of A-form DNA. 
 
A control experiment was conducted where only buffer, in equivalent volumes to the ligand, 
was added to a solution of the DNA. This experiment confirmed that the buffer itself did not 
interfere with the DNA signal in any way, and even the slight increase in volume of the 
system following addition of the buffer, did not lead to any noticeable differences (Figure 
53). 
 
Figure 53 Addition of buffer to a solution of CT-DNA results in no changes to the spectrum. 
The legend denotes the volume of buffer added, each in 1 µl aliquots. 
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AFM imaging experiments of DNA bound to different intercalators had allowed a 1 hour 
incubation time after the addition of the ligand to the DNA before an experiment was 
conducted. Due to practical considerations regarding the use of instrumentation, such a time 
allowance was not possible for any experiments with CD. However, the incubation time of 1 
hour that had been previously utilised was somewhat arbitrary, and different studies of 
intercalators have used different incubation periods of time.
33, 75
 To investigate the effect that 
time might have on the appearance of CD spectra, a sample was prepared using bisacridine 
2. Three, 1 µl aliquots of 3mM bisacridine 2 were added to the DNA solution. Spectra of the 
same sample were then obtained after periods of 5 minutes and 1 hour. No significant 
differences could be discerned between the spectra obtained after these different periods of 
time (Figure 54). 
 
Figure 54 CD spectra of CT-DNA bound to bisacridine 2. The legend refers to the periods of 
time that the sample was allowed to incubate. There is a very slight divergence of the spectra 
at approximately 235 nm, but otherwise, relative to the DNA without ligand, the change in 
the DNA signal after the two incubation periods is entirely the same. 
 
To ascertain an appropriate concentration range over which to conduct the experiments, 
bisacridine 2 was added to the DNA solution at increasing concentrations, over a range of 
chromophore to base pair ratios from 0 to 0.7. This experiment revealed stages in the binding 
process that would need to be considered for further studies. These data are provided in 
Figure 55. 
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Figure 55 Addition of bisacridine 2 to CT-DNA (DNA concentration 300 µM in base pairs). 
Values reported in the legend correspond to the ligand chromophore to base pair ratio. At a 
ratio of 0.3, a marked change in intensity of the DNA signal may be observed at 280 and 250 
nm. At a ratio 0f 0.7 the intensity of the signal, across the whole wavelength studied, has 
almost returned to zero. 
 
At a chromophore to base pair ratio in excess of 0.5 (1 chromophore per 2 base pairs), the 
dramatic reduction in signal intensity is likely to be due to precipitation of the DNA. This 
conclusion is supported by the observation that at these high ligand concentrations, 
aggregated material began to appear in the cuvette that could only be removed by soaking in 
concentrated nitric acid. Without proper cleaning, this residue interfered with the spectra of 
subsequent experiments and as such, experiments were limited to a concentration range that 
did not exceed a chromophore to base pair ratio of 0.5. Since this ratio corresponds to the 
maximum degree of intercalation stipulated by the neighbour exclusion principle, 
experiments in excess of this value were deemed to be unnecessary. 
 
Unfortunately, the natural products echinomycin and doxorubicin proved to be unsuitable for 
analysis in this fashion. Due to the chiral nature of the compounds, a signal, attributable to 
these compounds, was observed.
129
 These signals overlapped that of the DNA, making 
comparison between the spectra of these compounds and the reference samples impossible. 
In the case of echinomycin the problem was two-fold. The DMSO content of this poorly 
water soluble molecule also induced a large signal at 210 nm, again overlapping the DNA 
signal. Spectra obtained for these compounds, in the absence of DNA, are available in Figure 
56. These difficulties did not apply to the acridine compounds since none contained any 
chiral centres and all were soluble in water at the concentrations used.  
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Figure 56 Comparative spectra of doxorubicin (left) and echinomycin (right). Doxorubicin 
shows a negative band between 260 and 300 nm, and a positive band between 220 and 240 
nm. Echinomycin yields two negative bands, one at 240 and the other at 220 nm. The 
positive band at 210 nm is caused by the presence of DMSO. The legend refers to the 
concentration of the ligand that was added to the cuvette, in 1 µl aliquots. 
 
Figure 57 illustrates the spectra obtained for the various acridine based compounds. In the 
case of the monointercalator 9-aminoacridine, and the alkyl linked bisacridines 1 and 2, 
changes are seen in the intensity of the positive band at 260 nm and the negative band at 240 
nm. No meaningful change in the intensity of the band at 210 nm occurred during titration of 
these ligands. However, the rigid linked bisacridine 3 yielded a spectrum considerably 
different to those of the reference spectra and the other ligands. In the case of this compound, 
there is a noticeable change in the spectrum between 210 and 240 nm. Moreover, there is a 
significant change in the position of the peak between 260 and 280 nm, with there being a 
concentration dependent shift towards higher wavelengths. In the case of bisacridine 1 and 
bisacridine 2, the position of this peak remains unchanged over the range of ligand 
concentrations used, there being a distinct isodichroic point at approximately 260 nm. The 
loss of the isodichroic point in the case of bisacridine 3 would support the hypothesis that the 
DNA is undergoing a conformational change during the binding of this ligand.   
 
The fact that none of the compounds demonstrate spectra similar to that of A form DNA 
suggests that the contraction observed in the length of the DNA during AFM imaging did not 
constitute a conformational change to the A-form. However, this may be an 
oversimplification. All four acridines, and noticeably bisacridine 3, show an increase in the 
intensity of the negative band at 210 nm as the concentration of the ligand, relative to that of 
the DNA, is increased. Similarly, though with the exception of bisacridine 3, there is an 
accompanying increase in the intensity of the band between 260 and 280 nm. Since 
ellipticity is derived from the precise arrangement of the nucleotides in a DNA strand, it is 
clear that intercalation of the DNA is causing a rearrangement of the bases. This principle is 
180 200 220 240 260 280 300 320 340 360
-12
-10
-8
-6
-4
-2
0
2
4
6
8
10
12
14
180 200 220 240 260 280 300 320 340 360
-12
-10
-8
-6
-4
-2
0
2
4
6
8
10
12
14
C
D
 [
m
d
e
g
]
Wavelength / nm
 6mM
 12mM
 18mM
 24mM
 30mM
C
D
 [
m
d
e
g
]
Wavelength / nm
 3mM
 6mM
 9mM
Chapter 3 
74 
 
well established, and as previously discussed, there are several elegant treatments of the 
precise mechanism of DNA intercalation in the literature.
51, 130-132
 Although the intercalated 
DNA complexes do not therefore conform to the classical A form model, it is possible that 
they incorporate a degree of A form character. Certainly evidence from these studies 
demonstrates that the DNA does not remain in a strict B conformation. 
 
 
Figure 57 Spectra of CT DNA bound to four different acridine intercalators (DNA 
concentration 300 µM in base pairs). The legend denotes the ratio of ligand chromophores to 
DNA base pairs. Clockwise from top left, Bisacridine 1, 9-aminoacridine, bisacridine 3 and 
bisacridine 2. The spectrum for bisacridine 3 is noticeably different to those of the other 
compounds, and suggests that the linker in this compound is affecting the binding mode of 
the ligand. The induced ellipticity apparent with this compound at 340 nm, and the reduced 
intensity of the bands at high ligand concentrations, also suggests some precipitation of the 
DNA. 
 
The sensitivity of this technique is apparent from the differences that may be observed 
between bisacridine 1 and bisacridine 2. While bisacridine 1 yields a spectrum remarkably 
similar to that of 9-aminoacridine, the bisacridine literally being a dimerised 9-aminoacridine 
moiety, the intensity of the changes in the bands at 260 and 240 nm is less noticeable with 
bisacridine 2. The band between 260 and 280 nm is also slightly shifted towards higher wave 
lengths in the case of the latter. Given that the only difference between bisacridine 1 and 
bisacridine 2 is the substitution of the acridine chromophore with a carboxamide, this 
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difference most likely reflects the threading nature of bisacridine 2 and its capacity to 
interact not only with the minor but also the major grove of the DNA duplex. 
  
That bisacridine 3 yields a spectrum somewhat different to the other compounds requires 
further mention. The changes in the band at 220 nm may reveal a conformational change in 
the DNA that is not observed elsewhere. However, this is not the only possibility. Other 
studies of ligand-DNA interactions have proposed that this band may be indicative of a 
condensation of the DNA.
126
 Although the decrease in band intensity that was highlighted in 
Figure 55 was considered to be indicative of precipitation, the band at 220 nm may reflect a 
different form of binding mechanism. While bisacridine 1 and bisacridine 2 incorporate a 
flexible alkyl linker, the linker in bisacridine 3 is more rigid in character and, although 
experimental findings are mixed, there is speculation as to whether or not bisacridines of this 
kind are too constrained to adopt the normal staple like conformation necessary for 
bisintercalation.
19
 A comparison of bisacridine 3 with another rigid bisacridine, bisacridine 4, 
is provided in Figure 58. 
 
 
Figure 58 Comparative spectra of bisacridine 3 (left) and bisacridine 4 (right) binding to CT-
DNA (DNA concentration 300 µM in base pairs). The negative peak at 210 nm, indicative of 
DNA in the A conformation, is apparent at higher concentrations of bisacridine 4. The 
legend denotes the ratio of ligand chromophores to DNA base pairs. 
 
Although the structural difference between bisacridine 3 and bisacridine 4 is very slight, the 
more constrained linker of bisacridine 4 appears to cause a greater degree of change in the 
DNA spectrum than that of bisacridine 3. This finding would appear to support the notion 
that changes in the DNA spectrum at this wavelength are indeed indicative of condensation 
of the DNA, since the shorter rigid linker is even less likely to bind in an intra-molecular 
manner. Either that, or the increase in the intensity of the negative band at 210 nm, apparent 
with both of these compounds, reflects substantial deformation of the DNA duplex, due to 
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the conformational constraints imposed upon the duplex by intramolecular bisintercalation of 
these supposedly rigid ligands. The capability of bisacridines to bind in an intermolecular 
fashion will be explored in more detail in Chapter 4. 
 
Conclusions 
These experiments have revealed subtle differences between the binding mechanisms of 
various DNA intercalators. The quinoxaline antibiotic echinomycin, and the anthracycline 
doxorubicin, induce a progressive lengthening of DNA upon binding. By contrast, the 
binding of compounds sharing the acridine chromophore results in increases in DNA contour 
length that are preceded by a distinct shortening of the DNA at lower concentrations of the 
ligand. Interpreting this peculiarity is not straightforward, and could even be explained by 
these ligands adopting an alternative binding mechanism to that of intercalation at low ligand 
to base pair ratios such as groove binding. Although CD suggests that the different acridine 
ligands may bring about a conformational change in the DNA, the observed spectra of DNA 
bound to the compounds discussed here do not correspond exactly to the spectra of accepted 
DNA conformations such as A and B.
128
  
 
Nevertheless, some conclusions may be drawn from these data that refine our understanding 
of the intercalative mechanism. The shortening of the DNA that is apparent at low 
concentrations of the acridine compounds would support the hypothesis that the DNA is 
undergoing some form of conformational change, and that this is dependent upon the nature 
of the chromophore, since this contraction occurs even with 9-aminoacridine. Despite 
differences in the structure of the inter-chromophore linker of the bisacridines, and the 
absence of the carboxamide substituent on the monointercalator 9-aminoacridine, the degree 
of change in the contour length of DNA fragments bound to all of these ligands is 
approximately the same at particular chromophore to base pair ratios. By contrast, 
intercalators that do not incorporate the acridine chromophore do not induce a contraction in 
the length of DNA at low ligand concentrations. In the cases of echinomycin and 
doxorubicin, a progressive and consistent lengthening of the DNA is observed until 
saturation of the DNA strand with the intercalator. Taken together, these findings suggest 
that intercalation of an acridine occurs in two phases: initial intercalation accompanied by a 
dramatic switch in conformation in the nucleotides surrounding the binding site, followed by 
a progressive lengthening of the DNA at higher ligand concentrations as more molecules 
bind to the DNA. Indeed, the initial contraction occurs at such low concentrations of the 
ligand that conformational changes must occur some distance away from the site of 
intercalation.
120
 Hypothetically, this may reflect the relaxed nature of the unbound DNA, 
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able to adopt a new conformation before further intercalation renders the DNA more rigid 
and therefore unable to undergo further change. 
 
This does not mean that all of the acridine compounds bind to DNA in exactly the same 
fashion. Although changes in the physical length of DNA were broadly similar, the length of 
the DNA strand itself is not an indicator of conformation. CD spectra obtained for DNA 
bound to the acridine based ligands reveal distinctive differences, even between structurally 
similar compounds. This is particularly noticeable with the acidine bisintercalators, such as 
bisacridine 2 and bisacridine 3. Although changes in their CD spectra, relative to the 
unbound B conformation of calf-thymus, are similar in the region of 240 to 260 nm, there is 
a noticeable change in the intensity of the band at 210 nm, indicative of A form character, in 
the spectrum of bisacridine 3, but not that of bisacridine 2. Given that the chromophores of 
these compounds are identical, it follows that the chromophore linker and its interactions in 
the minor groove of the DNA are to some degree responsible for the precise nature of any 
conformational change that the DNA undergoes. This distinction in each compound’s 
respective CD spectra may even, as has been postulated in the case of bisacridine 3, be an 
indicator of intermolecular binding. 
  
These findings themselves do not resolve the mechanism by which DNA may undergo 
conformational change as a consequence of intercalation. In the case of some ligands, not 
studied here, any conformational changes may be minimal. Interpreted alone, the data 
obtained from any one particular experimental protocol may be misleading. Contour length 
increases in DNA have been considered to be diagnostic of intercalation.
73
 However, with 
the acridine ligands, at those chromophore to base pair ratios where the degree of contraction 
matches that of extension (i.e. the net change in length, in spite of ligand binding, is zero), no 
change in contour length may be discerned. Similarly, the results of the DNA unwinding 
assay conducted using gel electrophoresis do not suggest that shortening of the DNA occurs 
at any ligand concentration. In fact, at high acridine concentrations the mobility of the DNA 
is retarded in the same manner as it is for echinomycin, an observation generally attributed to 
lengthening of the DNA. Using a combination of techniques, peculiarities in the behaviour of 
individual intercalators have been identified that highlight the complexities of this particular 
mechanism of DNA binding. Such peculiarities may have implications for the therapeutic 
application of this class of compounds, including their ability to inhibit different types of 
intra-cellular enzymes, such as DNA topoisomerase and RNA polymerase. 
.
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Chapter 4 – Inter-molecular intercalation 
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Introduction 
As discussed in Chapter 1, the capacity of bisintercalators to bind to two separate strands has 
been understood for some time. Initial studies utilised gel electrophoresis to demonstrate the 
aggregation of DNA by bisintercalators such as luzopeptin and acridine derivatives.
33-34
 
More recently, the interaction between separate strands of DNA and luzopeptin has been 
suggested by AFM imaging.
74
 Full methods for each of the experiments described in this 
Chapter are provided in Chapter 7. 
 
Data collected during experiments conducted in Chapter 3 suggested that binding was not 
always occurring in an intramolecular manner for some compounds, noticeably bisacridine 3. 
During the course of this Chapter, we will employ single molecule force spectroscopy to 
examine, quantitatively, the mechanism of intermolecular bisintercalation, and also 
demonstrate a novel, bulk solution approach to visualise this process using gold 
nanoparticles (cAuNP), functionalized with DNA. 
 
AFM imaging of intercalated DNA reveals unusual complexes 
During the course of the imaging experiments conducted in Chapter 3, unusual DNA 
complexes were observed when the DNA had been treated with high concentrations of a 
bisacridine. CD spectra of compounds bisacridine 3 and bisacridine 4 were also suggestive 
of the formation of inter-molecular complexes of DNA (see Chapter 3).
126
 As previously 
stated, these compounds incorporate less flexible inter-chromophore linkers than their alkyl 
counterparts and, theoretically, the assumption has been that designing bisacridines in this 
fashion ought to encourage the kind of intermolecular binding described here.
35
 
 
Typically, DNA adsorbed to mica from aqueous solution retained a relaxed appearance. As 
demonstrated in Chapter 3, the lengths of DNA derived from AFM images of this kind 
correspond well with the theoretical length of such DNA in its B form. Although strands 
may be observed to coalesce, this is unusual where the concentration of the DNA is low and 
simply reflects how separate strands may adhere to the same area of mica, in close proximity 
with one another.  
 
A qualitative illustration of the differences between different types of intercalator is provided 
in Figure 59. A 1341 base pair, linear fragment of plasmid φX174, measuring 456 nm, was 
produced by restricting the plasmid with the enzyme BsaAI. Aliquots of this DNA solution 
were diluted further to 0.34 ng/ µl. A volume of 10 µl of this dilute DNA solution was 
combined with 15 µl of the appropriate ligand, or 15 µl of water for the control group. After 
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an incubation period of ten minutes, 25 µl of 10 mM MgCl2 was added, yielding a total 
volume of 50 µl as per previous AFM imaging experiments. 
 
The complexes observed on addition of bisacridine 3 to a 1341 base pair fragment of DNA 
adopt a range of morphologies. Separate strands tend to be aggregated and adopt loops and 
tangles that suggest that each section of DNA has been bound to another, either by an 
intermolecular interaction or a long-range intra-molecular mechanism. 
 
 
Figure 59 AFM images of DNA treated with different intercalators (scale bar denotes 250 
nm). Clockwise from top left, no ligand, 10 µM echinomycin (0.1% DMSO), 10 µM 
bisacridine 3, 20 µM ethidium bromide. The concentration of the DNA in these samples is 
0.16 nM. The appearance of the DNA bound to bisacridine 3 is very different to the other 
samples, losing its linear character and adopting more complex morphologies. 
 
Complexes of this kind are not observed with the monointercalator ethidium bromide. 
Although intercalation of this ligand may occur throughout a DNA strand, the molecule, 
comprised of a single chromophore, lacks further substituents with which to bind to any 
adjacent DNA strands. Similarly, no aggregation of the DNA was observed with the 
bisintercalator echinomycin. While in theory this compound, consisting of two 
chromophores separated by a peptide linker, could adopt an intermolecular configuration, 
similar to that known to occur with luzopeptin, such a rearrangement would be highly 
unfavourable due to the rigid configuration of the peptide component. As such echinomycin 
has always been assumed to bind in a staple like configuration to DNA, via an 
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intramolecular mechanism.
28, 133
 This hypothesis is supported by several NMR studies of 
DNA-echinomycin complexes,
29
 and the failure of any other techniques, notably AFM, to 
provide any evidence of echinomycin adopting an alternative binding mode.
74
 
 
Utilising single molecule force spectroscopy to examine intermolecular intercalation 
Intercalation of an acridine monomer has been studied using force spectroscopy.
99
 More 
broadly, this technique has been used to examine a wide range of issues, including protein 
binding and receptor ligand interactions, as discussed in Chapter 2. The technique has been 
demonstrated to be very sensitive, requiring only low concentrations and small volumes of 
materials. Given the lack of quantitative data surrounding the mechanism of Type II 
intercalation, it was decided to apply the principle of single molecule force spectroscopy to 
investigate this phenomenon.  
 
A consideration of the different types of interaction that may be observed during these 
experiments is provided in Figure 60. The stretching events associated with a positive 
interaction may be analysed in a variety of ways, depending on the nature of the molecules 
undergoing stress. Two common models for the elastic behaviour of materials are the 
extensible worm-like-chain model (EWLC) and the extensible freely-jointed-chain model 
(EFJC). These are both mathematical models that describe the flexibility and elasticity of 
different types of polymer. Typically, biological materials such as DNA are best described 
by the EWLC, while materials such as PEG are described by the EFJC. While the EWLC 
envisions a semi-rigid rod that is continuously flexible, the EFJC envisions a chain that is 
flexible only within distinct segments. Since the PEG component constituted approximately 
60 to 70 percent of the total length of the molecule that would be used in these experiments, 
it was decided to use the EFJC for analysis. 
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Figure 60 Typical force extension curves showing (from top to bottom) no interaction, single 
positive interaction, serial multiple interactions (left) and an exported image from JPK 
processing software, illustrating fitting of the EFJC (right). The y axis offset of the force 
curves is arbitrary for illustrative purposes and would be 0 pN in all cases. 
 
Figure 60 highlights a difficulty often encountered with force spectroscopy, that of 
distinguishing between ‘single’ and ‘multiple’ stretching events. The occurrence of multiple 
interactions, where more than one artefact is attached to the cantilever as it is retracted from 
the substrate may be controlled to some degree by the surface chemistry of the substrate. By 
using very dilute solutions of the DNA molecule, the likelihood of more than one strand 
adhering to the cantilever is reduced. Multiple attachments still occur however and must be 
dealt with at the data analysis step. Serial multiple events of the kind illustrated in Figure 60 
are easily identified. In these cases, only the final stretching event is analysed with the EFJC 
since preceding events are governed by the behaviour of the final event and therefore not a 
reliable reflection of the actual stretching event that was occurring. Parallel multiples are 
more commonly identified by the higher rupture forces with which they are associated, but 
this in itself is not sufficient to distinguish them from genuine single interactions. A protocol 
for separating events of this kind will be discussed in more detail later in this Chapter. 
 
Stretching a DNA oligonucleotide 
In order to characterise the functionalised substrate, an initial experiment was conducted 
using a bare AFM cantilever. The design of this experiment is illustrated in Figure 61. A pair 
of 33 base pair oligonucleotides were annealed and coupled to a 15.4 nm PEG polymer via 
an amine functionality at the 5’ terminus of one of the oligonucleotides. In turn, the PEG was 
coupled to propanedithiol, leaving a free thiol group at the PEG end of the molecule. The full 
sequence of the DNA is as follows: 
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1) 5’ – NH2 – CTACGTGGACCTGGAGAGAGGAAGGAGACTGCCTG – 3’  
2) 5’ – CAGGCAGTCTCCTTCCTCTCTCCAGGTCCACGTAG – 3’  
 
A 5 µl droplet of the PEG/DNA conjugate (60 ng/µl) was deposited on an atomically flat 
gold surface and placed in a humidity chamber for 20 hours, during which time coupling of 
the free thiol to the gold surface would occur. The surface was then passivated with a droplet 
of 10 mM 11-mercaptoundecanoic acid. Using a bare, gold coated cantilever (Asylum 
Research, BL-RC150VB) force spectroscopy was conducted in aqueous phosphate buffer by 
lowering and retracting the cantilever in arrays of 100 x 100 data points over areas of 10 x 10 
microns on the gold surface. 
 
 
Figure 61 Illustration of the experiment, showing a passivated and functionalised substrate 
and the opposing bare AFM cantilever to which the DNA would adhere. Legend denotes 1) 
Mercaptoundecanoic acid 2) PEG 3) DNA. These experiments are conducted in liquid, 
where both the cantilever and the substrate are immersed in solution in a liquid cell beneath 
the AFM head. 
 
Data obtained from this experiment are presented in Figure 62. Observed events, to which 
the EFJC could be fitted, rendered a mean breaking force of 53.2 pN and contour lengths of 
approximately 29.5 nm. The most probable force associated with these interactions is typical 
of the kinds of forces usually reported for experiments of this kind.
134
 Similarly, the contour 
lengths of these interactions were in good agreement with the theoretical length of the 
oligomer that had been attached to the substrate (27.2 nm). Values for the theoretical lengths 
of the individual components of the oligomer, and the total calculated length of the oligomer, 
are provided in Table 18.  
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Figure 62 Data obtained from fitting of the EFJC model to observed interactions. Clockwise 
from top left 1) Typical force extension curves 2) Histogram of rupture forces 3) Scatter plot 
of rupture forces versus Kuhn length, highlighting the relationship between higher breaking 
forces and low Kuhn lengths 4) Histogram of contour lengths. 
 
Table 18 Theoretical lengths of the components of the oligomer. Calculations assume a MW 
of the PEG of 2950 Da, and that the DNA is in a B conformation, with a mean distance 
between each base pair of 0.34 nm. 
Molecule Length / nm 
Propanedithiol 0.6 
PEG 15.4 
B-DNA 11.2 
Complete oligomer 27.2 
 
The problem of multiple interactions has already been discussed earlier in this Chapter. 
While serial multiple interactions may be eliminated from further analysis, parallel multiple 
interactions are much harder to distinguish. One means for achieving this is to use the elastic 
character of the PEG to distinguish between single and multiple attachments.
135
 Besides the 
rupture force and contour length of an interaction, another function of the EFJC provides a 
value referred to as the Kuhn length, a function of a molecule’s persistence length. A recent 
study has established a relationship between low Kuhn lengths and higher rupture forces in 
PEG based systems, suggesting that lower Kuhn lengths are associated with multiple, and 
non-specific, attachments.
135
 As may be discerned from Figure 62, these experiments 
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demonstrated a similar relationship, with forces greater than 100 pN typically occurring at 
Kuhn lengths lower than 0.6 nm. Accordingly, to reduce the impact that multiple 
attachments might have on the data, we applied a second filter to isolate those rupture events 
where the Kuhn length was greater than 0.6 nm.
135
 These interactions are presented in Figure 
63, along with new histograms of the lengths and forces associated with the isolated data. 
 
 
Figure 63 Clockwise from top left 1) Scatter plots of all the collected data and data where the 
Kuhn length was greater than 0.6 nm 2) Enlargement of the scatter plot for the selected data 
3) Histogram of rupture force 4) Histogram of contour lengths. 
 
A complete analysis of the values taken from these initial experiments is provided in Table 
19. The values obtained for the contour length of the oligomer do not differ, even when the 
Kuhn length filter is applied to the data, and remain in good agreement with the theoretical 
length of 27.2 nm. There is also a 20% reduction in the mean force once interactions with 
Kuhn lengths of less than 0.6 nm have been removed from the analysis.  
 
Table 19 Typical values for length and force associated with stretching of the oligomer by a 
bare cantilever. 
Sample Length / nm (SE) Force / pN (SE) n 
All data 29.5 (1.4) 53.2 (3.2) 310 
> 0.6 nm 30.4 (2.2) 43.3 (1.5) 94 
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That the observed contour lengths correspond so well with the theoretical value of 27.6 nm 
may be somewhat surprising, since mechanistically it seems unlikely that the AFM probe 
would ‘pick up’ the oligomer at the end of the DNA strand to which the PEG is attached. 
However, measurements of this kind may be subject to several variables. These include 
stretching of the oligomer beyond its relaxed length, the physical dimensions of the AFM 
probe itself, and the polydispersity of the PEG molecule to which the DNA is attached. Both 
the scatter plots and the histogram of length presented in Figure 63 reveal a degree of skew 
towards higher contour lengths, reflecting the polydispersity of the PEG molecule that was 
used for this study. 
 
The question of the frequency with which these events occur is more difficult to assess. 
Filtering events by Kuhn length in order to eliminate those not commensurate with stretching 
of a single polymer chain, eliminates legitimate stretching events where more than one PEG 
conjugate is attached to the AFM probe. As such, the frequency of observed events may 
appear artificially low, especially since single stretching events are made all the more 
unlikely by the use of a bare cantilever, where the exposed surface area is high. However, 
reporting the frequency of all those events to which a freely jointed chain could be fitted is 
equally misleading, since this value will include a number of non-specific interactions that 
could be associated with a range of phenomena, such as peculiarities in the composition of 
the substrate and surface adhesion of the probe tip. 
 
The relative frequency of these interactions is therefore provided both as a reflection of the 
number of events where the Kuhn length was greater than 0.6 nm, and of the total number of 
events to which the freely jointed chain model could be applied (Table 20). In reality, the 
frequency of events that constitute stretching of oligomers must be somewhere between 
these values. 
 
Table 20 Number of interactions observed when stretching the oligomer with a bare probe, 
comparing the total number of force extension curves against those with Kuhn lengths 
greater than 0.6 nm. 
Sample n Frequency / % n (total force curves)
 
All data 310 1.03 30000 
> 0.6 nm 94 0.31 30000 
 
In order to demonstrate further that observed interactions were the result of legitimate 
connections between the substrate and the cantilever, a further experiment was conducted 
where the probe, as well as the substrate, was passivated with mercaptoundecanoic acid. By 
blocking the Au surface of the cantilever, it should not be possible for the DNA to adhere to 
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the cantilever. As such the number of interactions should be significantly reduced. Data 
obtained from these experiments are shown in Table 21. 
 
Table 21 Number of interactions observed between the bare probe and a passivated probe. 
Only data for Kuhn lengths greater than 0.6 nm is shown. 
Sample n Frequency / % n (total force curves)
 
Passivated probe 1 0.01 20000 
Bare probe 94 0.31 30000 
 
There is a noticeable and unsurprising difference between the values reported in Table 21 
and those reported in Table 20. The decline in the absolute frequency of all of the observed 
stretching events reflects the successful passivation of the cantilever. The fact that this value 
did not fall to zero may indicate two things. First, non-specific interactions always occur 
during any force spectroscopy experiment, since any event that causes even a slight 
deflection of the cantilever will be observed during the retraction of the cantilever from the 
substrate. Second, any parts of the probe that retain a bare gold surface could adhere to the 
DNA on the substrate, although, as is evident from Table 21, this eventuality appears to be 
very rare, if indeed it applies at all.  
 
The  binding of monointercalators with DNA  
The final stage of the force spectroscopy experiments required the functionalisation of both 
the cantilever and the substrate with DNA. This arrangement is illustrated in Figure 64. 
Functionalisation and passivation of the cantilever was conducted in a similar fashion to that 
of the substrate, by immersing the cantilever in a droplet of the PEG/DNA solution or 
mercaptoundecanoic acid as appropriate. Having demonstrated the relationship between the 
Kuhn lengths of observed events and their associated rupture forces above, the following 
data will always represent only those events with Kuhn lengths greater than 0.6 nm.  
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Figure 64 Experimental protocol showing setup of force spectroscopy apparatus. Legend 
denotes 1) Mercaptoundecanoic acid 2) PEG 3) DNA 4) Bisintercalator. The top image 
shows a negative interaction, where there is no connection between the substrate and the 
opposing cantilever. The lower image shows a positive interaction where the cantilever is 
deflected by the binding of a bisintercalator to two opposing DNA strands. 
 
Figure 65 provides an illustration of the interactions that were observed when only buffer, 
and no ligand, was introduced to the liquid cell. Theoretically, under these conditions, no 
interactions should be observed, since there is no ligand in solution to bridge the opposing 
strands of DNA. This experiment was repeated using solutions of ethidium bromide and 9-
aminoacridine, by replacing the buffer in the liquid cell of the AFM with an aqueous 200 nM 
solution of either of these ligands. In theory at least, since these compounds consist of a 
single chromophore, no events should occur. 
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Figure 65 Data obtained from experiments conducted without a ligand (top left), and also the 
monointercalators 9-aminoacridine (top right) and ethidium bromide (bottom left). The 
frequency of stretching events in these samples was less than 0.1 %, comparable to a 
passivated cantilever. 
 
Although in principle no interactions should be observed in the control (no ligand) group, a 
small number of interactions were observed. Interactions were also observed in the case of 
ethidium bromide, and a single event with 9-aminoacridine. These are almost certainly a 
consequence of non-specific interactions between the AFM cantilever and unwanted 
artefacts within the liquid cell or on the substrate, and occur very infrequently 
(approximately one non-specific interaction for every 2000 force extension curves 
generated). 
 
Table 22 Relative frequencies of stretching events associated with different ligands. 
Although these ligands are known intercalators, binding is restricted to a Type I mechanism 
that cannot be observed using this protocol. 
Sample n  Frequency / % n (total force curves)
 
No ligand 11 0.06 20000 
9-aminoacridine 1 0.01 20000 
Ethidium Bromide 8 0.05 15817 
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The  binding of bisacridines with DNA 
On addition of a 100 nM aqueous solution of bisacridine 3 to the AFM liquid cell there was a 
dramatic change in the frequency of the events that were observed, and relative to the 
experiments conducted with a bare AFM probe, a significant change in the lengths at which 
these events occurred. Typical force extension curves and histograms of the observed lengths 
and forces are provided in Figure 66. Data derived from these histograms are presented in 
Table 23, relative to the results obtained where only the substrate was functionalised. 
 
Figure 66 Clockwise from top left, typical force extension curves where bisacridine 3 has 
been added to the system, histogram of the force at which these events ruptured, scatter plot 
of the interactions, and histogram of the length at which these events occurred. 
 
Table 23 Comparison of the lengths and forces obtained with a bare cantilever and where 
bisacridine 3 was introduced to a functionalised substrate and cantilever. The forces 
described here represent different processes; one the strength of the attachment between the 
AFM probe and the DNA, and the other the rupture of a bond between two separate DNA 
strands. 
Sample Length / nm (SE) Force / pN (SE) n 
Bare probe 30.4 (2.2) 43.3 (1.5)  94 
Bisacridine 3 51.6 (2.0) 49.7 (3.2) 113 
 
Comparison of the contour lengths derived from the freely jointed chain that was applied to 
the stretching events revealed a significant increase in the length at which the events were 
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occurring, with the reported length of 30.4 nm for the oligomer alone rising to 51.6 nm 
where opposing oligomers were bridged together by the bisacridine. 
 
Given the differences that were identified between the bisacridines in Chapter 3, these 
experiments were repeated with another bisacridine (bisacridine 2) with a different inter-
chromophore linker (Figure 67). A comparison of the data obtained for each of the two 
bisacridines is provided in Table 24.  
 
Figure 67 Clockwise from top left, typical force extension curves where bisacridine 2 has 
been added to the system, histogram of the force at which these events ruptured, scatter plot 
of the interactions, and histogram of the length at which these events occurred.  
 
Table 24 Comparison of values for length and force obtained for the two different 
bisacridines 2 and 3. Although the difference in observed contour length could be considered 
to be statistically significant for this data, estimation of the potential length of the oligomer is 
very complicated. 
Sample Length / nm (SE) Force / pN (SE) n 
Bisacridine 3 51.6 (2.0) 49.7 (3.2) 113 
Bisacridine 2 43.2 (3.3) 55.0 (3.7) 123 
 
The correlation between the observed lengths and forces for each of the bisacridines, 
suggests that the same interaction, a bridging of opposing DNA strands, was indeed taking 
place.  
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The relative frequencies with which these events were observed are shown in Table 25. 
Relative to the control and the monointercalators already discussed, there is a striking 
increase in the number of events that are observed when a bisacridine is added. While events 
observed in the absence of a ligand constituted only 0.06% of the total number of force 
curves, this rose to 1.13 and 0.62% in the case of bisacridine 3 and bisacridine 2 
respectively. 
 
Table 25 Comparison of the relative frequencies of events between two bisacridines, 
showing that the incidence of Type II events is greater in the case of bisacridine 3 than 
bisacridine 2.  
Sample n  Frequency / % n (force curves)
 
No ligand 11 0.06 20000 
Bisacridine 3 113 1.13 10000 
Bisacridine 2 123 0.62 20000 
 
The observed frequency of such interactions is governed to some degree by variations in the 
surface chemistry. However, the reduced frequency of interactions that were observed in the 
case of bisacridine 2 may also reflect the difference in the molecular structure of this 
compound relative to bisacridine 3. CD in Chapter 3 demonstrated that the structure of DNA 
intercalated with bisacridine 3 was subtly different to that of bisacridine 2, although AFM 
imaging demonstrated the capacity of both compounds for forming aggregates of DNA 
material. The rigid inter-chromophore linker of bisacridine 3 was in fact intended to restrict 
the ability of the compound to adopt an intra-molecular binding configuration and encourage 
the kind of inter-molecular activity observed via force spectroscopy. By contrast, the flexible 
alkane linker of bisacridine 2 permits the acridine chromophores of bisacridine 3 to adopt 
either a cis or a trans configuration. As such, the lower frequency of events observed for 
bisacridine 2 could reflect a greater degree of intra-molecular binding that would not be 
detected by this force spectroscopy assay. This could be tested by introducing the 
monointercalator 9-amino acridine to the liquid cell alongside a bisacridine. Due to 
competition between the monointercalator and the bisintercalator, the relative frequency of 
observed stretching events should decrease as the concentration of the monointercalator, 
relative to that of the bisintercalator, is increased.  
 
So far the discussion has centered on the relative frequency of any observed events and the 
forces with which these events are associated. However, the distance between the AFM 
probe and the substrate at the point of bond rupture is also an important diagnostic of the 
events being observed. The difference in the distances observed between a non-
functionalised (bare) cantilever and a cantilever functionalized with DNA has already been 
Chapter 4 
93 
 
discussed, and the increase in length observed with the latter supports the notion that 
opposing DNA strands are being coupled together. Unfortunately, the issue of length is 
somewhat complex in this scenario for a variety of reasons. 
 
The issue of polydispersity in the PEG component of the oligomer has already been 
discussed, but there are other factors that may aggravate the range of contour lengths over 
which interactions are observed to be occurring. Since the oligonucleotides used to assemble 
the oligomer consist of more than four base pairs, it follows that more than one arrangement 
of two separate oligomers may be possible. In fact, applying the neighbour exclusion 
principle, the 33 base pair oligonucleotide consists of 16 potential intercalation sites. An 
attempt to reconcile some of these arrangements is illustrated in Figure 68. 
 
 
Figure 68 Potential binding arrangements of two separate oligomers with a bisacridine(s). 
The lengths above each molecule correspond to the contour length that may be expected for 
that arrangement. These arrangements are illustrative only, and the bisintercalator itself is 
not to scale. 
 
Theoretically, as many as sixteen bisacridine molecules could bind simultaneously to two 
separate oligomers, although the chances of such an arrangement occurring in practice seem 
remote. Figure 68 emphasises that, even when only one bisacridine is binding, contour 
lengths of this coupling could vary by as much as 22 nm. In terms of observed breaking 
forces, binding of multiple ligands to the same strands ought to be associated with a higher 
observed force. However, this is not immediately obvious in the case of either of the 
bisacridines investigated so far.  
 
Nevertheless, the distribution of observed rupture forces for both of the bisacridines is quite 
broad, as may be discerned from the relevant histograms in Figure 66 and Figure 67. That 
some of these forces exceed a value of 65 pN raises another issue that has not been discussed 
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so far, that of the overstretching of DNA, otherwise referred to as the B to S-DNA transition. 
Covalent attachment and in situ annealing of ssDNA in force spectroscopy experiments has 
been shown to be associated with a distinctive plateau in the observed forces associated with 
stretching of the annealed sequences.
136
 At this point, the length of the DNA strand under 
stress may increase by as much as 70%, without a corresponding increase in force. Allowing 
for this mechanism, a further arrangement of the oligomers following binding of the 
bisacridine may be suggested Figure 69. 
 
 
Figure 69 Graphical illustration of how the oligomer could undergo a transition from the B 
conformation to the overextended S conformation. Such a transition would require the 
application of forces exceeding that reported elsewhere for this transition, typically in the 
region of 65 pN. 
 
However, the arrangement provided in Figure 69 ought to be considered unlikely. Firstly, the 
short length of the oligonucleotide may disguise the overstretching transition to some degree. 
Experiments elsewhere have utilised longer stretches of ssDNA, although admittedly the 
transition has been observed in sequences as short as 30 base pairs.
136
 Secondly, binding of 
the bisacridine will not occur solely in an intermolecular fashion. Almost certainly, there will 
be a degree of intramolecular binding occurring, which will prevent the overstretching 
transition from taking place.
137
 Nevertheless, since intercalation is known to be a dynamic 
process, with intercalating ligands effectively diffusing between a bound state and solution, 
it remains possible that overstretching may be occurring in some instances. Out of all of the 
force extension curves obtained during the course of these studies, only 2 or 3 force curves 
were observed to include a linear transition state at the point of rupture that may be 
indicative of the B to S transition. An example of one of these curves is shown in Figure 70. 
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Figure 70 Example of one of a small number of force curves that demonstrated a linear phase 
(circled) immediately prior to the point of rupture (lower curve, left) and the same curve 
enlarged (right). A typical force curve that does not demonstrate the transition is provided for 
comparison (upper left). 
 
The issue of the distribution of contour lengths at which events may be occurring is 
complicated by other factors identified in Chapter 3. Intercalation, at high degrees of DNA 
saturation, is associated with an increase in DNA contour length, while in the case of the 
bisacridines, lower concentrations of the ligand may induce a contraction in the DNA. A 
combination of all of these factors is likely to be responsible for the range of contour lengths 
over which interactions are occurring.  
 
The  binding of echinomycin and TANDEM with DNA 
As previously discussed, the bisintercalator echinomycin is thought to retain a staple like, 
intra-molecular binding configuration. Similarly, the triostin analogue TANDEM, though 
having different sequence specificities to echinomycin, is thought to be unable to bind in an 
intermolecular fashion due to the rigidity of the molecule’s interchromophore linker. As 
such, intermolecular binding of the kind demonstrated here by the bisacridines should not 
occur. To test this hypothesis, binding experiments were also undertaken using echinomycin. 
  
Figure 71 provides clear evidence that, contrary to what may have been expected, 
echinomycin does indeed bind in an inter-molecular fashion. Given the rigidity of the 
peptide interchromophore linker, this raises questions about the precise mechanism by which 
binding was occurring, especially since the triostin analogue TANDEM did not demonstrate 
any activity at all. Since a cis to trans rearrangement of the chromophores was considered to 
be energetically unfavourable, it was decided to investigate the hypothesis that binding was 
occurring exclusively at the termini of opposing DNA strands.  
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Figure 71 Data obtained for the bisintercalator echinomycin. Clockwise from top left, typical 
force extension curves, histogram of rupture force, scatter plot of observed interactions, 
histogram of contour lengths. 
 
To test this hypothesis, the experiment was repeated with the bisintercalator TANDEM. This 
ligand has a known preference for AT base pairs, whereas echinomycin has a preference for 
GC. Another oligonucleotide was used that reflected the difference sequence specificity of 
TANDEM. This oligonucleotide differed from that previously used only in the composition 
of the terminal base pair, one being GC and the other AT. The precise sequence is provided 
below: 
 
1) 5’ – NH2 – CTACGTGGACCTGGAGAGAGGAAGGAGACTGCCTA – 3’  
2) 5’ – TAGGCAGTCTCCTTCCTCTCTCCAGGTCCACTGAG – 3’ 
 
This sequence was annealed and prepared in exactly the same fashion as described 
previously. Results from experiments conducted with TANDEM, using the new 
oligonucleotide are shown in Figure 72. 
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Figure 72 Data obtained for the bisintercalator TANDEM. Clockwise from top left, typical 
force extension curves, histogram of rupture force, scatter plot of observed interactions, 
histogram of contour lengths. 
 
Having demonstrated that TANDEM exhibited similar activity to echinomycin, each 
compound was evaluated against the other oligonucleotide. That is to say, that echinomycin 
was tested against the AT terminated oligonucleotide and vice versa. Bisacridine 3 was also 
tested with the AT terminated oligomer.  
 
The results of these experiments reveal that binding activity with either echinomycin or 
TANDEM is sensitive to the precise composition of the terminal base pairs of the 
oligonucleotide. While echinomycin shows activity with an oligonucleotide terminated with 
a GC base pair and not AT, the exact opposite applies in the case of TANDEM. By contrast, 
binding of a bisacridine does not appear to be sensitive to the base pair sequence of the 
oligonucleotide, with binding occurring in both cases (Figure 73). 
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Figure 73 Histograms of contour lengths for the GC terminated oligonucleotide (left) and the 
AT terminated oligonucleotide (right). From top row to bottom, echinomycin, TANDEM, 
bisacridine 3. These histograms illustrate that in the cases of echinomycin and TANDEM, 
binding is dependent on the terminal base pairs of the oligonucleotides. 
 
Importantly, the precise composition of the terminal base pairs does not reflect the optimal 
binding sites of either echinomycin or TANDEM. Although these ligands have, respectively, 
a preference for GC and AT rich regions of DNA, the arrangement of the base pairs within 
these areas is known to have a significant bearing on the binding of the ligand. Studies 
involving DNase footprinting and NMR have shown that echinomycin has a preference for 
5’-CpG steps, while TANDEM binds with highest affinity to 5’-TpA.45, 138  In the scenario 
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indicated in these studies, echinomycin would be binding to a 5’-GpC step, while TANDEM 
would be binding to a 5’-ApT step. Although a crystal structure of the TANDEM intercalator 
that was published in 1981 suggested that binding at ApT steps would be preferred, this 
interpretation has since been disproved.
139
 
 
The fact, that the ligands would have a lower affinity for the nucleotide sequences occurring 
in this force spectroscopy study does not mean necessarily that binding cannot occur at all. 
Dissociation studies of echinomycin from DNA have demonstrated that the association rate 
constants for echinomycin with 5’-CpG and 5’-GpC steps differ only by a factor of 2.43 
Similarly, comprehensive DNase footprinting studies have indicated that although 
TANDEM does not bind to the tetranucleotide sequence 5’-AATT,140 binding does occur at 
the sequence 5’-TATA and that therefore some degree of binding to ApT steps cannot be 
excluded.
48
 All of these studies have emphasised the importance of the flanking base pairs of 
the nucleotide binding step. For example, although TANDEM binds to 5’-TpA steps, no 
binding at all is observed at the sequence 5’-CGTACG, which includes a TpA step. In this 
study, the tetranucleotide binding sequences would be 5’-TGCA and 5’-TATA for 
echinomycin and TANDEM respectively. Both of these flanking arrangements are known to 
support ligand binding at the central step.
45, 49
 Arguably, these considerations are difficult to 
apply to the binding arrangement provided by a junction between the oligonucleotides used 
in this study. In this scenario, the nucleotides that form the central binding step are not 
connected by a phosphate and have complete rotational freedom with respect to one another. 
 
Table 26 provides the most probable lengths and forces derived from these experiments with 
echinomycin, TANDEM and bisacridine 3.  Broadly speaking, where interactions are 
occurring, the values for these parameters are compatible with one another, irrespective of 
the individual ligand under investigation. As such, these values in themselves do not reveal 
potential differences in the binding mechanism of a particular ligand. However, the 
experiment clearly demonstrates that binding of either echinomycin or TANDEM is 
dependent on the precise arrangement of the terminal base pairs of the DNA. 
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Table 26 A comparison of most probable lengths and forces for echinomycin, TANDEM and 
bisacridine 3 relative to each of the two different oligonucleotides.  
DNA Ligand Length / nm (SE) Force / pN (SE) n 
GC Echinomycin 43.5 (3.5) 50.5 (1.7) 47 
 TANDEM - - 1 
 Bisacridine 3 51.6 (2.0) 49.7 (3.2) 113 
AT Echinomycin - - 1 
 TANDEM 42.9 (4.0) 40.4 (2.4) 23 
 Bisacridine 3 44.4 (1.8) 52.3 (3.2) 257 
 
The relative frequency of the events observed with echinomycin and TANDEM was 
noticeably lower than in the case of the bisacridines (Table 27). This could reflect several 
different factors. Firstly, that the affinity of echinomycin and TANDEM for DNA is lower 
than that of the bisacridines, making binding of any kind less likely to occur. Secondly, 
assuming, due to the dependence of the interaction on the terminal base pairs of the 
oligomer, that the interaction is occurring only at one point between the two complexed 
oligomers, the likelihood of such an arrangement occurring is less likely than with the 
bisacridines where binding can occur anywhere on the DNA. Thirdly, that the complex 
formed between either echinomycin or TANDEM and the DNA has a shorter half-life than 
that formed between a bisacridine and the DNA, and that therefore it will be harder to 
observe.  
 
Table 27 Relative frequencies of events occurring with echinomycin, TANDEM and 
bisacridine 3 relative to the composition of the terminal base pairs of the oligomer. The 
frequency of interactions observed in the absence of a ligand was 0.06%.  
DNA Ligand n  Frequency / % n (total force curves)
 
GC Echinomycin 47 0.19 25127 
 TANDEM 1 0.00 20355 
 Bisacridine 3 113 1.13 10000 
AT Echinomycin 1 0.01 20000 
 TANDEM 23 0.12 20000 
 Bisacridine 3 257 1.29 20000 
 
Since cross-linking of the DNA with echinomycin and TANDEM was dependent on the 
composition of the terminal base pairs of the oligomers, any proposed binding mechanism 
must take this into account. If the unlikely cis to trans rearrangement of each compound’s 
chromophores is occurring, then binding could occur throughout the DNA strand as in the 
case of the bisacridines. As such, it must be assumed that no reconfiguration of the 
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molecules is taking place, and that, retaining their cis conformation, the ligands are bridging 
the ends of opposing DNA strands (Figure 74). In one respect, that binding is occurring at 
the termini of the oligonucleotides, is not without a rational foundation. Computer modeling 
of doxorubicin binding to various short oligonucleotide sequences revealed that the ligand 
would bind preferentially to the ends of the DNA. The authors proposed that this was 
occurring because ‘the energetic and structural perturbations associated with disrupting the 
normal base stacking interactions are smaller for the end bases than for internal bases’.38 
 
 
Figure 74 a) Proposed binding mechanism of echinomycin and TANDEM (left) and of the 
bisacridines (right). This graphic was kindly provided by Mr. Richard Steel, University of 
East Anglia. b) Schematic illustration of the difference in the binding site between 
echinomycin (top) and TANDEM (bottom). 
 
Clearly, the mechanism proposed for echinomycin in Figure 74 could apply also to the 
bisacridines. However, in the case of the bisacridines, binding has been demonstrated to 
occur irrespective of the terminal base pairs of the oligomer and is therefore not sequence 
specific.  
 
This protocol has provided quantitative information of the nature of the interaction that 
occurs when bisintercalators bind in an intermolecular as opposed to intramolecular manner. 
Although this mechanism has been observed before, it has never been extensively studied 
and, beyond the normal explanation of enhanced binding affinity and greater structural 
deformation of the bound duplex, may also be another aspect of the enhanced cellular 
cytotoxicity of bisintercalators relative to monointercalators.  
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These experiments have also identified a previously unobserved binding mode of 
echinomycin and TANDEM. If exploited, this mechanism could provide a means of 
accomplishing sequence specific, blunt-end ligation of oligonucleotides. Such a possibility 
could have significant implications in the application of DNA-based nanotechnologies. 
 
Dynamic force spectroscopy of DNA bound to a bisacridine 
Thus far, force spectroscopy experiments have only utilised one retraction velocity (0.5 µ/s). 
Although this was adequate for demonstrating whether or not Type II intercalation was 
occurring, more information may be obtained about the nature of a given interaction by 
varying the retraction speed of the AFM. A relationship between rupture forces observed via 
AFM and the retraction velocity at which the measurement was taken has previously been 
identified.
90
 Combining this with an understanding of the energetics of bond formation and 
bond breaking permits the calculation of certain kinetic and dynamic parameters of the 
precise interaction that was broken at the point of rupture.
86, 88
 
 
In order to characterise further the inter-molecular binding of a bisacridine with DNA, 
further experiments were conducted using the AT terminated oligonucleotide and bisacridine 
2 at a range of different retraction velocities, ranging from 0.05 µ/s to 4 µ/s, covering three 
orders of magnitude. Slower retraction velocities were considered to be impractical, due both 
to the long periods of time that would be required to collect data and the effects of 
background noise. Similarly, although other studies have reported retraction velocities in 
excess of 4 µ/s,
90, 141
 at these speeds hydrodynamic effects on the cantilever begin to have a 
significant effect on the quality of force extension curves obtained. Data collected at 
different retraction velocities in this fashion permitted the assembly of a dynamic force 
spectrum for bisacridine 2. 
 
There is a clear relationship between the size of observed rupture forces and the critical 
loading rate (i.e. the loading rate at the point of bond rupture) at which the force was 
observed. Simply, any rupture force is proportional to the rate at which the force was 
applied, and as the velocity of the cantilever increases, so the measured rupture force 
increases. This pattern is illustrated in Figure 75, with a distinct increase in rupture forces 
noticeable at loading rates exceeding 1000 pN/s. Data obtained from analysis of the dynamic 
force spectrum are summarized in Table 28. 
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Figure 75 Top left, scatter plot of rupture force versus critical loading rate (showing the 
typical increase in rupture forces at higher loading rates) and histograms of forces at 
particular loading rates, showing the distribution of forces and gaussian fitting. 
 
Table 28 Table of data derived from the histograms presented in Figure 75, showing the 
relationship between increased loading rate and increased force. 
Mean critical loading rate / pN/s SE / pN/s Force / pN SE / pN 
108.8 46.3 21.3 0.5 
261.2 32.8 24.5 4.5 
564.7 134.7 23.9 1.0 
1033.1 132.8 34.3 7.4 
1851.8 382.8 42.1 2.6 
6728.2 3342.2 41.1 7.8 
30140.5 9050.8 70.4 11.6 
 
A plot of the most probable rupture force at each subdivision of the critical loading rate is 
provided in Figure 76. This graph reveals the existence of two separate regimes within the 
dynamic force spectrum, each of which reveals different information about the nature of the 
interaction that is being investigated. 
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Figure 76 Plot of the most probable rupture force versus the corresponding critical loading 
rate (black points with error bars), overlaid against the scatter plot of the events observed 
during the DFS experiment. This plot highlights the existence of two separate regimes from 
within the dynamic force spectrum. 
 
The sloping line at higher loading rates is representative of the kinetic regime of the bonding 
interaction to which a force is being applied.
89
 In this region of the force spectrum, the rate at 
which a force is applied exceeds the rate of dissociation of the ligand from the DNA. The 
gradient of the slope and the value of the intercept with the y axis are provided in Table 29. 
 
Table 29 Values for the gradient and the intercept of the linear regime observed at high 
loading rates as determined by Origin Pro™.  
Bisacridine 2 (R
2
 0.89) Most probable value SE 
Gradient 28.2 4.8 
y axis intercept - 53.3 13.7 
 
Since the slope of this line is inversely proportional to the distance to the transition state 
(xt)
86
 at which point rupture of the bond occurs, it is possible to determine the value of xt 
using this information, using a value of 4.11 pN.nm at 24 °C (kBT) to express the Boltzmann 
constant (kB, 1.3806488 * 10
−23
 J/K) in terms of force and distance: 
 
Gradient = kBT / xt 
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Rearranging the above formula yields a value of 1.5 Å for xt (within a range of 1.2 to 1.8 Å). 
It has been suggested that values of xt in the region of 1 Å are representative of single 
molecule interactions, while smaller values are indicative of the stretching of multiple 
bonds.
89
 Certainly, values of xt in the region of 1 to 10 Å likely represent the kinds of 
supramolecular reorganization and bond angle deformation liable to be occurring at the point 
of rupture where both the PEG tether and the DNA to which it is attached have been 
stretched to their full lengths.
142
 Similar values for xt have been reported in other 
spectroscopy studies that involve the stretching of DNA. A study utilising optical tweezers to 
examine the binding of actinomycin to DNA found a value of 1.1 Å (± 0.2 Å) for the 
distance from the bound to the unbound state of the ligand.
143
 
 
Extrapolating the line to the critical loading rate at which the applied force is 0 pN (r0) 
allows calculation of the kinetic unbinding rate of the system, according to the following 
equation: 
 
k
0
off = r0 e
-.577
xt/kBT 
 
In this context, r0 may be calculated by rearranging the typical formula of y = mx + c, so 
that: 
 
r0 = 53.3 / 28.2 
 
Taking the inverse log of 53.3 / 28.2 yields a value for r
0
 of 77.6 pN/s, which subsequently 
provides a value for k
0
off of 1.59 s
-1
 (within a range of 0.1 to 18.0 s
-1
). Values for xt and k
0
off 
are summarized in Table 30. 
 
Table 30 Values for xt and k
0
off determined from the dynamic force spectrum in Figure 76. A 
range for each of these values was calculated using the standard error of each parameter 
shown in Table 27. 
 Most probable value Range 
xt / Å 1.5 1.2 to 1.8 
k
0
off / s
-1 
1.6 0.1 to 18.0 
 
The thermal off rate, koff, alone does not provide an indication as to the affinity of the 
bisacridine for the inter-molecular binding arrangement. However, a study by Liu et al. into 
the binding of 9-aminoacridine to DNA, using a force spectroscopy apparatus not dissimilar 
to that described here, reported a similar range of values for koff from 1.2 s
-1 
to 21.7 s
-1
.
99
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The lower region of rupture forces shown in Figure 76 may be interpreted in two different 
ways. According to the Bell-Evans model, different regimes within a dynamic force 
spectrum were considered to be indicative of different barriers within the energy 
landscape.
86, 88
 However, an alternative interpretation of the energy landscape has more 
recently been proposed. According to Friddle and Noy, the alternative regime observed at 
low critical loading rates reflects an equilibrium regime, where the rate of applied force does 
not exceed the rate of dissociation of the ligand from the DNA. The height of this 
equilibrium regime is representative of the free energy (ΔGu) of the unbinding interaction 
that is being observed.
89, 144
  
 
Assuming, as illustrated in Figure 76, that this region of the force spectrum is indeed an 
equilibrium state where the gradient of the fitted line is zero, it is possible to estimate a value 
for ΔGu. Extrapolating this line to the point where x is equal to zero yields a value for y (or 
feq) of 21.84 pN (SE 0.76). The relationship between feq and ΔGu may be described as: 
 
feq
2
 = 2k ΔGu 
 
Applying this relationship requires the estimation of a value of k, or in this instance keff a 
combination of the spring constant of the cantilever and of the PEG tether that was utilised in 
this experiment. The nominal spring constant of the cantilever that was provided by the 
manufacturer was 0.027 N / m. However, the values derived from thermal tuning of the two 
cantilevers used to obtain the force spectrum were 0.0393 and 0.0384 N / m. Taking a mean 
average of these two experimentally determined spring constants yields a value for kcantilever 
of 0.0389 N/m. Assuming a typical spring constant for PEG of 150 N/m gives: 
 
keff = 150*0.0389 / (0.0389 + 150) 
keff = 0.0389 N / m or 38.9 pN / nm 
 
Applying these values for keff to feq yields a value for ΔGu of 6.13 in terms of force and 
distance. This value may be converted into kJ/mol: 
 
(6.13 / 4.11)*2.479 = 3.70 kJ/mol  
 
Finally, converting this value of 3.70 kJ/mol into kcal yields a ΔGu of 0.88 kcal/mol. 
 
Data of this kind are relatively lacking, certainly from force spectroscopy investigations into 
the behaviour of intercalators with DNA. The study of the intra-molecular binding of 
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acridine with DNA by Liu et al. did not provide a value for ΔGu. Similarly, studies of the 
capacity of bisacridines to form inter-molecular junctions, using agarose gel electrophoresis, 
did not provide any thermodynamic data for this particular binding mechanism.
33-34
  
 
However, studies have been conducted into the intra-molecular binding of intercalators using 
other techniques. These studies have reported values for ΔGu of around 7.6 kcal/mol for 
echinomycin and 5 kcal/mol for acridine.
145-146
 The value of 0.88 kcal/mol reported here for a 
Type II intercalation event could be considered to be fairly consistent with these values, 
especially when considering that the ΔGu for a well studied, high affinity, interaction such as 
that of biotin and streptavidin has been reported to be in excess of 20 kcal/mol.
147
 Certainly, 
given the nature of a Type II intercalation event, it is not surprising that any value for ΔGu 
would suggest this to be a weaker interaction than that of a Type I, intra-molecular event.  
 
There nonetheless remain some important limitations to the value of 0.88 kcal/mol that has 
been obtained here. The value itself is derived from an approximate value of the effective 
spring constant that may not accurately reflect the elastic nature of the various components 
of the system, namely the combination of the cantilever, the PEG and the intercalated DNA. 
Moreover, the value of 0.88 kcal/mol represents an average of all of the potential binding 
arrangements that may occur between the two separate strands of DNA. The precise value 
for binding at different nucleotide steps within the DNA could be different depending on the 
precise arrangements of the nucleotides at the binding site. 
 
Visualising Type II intercalation with gold nanoparticles 
Gold nanoparticles are of interest in several fields, notably as a means of detecting 
contamination of water by mercury, forensic science, drug delivery and in the development 
of conducting materials.
148-151
 The particles themselves are very versatile, and can be 
functionalised in a number of ways with proteins or DNA, typically via thiol chemistry. 
 
Disperse suspensions of gold nanoparticles have a characteristic red colour that becomes 
colourless when the particles aggregate. Precipitated gold nanoparticles are typically blue in 
colour. Controlled aggregation of gold nanoparticles has been demonstrated in a number of 
ways, including by the addition of sodium chloride, or the annealing of particles 
functionalised with ssDNA.
152-154
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Figure 77 Graphical illustration of the experimental concept, showing how aggregation of 
the particles occurs on addition of a bisintercalator. The legend denotes 1) DNA 2) 
Bisintercalator 3) Gold nanoparticle. 
 
Theoretically, cross-linking of DNA by bisintercalators should yield the typical red to 
colourless change in a solution of these particles functionalised with dsDNA. A schematic of 
the experiment is provided in Figure 77. Although the cross-linking of DNA by 
bisintercalators has been demonstrated using force spectroscopy, these experiments were 
relatively slow and required complex analysis in order to interpret the data. The simple 
colour change associated with aggregation of the gold nanoparticles would provide a simple 
assay for determining, instantly, whether or not cross-linking of DNA is occurring.  
 
A 3 nM stock solution of gold nanoparticles was prepared by mixing separate solutions of 
gold (III) chloride trihydrate (32 µM) and trisodium citrate (170 µM) at 85°C for two and a 
half hours.
155
  Two complementary oligonucleotides, with the same sequence as used in the 
force spectroscopy experiments were annealed. One of these oligonucleotides incorporated a 
thiol group at the 5’ terminus. The sequences of the DNA are as follows: 
 
1) 5’ – [ThiC6] – CTACGTGGACCTGGAGAGAGGAAGGAGACTGCCTG – 3’  
2) 5’ – CAGGCAGTCTCCTTCCTCTCTCCAGGTCCACGTAG – 3’ 
 
In order to attach the DNA to the gold nanoparticles, 31.5 µl of a 25 µM solution of the 
thiolated DNA was added to 1.5 ml of the gold nanoparticles along with a volume of 30 µl of 
500 µM trisodium citrate (pH 3.0). After mixing, the solution was left standing for 10 
minutes before 52.5 µl of 2 M sodium chloride was added, whereupon the solution was left 
in a rotary mixer for 20 minutes. A further 150 µl of 2 M sodium chloride were subsequently 
added to the solution, and the system returned to the rotary mixer for 40 minutes. In order to 
1)
2)
3)
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remove unbound nanoparticles and DNA, the solution was centrifuged at 8000 rpm for 30 
minutes. The supernatant was decanted, and the red aggregate resuspended in 10 mM 
phosphate buffer (pH 7.4). Successful attachment of the DNA to the nanoparticles was 
confirmed by UV spectrophotometry. Gold nanoparticles have a characteristic absorption 
band at 520 nm, which shifts to 525 nm when DNA is coupled to the particle surface. 
 
Adding intercalators to solutions of gold nanoparticles 
In order to ascertain whether or not cross-linking of the DNA on the nanoparticles occurs 
when a bisintercalator is added to the solution, experiments were conducted using UV 
spectrophotometry. A volume of 570 µl of the gold nanoparticle and DNA solution was 
transferred to a cuvette, to which 1 µl aliquots of the relevant ligand were then added. 
Spectra were obtained after each addition. 
 
Addition of either an increased volume of PBS buffer or sequential addition of a 2 mM 
solution of 9-aminoacridine caused no change to the position of the peak at 525 nm, 
indicating that under these conditions the gold nanoparticles remained stable. On addition of 
increasing concentrations of the acridine monointercalator, a new peak was observed around 
400 nm, typical of UV absorbance by an acridine (Figure 78). At the same time, no change 
in the colour of the solution could be observed following the addition of the acridine, with 
both the control, and the solution remaining a brick red colour. 
 
 
Figure 78 UV absorbance spectra of gold nanoparticles functionalised with dsDNA. 
Stepwise addition of 10, 1 µl aliquots of PBS buffer did not change the appearance of the 
spectra in any way (left). Addition of 10, 2 µl aliquots of 2 mM 9-aminoacridine did not 
cause a change in the peak at 525 nm, but did result in the appearance of a new peak at 400 
nm. 
 
Addition of the bisacridines to the nanoparticle solution produced a measurable change in the 
position of the peak at 525 nm that is characteristic of the aggregation of gold particles. A 
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colour change from red to colourless was also observed with the two bisacridines, 
bisacridine 2 and bisacridine 3. 
 
 
Figure 79 Spectra of the bisacridines bisacridine 2 (left) and bisacridine 3 (right). With 
bisacridine 2, there is a rapid change in the position of the peak at 525 nm, accompanied by a 
shoulder in the wavelengths around 600 nm, indicative of aggregation. The fall in intensity 
of this peak reflects a degree of precipitation. The characteristic absorbance peak of the 
acridine may also be seen at 400 nm. With bisacridine 3 the peak shift occurs more 
gradually, and there is no shoulder at 600 nm, suggesting that here, aggregation of the gold 
particles is following a different mechanism. 
 
A comparison of the colour of the solutions, following addition of the monointercalator and 
the bisintercalators, also demonstrates the differences between the various compounds. This 
change from red to colourless is shown in Figure 80. 
 
Figure 80 Solutions of gold nanoparticles. From left, control (no ligand), 10 mM bisacridine 
2, 20 mM 9-aminoacridine, 10 mM bisacridine 3. The colour change from red to colourless 
is typical of gold nanoparticle aggregation caused by the bisacridines. 
 
Since the oligonucleotide utilised in these experiments was identical to the GC terminated 
oligonucleotide used in the force spectroscopy experiments, it was hoped that binding may 
also be observed with echinomycin. Due to the poor aqueous solubility of echinomycin, it 
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was necessary to suspend the compound in DMSO. This was further diluted to an aqueous 
solution of 10% DMSO in PBS. Stepwise addition of DMSO to the gold nanoparticles 
without the ligand was conducted in order to ascertain if the solvent might cause the particles 
to aggregate. 
 
 
Figure 81 Spectra showing stepwise addition of 1 µl aliquots of DMSO (left) and addition of 
1 µl aliquots of a 1mM solution of echinomycin in 10% DMSO (right). The bands evident at 
320 nm in the echinomycin sample are likely indicative of the presence of echinomycin, 
which absorbs UV at 243 and 320 nm. 
 
Figure 81 demonstrates that no change in the peak at 525 nm was observed, either with 
DMSO or echinomycin. A comparison of the colours of the gold nanoparticle solution after 
the addition of each of the ligands is provided in Figure 82. Addition of echinomycin to the 
gold nanoparticles did not result in a change from red to colourless. Given the results of the 
force spectroscopy experiments, this was somewhat disappointing. However, this may be 
attributable to several factors, which should be considered in turn. First, force spectroscopy 
experiments were conducted at a much lower echinomycin concentration than experiments 
with the gold nanoparticles (100 nM and 1 to 10 mM respectively). At nanomolar 
concentrations, echinomycin is water soluble and hence it was possible to reduce the DMSO 
content of the solution to only 0.1%. DMSO has been shown to cause changes in DNA 
secondary structure, typically a slight contraction, which may inhibit the attachment of a 
ligand. Second, the frequency of the events observed via force spectroscopy was, in the case 
of echinomycin and TANDEM, significantly lower than with the bisacridines. Furthermore, 
by lowering the AFM cantilever towards the substrate, connections of this kind would have 
been more likely to occur due to the increased proximity of the oligomers, whereas the gold 
nanoparticles are moving freely in solution. Third, it has not been possible to quantify the 
amount of DNA attached to any of the gold nanoparticles. Although studies elsewhere are 
attempting to address this issue, there does not currently exist an accessible protocol capable 
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of rendering an accurate concentration for the DNA on the surface of the gold 
nanoparticles.
152
 As such it is not possible to determine the ratio between the ligands and the 
DNA. Since Type II intercalation is known to occur at high ligand to DNA base pair ratios, it 
is possible that, at the concentrations utilised in these experiments, the ratio of echinomycin 
to DNA was not sufficiently high to give way to cross-linking of separate DNA strands.  
 
 
Figure 82 Solutions of gold nanoparticles containing different ligands. a) no ligand b) 10 
mM bisacridine 2 c) 20 mM 9-aminoacridine d) 10 mM bisacridine 3 e) DMSO f) 10 mM 
echinomycin. Colour changes with the bisacridines reveal the Type II binding mechanism, 
which is not observed with echinomycin. 
 
Reversing ligand induced aggregation of gold nanoparticles 
The binding activity of intercalators has been demonstrated previously via sequestration with 
the surface active agent sodium dodecyl sulphate (SDS).
156
 Simply, by changing the binding 
equilibrium between the ligand and the DNA, SDS will remove bound ligand from DNA, 
reversing the process of intercalation. In order to ascertain whether or not the process of 
nanoparticle aggregation could be reversed via this mechanism, SDS was added to solutions 
of gold nanoparticles that had been aggregated with the bisacridines.  
 
In order to establish whether or not the SDS itself would change the stability of the 
nanoparticle suspension, 1 µl aliquots of 20 mM SDS (10 mM phosphate buffer, pH 7.4) 
were added to a solution of 570 µl of the nanoparticles and no changes were observed 
(Figure 83). 
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Figure 83 Addition of 1 µl aliquots of SDS to the gold nanoparticle solution. No changes to 
the appearance of the spectrum are observed. 
 
In order to test the reversibility of the aggregation process following the addition of a ligand, 
aliquots of bisacridine 2 were added to the gold nanoparticle solution until a change in the 
spectrum was observed that indicated that aggregation of the nanoparticles was occurring. At 
this point, successive quantities of SDS were added to the aggregated solution until the 
spectrum had returned to that of the gold nanoparticle solution prior to aggregation (Figure 
84). 
 
Figure 84 Spectra of gold nanoparticles binding to increasing concentrations of bisacridine 2 
(left) and reversal of DNA-ligand binding by addition of an increasing concentration of SDS 
(right). 
 
This experiment was repeated using another bisacridine, bisacridine 3, and similar results 
were obtained (Figure 85). 
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Figure 85 Spectra of gold nanoparticles binding to increasing concentrations of bisacridine 3 
(left) and reversal of DNA-ligand binding by addition of an increasing concentration of SDS 
(right). 
 
Both Figure 84 and Figure 85 illustrate that aggregation of gold nanoparticles by bisacridines 
is a reversible process. There is also an associated colour change, from colourless to red 
(Figure 86). 
 
 
Figure 86 Solutions of gold nanoparticles containing 2mM bisacridine 2. A change from red 
to colourless corresponding to the change in peak position in Figure 84 is shown (left) 
alongside the same solution after the addition of 12 µl of 20 mM SDS (right). In each case, 
the left hand eppendorf contains a solution of gold nanoparticles and DNA. 
 
An alternative means of demonstrating the reversibility of the intercalation of DNA with a 
ligand is via the use of CT-DNA in place of SDS. Whereas the surfactant removes bound 
ligand from the DNA attached to the gold nanoparticles, addition of further quantities of 
DNA, freely in solution, effectively reduces the ratio of ligand molecules to available DNA 
base pairs (Figure 87). Addition of calf-thymus DNA to the aggregated solutions of gold 
nanoparticles caused a reversal of the aggregation. In all cases, a colour change was 
observed from colourless to red.  
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Figure 87 UV absorbance spectra of gold nanoparticles, showing that the addition of 
successive, 1 µl aliquots of CT-DNA does not affect the spectrum (top) but that increasing 
the amount of free DNA in solution can reverse the aggregation process after the addition of 
bisacridine 2 (bottom). 
 
Measuring the aggregation of gold nanoparticles via DLS 
An alternative means of demonstrating the reversible aggregation of gold nanoparticles is 
that of dynamic light scattering (DLS). Not only the colour and UV absorbance spectra of 
solutions of gold nanoparticles may be diagnostic of aggregation, but also the size of 
individual or aggregated particles within the solution. 
 
Experiments were conducted in order to ascertain whether or not a difference in the diameter 
of any aggregated material within the solution could be found after the addition of a 
bisintercalator. Experiments were also conducted to confirm whether or not these aggregates 
were broken down by the process of surfactant sequestration as suggested by the colour 
change of the solution from colourless to red. Data obtained from these experiments are 
provided in Table 31. Particle size analysis of the nanoparticles was performed in a 1.5 ml 
plastic UV-visible absorbance cuvette using a Malvern Zetasizer Nano-ZS. Measurements 
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for the ligands were taken after the addition of 4 µl of 500 µM solutions of the bisacridines 
bisacridine 2 and bisacridine 3, each to an initial volume of 570 µl of the gold nanoparticles. 
Measurements involving SDS were taken after the addition of 12 µl of 20mM SDS to an 
aggregated solution of the gold nanoparticles, containing 4 µl of either of the bisacridine 
ligands. 
 
Table 31 Mean diameters for different solutions of gold nanoparticles obtained via DLS. 
Note that addition of SDS to a solution of gold nanoparticles functionalised with DNA 
results in a change in mean diameter from 31 to 56 nm. Addition of the bisacridines yields a 
large increase in mean particle diameter. 
 Mean diameter / nm max / nm 
cAuNP 24.17  519 – 520 
cAuNP + DNA 31.30 523 – 527  
cAuNP(DNA) + SDS 55.86 523 - 527 
cAuNP(DNA) + bisacridine2 645.03 560 – 561  
cAuNP(DNA) + bisacridine 2 + SDS 48.26 525 – 527  
cAuNP(DNA) + bisacridine 3 113.47 530 - 533 
cAuNP(DNA) + bisacridine 3 + SDS 50.94 524 – 528  
 
These experiments confirm the results obtained via UV absorbance. The mean diameter of 
the gold nanoparticles following the addition of both a bisacridine ligand and SDS is 
approximately the same as the diameter of the particles prior to the addition of SDS, around 
50 nm. However, on addition of bisacridine 2, there is a significant change in the mean 
diameter of the particles present in solution from 24.17 nm to 645.03 nm. 
 
The DLS data also highlight a significant difference between particle sizes observed with 
bisacridine 2 and bisacridine 3. While the mean diameter of aggregates observed on binding 
of bisacridine 2 is 645 nm, that of those bound to bisacridine 3 is 113 nm. Whether or not 
this difference is actually significant is open to question, since the values for particle sizes 
determined by DLS are averages of the entire range of particle sizes present in solution. 
However, the UV spectra presented in Figure 79 showed a difference in the spectral changes 
that could be observed with bisacridine 2 and bisacridine 3. If this difference is indeed 
significant, it might be explained in a number of ways. Firstly, aggregation of the gold 
nanoparticles may be occurring in a different way with each compound. Although the 
chromophore of each of these bisacridines is identical, the structure of their 
interchromophore linkers is very different. This may lead to differences in their respective 
modes of intercalation. Secondly, the affinity of each compound for binding of this kind may 
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be different. Monitoring the Type II binding of these compounds via force spectroscopy 
revealed a higher incidence of interactions with bisacridine 3 relative to bisacridine 2. 
 
Visualising the aggregation of gold nanoparticles using TEM 
Further evidence that bisintercalators are cross-linking DNA attached to the gold 
nanoparticles is provided by TEM. Samples of gold nanoparticle solutions, before and after 
the addition of a ligand, were deposited on carbon films and pictures were obtained that 
reveal the clusters of gold nanoparticles that have formed as a result of the presence of the 
bisintercalator in the solution. 
 
Pictures of two TEM samples are provided in Figure 88. While the gold nanoparticle 
solution provided a uniform coverage of the carbon scaffold demonstrating individual or 
clusters of 2 or 3 separate gold nanoparticles, the ligand sample was very different. Addition 
of bisacridine 2 yielded large clusters of gold nanoparticles due to the inter-molecular DNA 
binding mechanism of this compound.  
 
 
Figure 88 TEM images of gold nanoparticles functionalised with DNA (left) and the same 
nanoparticles after the addition of bisacridine 2 (right), showing the kinds of large 
nanoparticle aggregates formed by Type II intercalation. 
 
Conclusions 
These experiments have demonstrated conclusively that bisintercalators are capable of 
binding to DNA in two different ways; via the intra-molecular mechanism referred to as 
Type I intercalation, and via the inter-molecular mechanism referred to as Type II 
intercalation. Type II intercalation by luzopeptin and some bisacridine analogues has already 
been shown elsewhere as discussed, however, the force spectroscopy study described here 
constitutes the first attempt to characterise the strength of this particular binding interaction. 
Further work will be required in order to ascertain whether or not Type II intercalation of 
DNA may have a chemotherapeutic application.  
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The force spectroscopy assay used for investigating Type II intercalation also revealed an 
unexpected binding mode of the bisintercalators echinomycin and TANDEM.
157
 The 
sequence-specific Type II intercalation of the termini of opposing strands that is suggested 
by these experiments has never been revealed in any other studies involving the DNA 
binding behaviour of these two compounds. This particular finding is unlikely to find an 
application in the treatment of cancers, and so far has only been visualised using short 
stretches of DNA under the idealized conditions described above. However, in theory such a 
binding mechanism could be of considerable value in the field of the nanosciences. 
Reversible, controlled coupling of the termini of different DNA strands would enable the 
construction of longer DNA sequences, a process that is currently only possible by enzyme 
ligation.  
 
The results of the force spectroscopy experiments with the bisacridines are supported by a 
gold-nanoparticle aggregation assay. When functionalised with DNA, gold nanoparticles 
aggregate readily on addition of a bisintercalator. There are a number of ways in which this 
experiment could be adjusted to provide more information about the cross-linking process. 
For example, by changing the nucleotide composition of the DNA, the sequence specificity 
of the intercalating ligand could be examined. Alternatively, the DNA could be replaced with 
an alternative structure such as RNA. Although the assay is restricted to ligands that bind in 
an inter-molecular fashion, there are many ways in which this assay could be adjusted to 
provide further information about the binding behaviour of such a compound. 
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Introduction 
Ligands that bind to DNA are known cytotoxics, some of which have proven to be clinically 
useful (such as amsacrine), but the binding behaviour of small ligands such as intercalators 
does not demonstrate a high degree of specificity. The preference of some intercalators, such 
as echinomycin, for DNA sequences rich in particular nucleotides in the context of the 
extensive DNA sequences present in the nucleus of a cell, does not afford a means for 
effectively controlling the delivery of a cytotoxic agent to a patient.  
 
This kind of relatively indiscriminate binding results in many ligands currently in clinical 
use, such as doxorubicin or cisplatin, suffering from narrow therapeutic indices where the 
margin between a therapeutic or a toxic dose is very small.
36
 Ideally, it would be possible to 
deliver a ligand exclusively to the preferred site of action, thereby avoiding any dose related 
toxicities caused by indiscriminate binding activity. This problem has been approached in a 
number of ways, including through the development of pro-drugs that are activated by 
endogenous metabolic pathways (e.g. cyclophosphamide and 5-fluorouracil) to drug delivery 
systems or techniques that ensure the release of a ligand only at the desired site of action.
158
  
 
Another approach to targeted drug delivery stems from more sophisticated understanding of 
particular disease states. Discovery of the genetic components of certain kinds of breast 
cancer led to the design of the monoclonal antibody trastuzumab (Herceptin™), a therapy 
which has revolutionized the treatment of HER2 positive metastatic breast cancer. 
Classically, the specificity of many chemotherapies has stemmed from the accelerated rate of 
cell division that occurs in most tumours. Targeting particular cellular processes associated 
with cell division offers a means of refining specificity of this kind. 
 
Higher order DNA structures have been of interest for some time, offering a means of 
directing ligand binding towards DNA in a more controlled fashion than the simple primary 
sequence of the DNA itself.
159-160
 These higher order structures are often prominent in the 
promoter regions of oncogenes and telomeres, suggesting a relationship between such 
secondary structures and the uncontrolled cell division associated with a tumour.
161
 Specific 
examples of DNA secondary structures are G-quadruplex, associated with guanine rich 
regions, I-motif (associated with cytosine rich regions) and three or four-way DNA junctions 
such as the Holliday junction. The following experiments will examine two of these 
secondary structures, the Holliday junction and the I-motif. Full methods for each of the 
experiments described in this Chapter are provided in Chapter 7. 
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AFM imaging of the Holliday junction 
In 2007 the crystal structure of an acridine binding at the cross-over region of a Holliday 
junction was published.
160, 162
 In theory at least, stabilizing a Holliday junction via a small 
ligand should interrupt homologous recombination and thereby induce apoptosis. Techniques 
for studying the Holliday junction have hitherto tended to be indirect, such as gel 
electrophoresis, fluorescence titrations and CD.
163-164
 However, a few papers have been 
published that have utilised AFM to provide direct visualization of the Holliday junction, as 
well as other secondary structures such as G-quadruplex.
165-166
 One particular study used 
AFM to follow the branch migration of the Holliday junction, from initial formation of the 
cruciform structure (in its open conformation), to resolution where the DNA strands 
separate.
167
 Borrowing the techniques of some of these earlier studies, our intention was to 
use AFM to provide direct evidence of the stabilization of the Holliday junction by an 
acridine. 
 
Figure 89 Cartoon of a four-way DNA structure, the Holliday junction.
168
 Each of the 
separately coloured strands represents a strand of ssDNA. 
 
Four separate oligonucleotides, capable of forming a four-way cruciform structure, were 
purchased (New England Biolabs, UK). The arrangement of the four separate 
oligonucleotides in a HJ structure is illustrated in Figure 89. The four oligonucleotides 
constituted two pairs of hemi-junctions. Each pair of oligonucleotides from each hemi-
junction was annealed to its complementary strand, one strand being 39 base pairs in length, 
the other 35. The four base pair overhang permitted the attachment of a longer DNA tether, a 
428 base pair linear fragment of DNA restricted from the plasmid pcDNA3.1/Hygro (+) 
(Invitrogen, UK). After ligation of the oligonucleotides to the longer DNA tether, the two 
separate hemi-junctions were annealed at equimolar ratios in TNM buffer for 4 minutes at a 
temperature of 50°C. The annealed material was then added to 45 µl of a solution of 10 mM 
MgCl2 and immediately transferred to freshly cleaved mica for AFM imaging. 
 
Unfortunately, repeated scans did not reveal any homogeneity in the surface features. 
Broadly speaking, DNA structures fell into one of three categories (Figure 90). First, and by 
far the most extensive, were linear DNA structures very similar to those observed prior to 
annealing. Second, were linear DNA structures approximately twice the length of those 
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structures that fell into the previous category. Finally, a very small number of potential 
cruciform structures were also identified (Figure 92).  
 
 
Figure 90 AFM images of the annealed Holliday junction hemi-junctions. The enlargements 
show the three typical types of features that were isolated from these images. The scale bars 
denote 200 nm. 
 
Those DNA structures that were similar in conformation and physical dimensions to the 
original 427 base pair DNA fragments may be considered in three ways. First, they could be 
427 base pair fragments of DNA that had failed to ligate to the oligonucleotides. Second, 
they may have been fragments that had failed to join together during the annealing process. 
Third, these particular DNA strands may have annealed, forming unstable cruciform 
structures that had resolved and separated before the samples were transferred to mica. The 
longer DNA strands, measuring approximately twice the length of the other linear DNA 
strands could be another product of the earlier ligation step. However, this is unlikely since 
the ligation products had been separated via electrophoresis, where the respective bands were 
clearly defined from one another. The effectiveness of this technique is supported by data 
collected from this experiment and the previous AFM experiment with a 771 base pair DNA 
fragment, where larger strands were not observed in the control groups. More likely, these 
linear structures are separate hemi-junctions that have successfully annealed, but where 
branch migration of the junction is not apparent.  
 
Obviously, the original intention of this experiment was to identify cruciform structures 
typical of the open conformation of the Holliday junction. The few cruciform structures that 
were observed need not necessarily have been partially resolved Holliday junctions and 
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despite the low concentration of DNA material that was adsorbed onto the mica these 
structures may in fact be separate strands lying either on top of or next to one another. The 
possibility that these strands are lying on top of one another may be eliminated in individual 
cases by considering a cross-sectional profile the z axis of an image (Figure 91).
169
  
 
 
Figure 91 AFM image of an isolated DNA cruciform structure (left). The scale bar denotes 
50 nm. The red line corresponds to a cross section of the image which is illustrated (right). 
This illustration demonstrates that there is no increase in the value of the z axis where the 
two strands meet, proving that these strands are not overlapping. 
 
Furthermore, of the few cruciform structures that were isolated, in some cases the arms of 
the structures were equal in length. In the case of a situation where two strands had collided 
on the mica, it is probable that one arm would be longer or shorter than the other three, 
reflecting the random nature of the process. It therefore remains possible that these structures 
are indeed Holliday junctions showing varying degrees of branch migration.
167
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Figure 92 Cruciform structures isolated during AFM scanning of the annealed Holliday 
junction material. Clockwise from top left 1) A probable random arrangement of DNA, 
where one arm of the cruciform is noticeably shorter than the others 2 + 4) Potential 
Holliday junctions 3) 3 dimensional representation of the cruciform structure identified in 4. 
The scale bars denote 100 nm. 
 
In an attempt to increase the number of cruciform structures, the annealing process was 
adjusted in a number of ways. Annealing was conducted in a range of buffers, including 
TBE, sodium cocodylate and HEPES, while the temperature of the heat block was also 
adjusted over a range from 40 to 60°C and periods of time from two to ten minutes. None of 
these adjustments yielded an increase in the number of potential Holliday junctions that were 
observed. 
 
Force spectroscopy of the I-Motif 
The binding of a bisacridine to another DNA secondary structure, the I-motif (Figure 93), 
has also been suggested.
170
 Although the biological significance of this structure remains 
uncertain, its association with G-quadruplex, known to be associated with the enzyme 
telomerase and a large number of cancers, suggests that this structure may also be a viable 
target for chemotherapies.
171
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Figure 93 Graphical illustration of the I-motif structure, showing the H-bonding arrangement 
with a protonated cytosine base.
172
 
  
The unfolding of a G-quadruplex has been examined using force spectroscopy, a technique 
that could be readily applied to monitoring the unfolding of the I-motif.
173
 Using apparatus 
similar to that employed earlier in this study to explore inter-molecular intercalation (Figure 
94), an oligonucleotide containing I-motif forming regions was stretched between the 
substrate to which it was attached and the opposing, bare AFM cantilever. The sequence of 
the oligonucleotide is as follows: 
 
1) 5’ – [NH2] – TAACCCTAACCCTAACCCTAACCC – 3’ 
 
 
Figure 94 Illustration of the experimental design for stretching a ssDNA molecule. The 
surface of the AFM probe is bare and as such is able to adhere to the DNA attached to the 
substrate. The legend denotes 1) mercaptoundecanoic acid 2) PEG 3) ssDNA. 
 
The preparation of the PEG tether and the passivation of the substrate were conducted in the 
same manner as previously described for the DNA cross-linking experiments. This 
experiment was conducted under three different sets of buffer conditions: at pH 7, where the 
I-motif is not believed to occur; pH 5, where the protonated cytosine regions of the 
oligonucleotide should form an I-motif; and at pH 7 in the presence of silver ions which are 
believed to induce I-motif formation even at neutral pH.
172
 Using a bare, gold coated 
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cantilever (Asylum Research, BL-RC150VB) force spectroscopy was conducted in liquid by 
lowering and retracting the cantilever in arrays of 100 x 100 data points over areas of 10 x 10 
microns on the gold surface. 
 
 
Figure 95 Scatter plot of observed interactions with Kuhn lengths greater than 0.6 nm (left) 
and histogram of lengths (right). These data were collected at pH 7. 
 
An initial experiment to explore the range of lengths and forces that would be encountered 
yielded the data presented in Figure 95. Although events covered a fairly wide range of 
forces, gaussian fitting of the observed lengths provided a contour length for the 
oligonucleotide of 30.8 nm (SE 0.9 nm). Given that the oligonucleotide utilised here was 24 
bases in length, and that the rise per base pair in ssDNA is 0.68 nm, the experimentally 
determined value corresponded well with the theoretical length of the molecule of 31.72 nm 
for the ssDNA coupled to the 15.4 nm PEG tether.  
 
This same experiment was repeated under the other two sets of conditions. Firstly, the pH 7 
buffer was substituted with 10 mM sodium cacodylate buffer pH 5.5. Secondly, the buffer 
was substituted with 10mM sodium cacodylate buffer pH 7.4 containing 100 µM AgNO3. 
Figure 96 provides a comparison of the forces observed under each set of conditions and the 
data are tabulated in Table 32. 
0 25 50 75 100 125 150
0
25
50
75
100
125
150
F
o
rc
e
 /
 p
N
Length / nm
0 25 50 75 100 125 150
0
10
20
30
40
C
o
u
n
t
Length / nm
Chapter 5 
127 
 
 
Figure 96 Histograms of force for stretching of the I-motif forming oligonucleotide sequence 
under different conditions of pH and buffer ion content. These histograms do not reveal any 
significant differences in observed forces under the different conditions of buffer and pH. 
 
Although the distribution of observed forces is greater at pH 7, and mean observed forces for 
each set of conditions are different from one another, these observations are unlikely to be 
significant. It is important to note that, at a single retraction velocity, the precise numerical 
value of the most probable rupture force is a meaningless figure.
89
  
 
Table 32 Comparison of the different forces obtained from the histograms in Figure 96 for 
each pH and buffer, showing the similarities in observed rupture forces. 
 Mean force / pN (SE) n 
pH 7 37.1 (5.2) 60 
pH 5.5 27.3 (5.1) 55 
pH 7 + Ag
+
 41.9 (1.8) 27 
 
Conclusions 
The failure of the Holliday junction binding assay may be attributed to several different 
factors. Primarily, the DNA preparation techniques yielded insufficient DNA material for 
extensive adjustment of the final annealing step. The initial cleavage of the plasmid DNA 
resulted in a considerable loss of DNA, the 427 base pair fragment constituting only 8% of 
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the 5428 base pair plasmid. Separation of the DNA following digestion and ligation reduced 
yields further, with the separation of the DNA from the agarose gel inherently inefficient.  
 
The AFM imaging of the DNA hemi-junctions after annealing suggests that the 
complementary halves of the expected Holliday junction were aligning. If a more efficient 
means of generating the requisite DNA starting materials was utilised, theoretically the 
Holliday junction structure could be separated from other DNA material after the annealing 
process, thereby increasing the number of cruciform structures that may be visualized and 
also providing a secondary means of verifying that such cruciform structures are indeed true 
DNA secondary structures and not simply the result of separate strands lying in close 
proximity to one another.  
 
Such an approach has already been demonstrated elsewhere using PCR to generate the hemi-
junctions and agarose gel electrophoresis at 4°C to separate annealed Holliday junctions 
from non-annealed material.
167
 This approach also resolves another problem with the 
experimental approach that was utilised here, specifically that of the annealing buffer. 
Successful annealing is dependent on the presence of metal ions such as magnesium, to 
facilitate the alignment of complementary nucleotide base pairs. Unfortunately, these same 
ions also stabilize the Holliday junction and prevent, or significantly slow, branch migration. 
Gel electrophoresis offers a means of removing the annealing buffer and subsequently 
replacing it with another such as TE buffer, under which conditions branch migration may 
occur.  
 
That aside, this procedure did re-emphasize the capability of AFM as a means for providing 
direct evidence of activity at a single molecule level. The products of the DNA annealing 
process could be separated from one another using quantities of material that would be 
below the sensitivities of other commonly used processes such as gel electrophoresis. If the 
experimental procedure could be refined in the ways previously suggested, there is no doubt 
that AFM imaging would be capable of providing direct evidence of ligand-induced 
stabilization of a Holliday junction. 
 
The results of efforts to discern differences in a short oligonucleotide capable of forming an 
I-motif structure were equally disappointing. Although the preliminary results demonstrated 
the capability of the AFM apparatus to resolve even a short oligonucleotide sequence such as 
that utilised here, the protocol would need to be developed if the unfolding of an I-motif 
structure is to be observed in this fashion. The next step, potentially, would be to attach a 
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functional group to the 3’ end of the oligonucleotide, perhaps a biotin bead, which could be 
trapped by a streptavidin coating on the AFM probe (Figure 97).  
 
Figure 97 Conceptual arrangement of a ssDNA (green) coupled to a biotin bead (red). By 
lowering the streptavidin functionalised PEG attached to the AFM probe towards the 
substrate, coupling of the biotin and streptavidin will occur. The arrow demonstrates the 
direction of retraction after coupling has occurred. 
 
Under the arrangement described in Figure 97, the oligonucleotide could be stretched over a 
range of loading rates, between the covalent gold-thiol linkage of the 5’ terminus, and the 
streptavidin-biotin complex at the 3’ terminus. However, given the small size of the I-motif, 
effectively spanning only four, tri-nucleotide cytosine regions, the oligonucleotide sequence 
may also require modification. Lengthening the sequence to incorporate multiple I-motif 
forming regions might facilitate the observation of unfolding of these regions as serial 
multiple events within a given force extension curve, so revealing the transition from the 
folded to the unfolded state of the I-motif.  
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Conclusions and future work 
Despite advances in the diagnosis and treatment of cancer, there remains a pressing need for 
new chemotherapeutic agents. Although an improved medical understanding of specific 
cancers, such as those of the lung or prostate, has improved patient outcomes in certain cases 
there is no doubt that cancer will continue to be one of the leading causes of death in the 
human population.
174-176
 As such, the discovery of new lines of treatment, whatever their 
nature, is of considerable importance. 
 
Although a considerable period of time has elapsed since amsacrine was licensed for clinical 
use in the UK, research has continued into this class of ligand and the acridine analogues 
examined in these studies offer various advantages relative to other ligands.
177-179
 First, these 
compounds are relatively straightforward to synthesize. Second, unlike the larger peptide 
bisintercalator echinomycin, all of the acridine dimers used in this study are water soluble. 
The failure to translate the in-vitro cytotoxicity of bisintercalators to a clinical environment 
does not necessarily preclude them from being chemotherapeutic agents of the future. Many 
of the limitations of small DNA binding ligands, such as a relative lack of specificity, could 
potentially be overcome by innovations in formulation and drug delivery.  
 
These studies have confirmed previous theoretical assumptions that the acridine 
chromophore induces wide ranging deformation of the DNA duplex, the intercalated 
structure akin to that of the dehydrated A form of the classical Watson-Crick duplex.
120
 
Given the sensitivity of many intra-cellular enzymes, not only topoisomerase II, the ability of 
the acridines to induce a conformational switch in DNA sequences may yet find a 
chemotherapeutic application.  
 
The capacity of bisintercalators to bind to DNA in an inter-molecular fashion has attracted 
considerably less attention than the mechanism of intra-molecular intercalation. Although 
previous studies have demonstrated the coalescence of DNA bound to luzopeptin and 
various bisacridine analogues,
33-34
 the importance of this mechanism, as a factor either of the 
enhanced in vitro cytotoxicity of bisintercalators or of their narrow in vivo therapeutic 
window, has never been fully explored.  
 
Given the success of agents such as cisplatin, it is perhaps surprising that inter-molecular 
binding of a ligand to separate DNA strands has attracted so little attention. Although the 
inter-molecular binding of a platinating agent occurs between adjacent strands of ssDNA 
within a double stranded duplex, the cytotoxic effect would presumably be similar. Physical 
knots and tangles within DNA would provide a physical barrier to transcription, interfering 
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with strand separation and thereby inducing apoptosis. Such an occurrence must be 
considered all the more likely when DNA is packed tightly in the nucleus of the cell.
55
   
 
Advances have been made in refining the chemistry of intercalators in order to enhance the 
specificity of these ligands for particular DNA structures.
180
 Although efforts in this study to 
visualise a Holliday junction using AFM were not entirely successful, the binding of a 
bisacridine at a four way Holliday junction has been demonstrated via crystallography.
160, 162
 
An improved understanding of the role that higher order structures such as the Holliday 
junction and the G-quadruplex play in DNA replication and repair will doubtless facilitate 
the use of ligand binding in these regions for oncological purposes.
161
  
 
These studies have also revealed a previously unobserved intercalative mechanism that has 
implications for the employment of bisintercalators, not as medical agents, but nano-
engineering tools. Sequence specific, blunt-end, inter-molecular binding of DNA by 
echinomycin and TANDEM could be exploited in a number of ways.
157
 In recent years there 
has been considerable interest in the creation of nanoscale structures using short 
oligonucleotide sequences.
181
 Although initially a novelty, the ability to manipulate 
biological material in a controlled fashion could have profound implications for both medical 
technologies and materials’ science. Current techniques, involving ligase enzymes, are 
hampered by the inefficiency of blunt-end ligations, particularly with short oligonucleotide 
sequences.
182
 A recent paper has demonstrated the use of intercalators as molecular 
chaperones.
183
 Since intercalation is a non-covalent interaction, use of these ligands in this 
context is ideal since the process is non-destructive and the ligand is easily removed via 
surfactant sequestration. 
 
In view of the application of intercalators in a chemotherapeutic context, it is possible to 
overlook the other areas where intercalators have been shown to be medically useful agents. 
The quinoxalines, such as echinomycin and echinoserine, have been evaluated for their 
antibacterial properties.
17
 Similarly, artemisinin-acridine conjugates have been examined not 
only for their anti-tumour activity but also for their potential in combating malaria.
178
 There 
is also a report of the quinomycin antibiotic, quinaldopeptin, having anti-viral properties.
184
 
Even if the mechanism of DNA intercalation itself is found to have little direct application in 
other therapeutic areas, intercalators may function as a scaffold, anchoring an additional 
functionality or a pro-drug within nucleosomal DNA. 
 
These experiments have utilised the technique of AFM to gain an insight into the behaviour 
of intercalating ligands with DNA. This technique has been demonstrated to offer numerous 
Chapter 6 
133 
 
advantages to alternative analytical techniques that have previously been used for studies of 
this kind. Although some expertise is required on the part of the operator, in order to obtain 
AFM images of reasonable clarity, samples are relatively straightforward to prepare and may 
be obtained in a short period of time. The assay of DNA contour lengths conducted in this 
study has revealed some aspects of DNA intercalation with acridines that had hitherto only 
been suggested by theoretical models. In this case, direct examination of the physical 
characteristics of individual molecules has revealed a phenomenon that may have been 
disguised by bulk techniques such as flow viscometry and gel electrophoresis. Although 
greater resolution may be obtained via NMR and X-ray crystallography, experiments of this 
kind can be difficult to conduct, reflected in the paucity of any crystal structures for DNA-
acridine complexes.
118
 
 
Similarly, despite a significant body of published literature surrounding the intra-molecular 
binding of echinomycin, no evidence has been reported to suggest that this molecule is 
capable of binding to separate DNA strands.
75
 Clearly, the nature of the inter-molecular 
mechanism suggested herein would prohibit its detection; the event occurs at low 
frequencies and only where blunt-end fragments of DNA are in close proximity with one 
another. This would automatically preclude its detection via, for example, a plasmid 
unwinding assay. This in itself demonstrates the remarkable sensitivity of single molecule 
force spectroscopy. 
 
Continued advances in AFM technology, such as faster scan rates, and improvements in 
AFM probe design, are likely to ensure that AFM becomes a more accessible and even more 
sensitive technique. Given that AFM images of benzene rings have already been reported 
elsewhere,
185
 it is not difficult to envisage that AFM may yet prove to be capable of 
distinguishing individual ligands bound to a DNA structure. Data derived from AFM 
experiments are now available in a growing number of publications, and this is certain to 
continue in the future.  
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Plasmid DNA unwinding assay 
A protocol for visualizing the unwinding of plasmid DNA was modeled on the protocol 
described by Wakelin et al.
19
 Agarose gels (1%) were prepared using 1 g of agarose in 100 
ml of 1xTAE buffer (pH 8). The solution was heated until all of the agarose had dissolved. 
After being allowed to cool for a period of a few minutes, the solution was transferred to an 
electrophoresis tank (10 by 6.5 cm) and allowed to set. The gel was then covered in an 
appropriate volume of 1xTAE buffer.   
 
Samples were prepared by the addition of 2 µl of φX174 RFI plasmid DNA (New England 
Biolabs, UK, concentration 1 mg/ml), to 70 µl of 10 mM tris HCl buffer (pH 7), yielding a 
final volume of 72 µl. A total of 8, 9 µl aliquots were taken from this solution, to 7 of which 
were added 1 µl of relevant concentrations of a particular ligand and to the eighth 1 µl of 
DMSO or water as a control. This yielded a final volume per sample of 10 µl. Assuming a 
molecular weight of 650 g/mol for each nucleotide, and knowing that the plasmid consisted 
of 5386 base pairs, the concentration of the DNA in each 10 µl sample was determined to be 
7.1 nM.  
 
After an incubation period of one hour, 2 µl of loading buffer were added to each sample and 
the samples were transferred to separate wells on the agarose gel. A power pack was 
connected to the electrophoresis chamber and set at 70 V for a period of approximately two 
and a half hours.  
 
After this period of time, the gel was removed from the electrophoresis chamber and 
transferred to a plastic container. The gel was covered with a 1 µg/ml solution of ethidium 
bromide for ten minutes and then rinsed with 1xTAE buffer. The gel was exposed to a UV 
light source and images of the gel were obtained for analysis. All images were processed 
using GeneSnap
©
 (Synoptics, UK) and adjusted for brightness and contrast. 
 
Synthesis of bisacridine 1 
Bisacridines 2, 3, and 4 were synthesized by Dr. L. A. Howell at the University of East 
Anglia.
50
 The bisacridine N-(6-(acridin-9-ylamino)octyl)acridine-9-amine was synthesized 
from acridone and 1,8 diaminooctane using procedures that have been described elsewhere.
54
 
Acridone (1 g, 5.15 mmol) was hearted to reflux in SOCl2 (10 ml) with 2 drops of DMF for 1 
hour. SOCl2 was removed under vacuum and the residue dissolved in dry phenol (10 g) 
which was then heated to 110°C. After 15 minutes, the temperature was reduced to 55°C and 
1,8 - diaminooctane (0.38 g, 2.56 mmol, 0.5 equivalents) was added. The mixture was stirred 
for 2 hours and an aqueous solution of NaOH (2 M, 20 ml) was added. The resulting solution 
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was extracted with DCM (15 ml) which was dried (MgSO4) and evaporated to give the crude 
product. Purification by flash column chromatography was followed by dissolution in 1.25 
M HCl in MeOH to give the final product. After removing the methanol under vacuum, the 
final product was dissolved in water and stored at -20°C. 
 
 
Figure 98 Synthesis of bisacridine 1, showing the Meisenheimer complex that is generated 
by the interaction between phenol and 9-chloroacridine.  
 
Generation of the product was confirmed by 
1
H NMR (400 MHz, CD3OD). Due to the 
symmetrical nature of the compound each signal in the 
1
H NMR spectrum equated to double 
the number of protons in that environment. There were four signals in the aromatic region of 
the spectrum, corresponding to the 16 acridine protons at 8.5 (d), 7.97 – 7.93 (m), 7.81 (d) 
and 7.55 ppm (t). In the aliphatic region of the spectrum there were three signals, excluding 
the solvent, at 4.14 (t), 2 – 1.97 (m) and 1.49 – 1.45 (m) ppm, attributable to the 8 methylene 
groups of the inter-chromophore linker. 
 
DNA contour length assay 
This protocol was modeled on that described by Tseng et al.
75
 A plasmid DNA, φX174 RF I, 
was obtained from New England Biolabs (UK) in a concentration of 1 mg/ml. A portion of 
this was restricted using the enzyme BfaI (NEB, UK). 5 µl of the stock solution of DNA was 
added to 35 µl of water and 5 µl of restriction buffer in an eppendorf tube (New England 
Biolabs Buffer 4). Finally, 5 µl (25 units) of the enzyme BfaI was added to the solution, 
giving a final volume of 50 µl, and it was mixed thoroughly before being incubated at 37°C. 
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After one hour, the solution was removed from the incubation chamber and the restriction 
digestion was stopped by the addition of 10 µl of loading buffer.  
 
Aliquots of this solution were loaded onto a 1% agarose gel, prepared as previously 
described. A power pack was connected to the gel and allowed to run for a period of 
approximately two hours at 70 volts. This was found to provide adequate separation of the 
three fragments yielded by the digest. The gel was then removed from the electrophoresis 
chamber, and stained with 0.1% ethidium bromide solution for ten minutes. The gel was 
visualised by exposure to UV light. 
 
The band corresponding to the 771 base pair fragment (Figure 99) was excised and then 
purified using a QIA Quick Kit
©
 (QIAGEN, UK) following the supplier’s instructions. The 
concentration of the derived DNA solution was determined via NanoDrop
©
 instrument at a 
wavelength of 260 nm (ThermoScientific, UK), and the solution stored at -20°C until used.  
 
 
Figure 99 Agarose gel showing the three products of BfaI digestion of φX174 (left). The 
lowest of the three bands was the one excised, and is seen part way between the bands at 500 
and 1000 base pairs on the ladder (lane 1, New England Biolabs 1 kb DNA ladder). The 
restriction map shows the precise locations of cleavage by the enzyme. 
 
Samples for DNA imaging were prepared by the addition of 15 µl of Nanopure™ water to 
10 µl of a solution of the 771 base pair fragment of φX174 DNA (concentration 2.35 ng/µl). 
25 µl of 10 mM MgCl2 were then added, giving a final system volume of 50 µl. Assuming a 
molecular weight of 650 g/mol, the concentration of DNA in the initial solution volume of 
25 µl was found to be 1.9 nM. The entire volume of 50 µl was transferred to freshly cleaved 
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mica that had been mounted on a metallic AFM disc. Cleaving of the mica was performed by 
peeling with adhesive tape. After a period of 10 minutes to allow DNA strands to adhere to 
the mica, the disc was rinsed using 10, 1 ml drops of distilled water and then air-dried under 
nitrogen.  
 
Samples prepared to test particular ligands were prepared by the addition of 15 µl of an 
appropriate concentration of the ligand to 10 µl of a solution of the 771 base pair fragment of 
φX174 DNA. Controls were prepared using water in place of the ligand. Following an 
incubation period of one hour, 25 µl of 10 mM MgCl2 were added, giving a final system 
volume of 50 µl. The system was then transferred to freshly cleaved mica, mounted on a 
metallic AFM disc as before. 
 
Imaging was conducted in tapping-mode in air using a CPII
©
 AFM (Veeco Instruments, 
USA), equipped with a small area scanner. Calibration of the instrument in the x and y 
dimensions was conducted according to the manufacturer’s instructions using commercially 
available calibration grids. Commercially available cantilevers were used (Veeco 
Instruments, models RTESPA-CP and TESP as appropriate), with images captured in height 
mode. In order to minimize the forces between the cantilever and the substrate, the set-point 
was increased until contact with the surface was lost and then gradually decreased until a 
surface trace was again visible. Gains were adjusted to optimise image clarity as required.  
 
Using the seven hundred and seventy-one base pair fragment of φx174, it was found that 
images conducted at speeds of approximately two hertz, over a region of two by two microns 
yielded images of sufficient sharpness and contrast to ensure reproducible measurement of 
the fragments adsorbed to the mica surface. A pixel resolution of 1024 by 1024 pixels 
provided a physical resolution of 1.9 nm per pixel versus 3.9 nm for scans conducted at 512 
pixels. Assuming a helical rise of 0.34 nm per intercalation event according to the classical 
principle of intercalation, this corresponded to an experimental sensitivity of 5.5 intercalation 
events at the former resolution versus 11 at the latter. To ensure consistency of calibration, 
measurements of DNA length were only taken from images obtained using the CPII AFM. 
 
Collected images were processed and examined using WSxM (Nanotec) and adjusted as 
required for brightness and contrast.
186
 Contour length measurements of DNA strands were 
made manually using the ‘segmented line’ tool in the programme ImageJ© (NIH, public 
domain). Statistical analyses were conducted using OriginPro
©
 (OriginLab Corporation, 
USA). Measurements of individual DNA strands were tabulated and plotted as a histogram 
of contour lengths. Mean values and standard error for each population were derived from 
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the peak of a gaussian curve fitted to the histogram. Measurements of the contour lengths of 
DNA treated with the acridines were expressed as a percentage change in the length of the 
DNA fragments.  
 
Fourier transform infrared spectroscopy 
Experiments were conducted using a Bruker IFS 66/S Spectrometer (Bruker Optics UK, 
United Kingdom) fitted with a Specac (Orpington, UK) Golden Gate Single Reflection 
Diamond ATR, using a method described by Whelan et al.
125
 Samples were prepared using 
CT-DNA (Sigma, UK), at a stock concentration of 1mg/ml. A 5 µl aliquot of the DNA 
solution was deposited on the diamond, and spectra collected over various periods of time 
under standard conditions, at wavelengths between 4000 and 550 cm
-1
. Scans were repeated, 
at a scan time of 40 scans and intervals of 60 seconds for one hour at a resolution of 2 cm
-1
. 
Spectra were analysed using OPUS (Bruker Optik, version 6). 
 
Circular dichroism 
CD was conducted using a Jasco J-810 spectropolarimeter, adapting a methodology 
described by Ivanov et al.
128
 All experiments used a quartz cuvette with a path length of 1 
mm. Spectra were collected over a wavelength from 350 to 200 nm at a data pitch of 0.5 nm 
in continuous scanning mode at room temperature. The scanning speed was set at 200 nm / 
minute with a response of 1 second at a band width of 2 nm. Spectra were accumulated in 
triplicate and averaged. Samples were prepared using CT-DNA (Sigma, UK) at a stock 
concentration of 1mg/ml (3007 µM in DNA base pairs). The control was prepared by the 
addition of 20 µl of 200 µM NaCl to 20 µl of DNA. The volume was made up to 200 µl by 
the addition of 10 mM tris HCL buffer (pH 7). 1 µl of the appropriate concentration of each 
ligand was added to this volume and mixed. In the case of bisintercalators, a stock solution 
of 3 mM was used. To preserve the ligand to base pair ratios for direct comparison between 
bisintercalators and monointercalators, stock solutions of 6 mM were used for the 
monointercalators. The A form of CT-DNA was induced by the substitution of the tris buffer 
with ethanol. After subtracting the buffer from the signal, each spectrum was zero corrected 
at 320 nm and processed using OriginPro™ (OriginLab, ver. 8.0724). 
 
Visual DNA cross-linking assay 
A 1341 base pair, linear fragment of plasmid φX174, measuring 456 nm, was produced by 
restricting the plasmid with the enzyme BsaAI. This restriction enzyme yields two 
fragments, one of 1341 base pairs and the other of 4045 base pairs.  
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Fragments were separated via agarose gel electrophoresis and purified using a Qiagen 
agarose removal kit in the manner previously described. A stock solution of DNA was 
prepared and the concentration determined via NanoDrop
©
.  
 
Aliquots of this DNA solution were diluted further to 0.34 ng/µl. 10 µl of this dilute DNA 
solution was combined with 15 µl of the appropriate ligand, or 15 µl of water for the control 
group. The concentration of DNA in this solution, assuming a molecular weight per base pair 
of 650 g/mole, was calculated to be 0.16 nM. After an incubation period of ten minutes, 25 
µl of 10 mM MgCl2 was added, yielding a total volume of 50 µl, and the solution deposited 
on freshly cleaved mica for a period of 10 minutes. Samples were then rinsed with 
Nanopure™ water and dried under nitrogen. 
 
Imaging was conducted using a Veeco Instruments CPII. Data were collected in intermittent-
contact mode at 512x512 over regions of 2x2 microns at a scan rate of 2 Hz. Cantilevers 
were purchased from Asylum Research UK (AC160TS). Images were collated and processed 
using WSxM (Nanotec).
186
 
 
Force spectroscopy of DNA 
Force spectroscopy was conducted using a NanoWizard 2™ AFM fitted with a liquid cell 
(JPK, DE) containing 3 mM phosphate buffer (Fisher Scientific, UK, pH 7) or the 
appropriate concentration of a ligand. In order to maintain the same ratio of ligand 
chromophores to DNA base pairs, bisintercalating compounds were used at half the 
concentration (100 nM) of the monointercalators (200 nM). Solutions were prepared in 
phosphate buffer and filtered using syringe filters with a 0.2 µm PTFE membrane and used 
immediately. 
 
Gold coated cantilevers were purchased from Asylum Research (BL-RC150VB) and used as 
received (nominal spring constant 0.027 N/m). Cantilevers were calibrated using the thermal 
tune method (range 0.016 N/m to 0.058 N/m).
187
 Experiments were conducted in contact 
mode, at a relative setpoint of 0.2 nN. The z-length for all experiments was 150 nm and the 
approach and retract speeds set at 0.5 microns per second and a resolution of 2048 Hz. Force 
spectra were collected in arrays of 100 x 100 data points over areas of 10 x 10 microns. 
Dynamic force spectroscopy was conducted by adjusting the retraction velocity over a range 
of speeds from 0.05 to 4 microns per second. Spectra were exported and analysed using 
JPK’s data processing software (JPK instruments, DE, ver. 4.0.0). Data sets were exported 
and analysed using OriginPro™ (OriginLab, ver. 8.0724).  
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Designing a tether for force spectroscopy experiments 
In order to conduct stretching experiments with DNA, it is essential for the DNA to be 
attached securely to another surface. Although DNA may be attached directly to another 
surface such as gold, it is also advisable to incorporate a spacer molecule in the arrangement, 
in order to keep the DNA clear of any non-specific attachments with the gold surface to 
which it is attached.  
 
Two pairs of 33 base pair oligonucleotides, with an amine functionality at the 5’ position, 
and their complementary sequences were purchased from Sigma UK. The sequences of the 
oligonucleotides were: 
 
1) 5’ – NH2 – CTACGTGGACCTGGAGAGAGGAAGGAGACTGCCTG – 3’  
    5’ – CAGGCAGTCTCCTTCCTCTCTCCAGGTCCACGTAG – 3’  
 
2) 5’ – NH2 – CTACGTGGACCTGGAGAGAGGAAGGAGACTGCCTA – 3’  
    5’ – TAGGCAGTCTCCTTCCTCTCTCCAGGTCCACGTAG – 3’ 
 
These sequences were annealed according to the protocol provided by the manufacturer and 
purified using a Qiagen nucleotide clean up kit. A 25 nm, 2950 Da PEG with a 
polydispersity index of 1.03 (Iris Biotech, DE) was coupled to the oligonucleotide via a 
hydroxysuccinimide functionality using a literature protocol and purified via ethanol 
precipitation (Figure 100).
188
  
 
 
Figure 100 Coupling of the amine terminated DNA to PEG. 
 
The successful coupling of PEG with the DNA was confirmed by gel permeation 
chromatography (Table 33) using a 30 cm TSKgel 3000PW column (Sigma, UK) at a flow 
rate of 0.8 ml/min. A significant shift in the retention time of the DNA was observed after 
the attachment of the PEG (Figure 101). 
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Table 33 Retention times (minutes) for the separate components and for the coupled PEG / 
DNA tether, showing an increase in retention time for the PEG/DNA conjugate relative to 
the DNA alone. 
  DNA PEG PEG / DNA 
MW / g/mol 20457 2950 23407 
Run 1 22.66 29.26 22.54 
Run 2 22.63 29.38 22.57 
Run 3 22.62 29.38 22.56 
Mean time 22.63 29.34 22.56 
 0.02 0.07 0.01 
 
 
Figure 101 Difference in the mean retention time, as determined by GPC, of the DNA alone 
and the DNA after attachment to the PEG, confirming attachment of the DNA to the PEG. 
 
A thiol termination was added to the oligonucleotide and PEG conjugate by the addition of 
propanedithiol (Figure 102) and purified again via ethanol precipitation. The final solution 
was diluted to a concentration of 60 ng/µl with phosphate buffer and stored at -20°C until 
used. 
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Figure 102 Attachment of propanedithiol to maleimide. 
 
Preparing a substrate for force spectroscopy experiments 
Successful AFM experiments are dependent on the quality of the surface underneath the 
AFM cantilever.
189
 In order to provide a flat gold surface to which the thiol functionality of 
the PEG and DNA could be attached, freshly cleaved mica was coated with gold using an 
Auto306 vacuum coater (Edwards), according to the manufacturer’s instructions. Deposition 
was stopped once the gold layer had reached a thickness of 50 nm. The gold-coated mica 
was then glued to microscope slides using a thin layer of Araldite™ glue, sandwiching the 
gold between the mica and the glass. The slides were stored at room temperature until used. 
The gold surface was exposed for use by peeling away the mica layer with adhesive tape 
which was then disposed of, leaving the gold attached to the glass slide.
190
 
 
Gold coated cantilevers were purchased from Asylum Research (BL-RC150VB) and used as 
received (nominal spring constant 0.027 N/m). Functionalisation was performed by 
depositing a 5 µl droplet of the PEG and DNA conjugate on an exposed gold surface, and by 
immersing a clean cantilever in a droplet of the same solution (Figure 103). 
  
Chapter 7 
144 
 
 
Figure 103 Schematic illustration of sulphur co-coordinating with a gold surface. 
 
The mechanism by which a thiol interacts with gold is not fully understood.
191-192
 It has been 
suggested that the thiol proton is lost as hydrogen gas.
193
 Importantly, the strength of the 
coupling has been ascertained, and reported to be approximately 45 kcal/mol.
191
 Although 
the bond between gold and sulphur is semi-covalent, with both electrons donated by the 
sulphur, the strength of this bond significantly exceeds that of the typical interactions, such 
as hydrogen bonds, that may be investigated using AFM and thus provides a suitable anchor. 
The substrates and the cantilevers were placed in a humidity chamber at 6°C and left for 20 
hours.
194
 The reaction was terminated by rinsing with Nanopure™ water. Passivation of 
substrates and cantilevers was performed immediately using a 10 mM solution of 11-
mercaptoundecanoic acid (Figure 104) in a fifty percent solution of DMSO in water for a 
period of one hour. Passivation was terminated by rinsing with Nanopure™ water. 
 
 
Figure 104 The molecular structure of 11-mercaptoundecanoic acid. 
 
The effects of 11-mercaptoundecanoic acid on the substrate are two-fold. Firstly, non-
specific adhesion between bare gold surfaces, on the substrate and the opposing cantilever, is 
eliminated by successful blockade of these areas. Secondly, hydrophobic interactions 
between neighbouring chains of 11-mercaptoundecanoic acid and the PEG/DNA tether 
promote the formation of a monolayer of these chains, where the body of the chain is 
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perpendicular to the anchoring surface. This facilitates the ‘pick-up’ of molecules by the 
AFM cantilever.
195
 
 
Synthesis of gold nanoparticles 
Separate solutions of gold (III) chloride trihydrate (32 µM) and trisodium citrate (170 µM) 
were heated to 60°C. The trisodium citrate was mixed with the gold (III) chloride under 
rapid stirring, and the temperature increased to 85°C for two and a half hours, yielding a 
transparent, red solution of gold nanoparticles of approximately 3 nM concentration.
155
 
 
A 33 base pair oligonucleotide, with a thiol functionality at the 5’ position, and its 
complementary sequence were purchased from Sigma UK. The sequences of the 
oligonucleotides were:  
 
1) 5’ – [ThiC6] – CTACGTGGACCTGGAGAGAGGAAGGAGACTGCCTG – 3’  
2) 5’ – CAGGCAGTCTCCTTCCTCTCTCCAGGTCCACGTAG – 3’ 
 
Stock solutions of each oligonucleotide were prepared according to the manufacturer’s 
instructions. Annealing was conducted using equimolar quantities of each oligonucleotide in 
10 mM trisodium citrate and 5 mM HEPES buffer. The solution was heated to 95°C for five 
minutes in a standard heat block and then allowed to cool to room temperature over a period 
of one hour. The solution was stored at -20°C until required. 
For some time, DNA has been attached to gold nanoparticles using a salt aging process 
described by Mirkin et al.
196
 This approach requires the introduction, gradually, of high 
concentrations of sodium chloride to the suspension of gold nanoparticles. After repeated 
attempts, the authors were unable to replicate this approach due to the instability of the 
nanoparticles in NaCl. 
 
Recently, an alternative method has been published for attaching DNA to gold nanoparticles 
that reduces the need for sodium chloride.
197
 Instead, the functionalisation is conducted 
under acidic pH. In order to attach the DNA to the gold nanoparticles, 31.5 µl of a 25 µM 
solution of the thiolated DNA was added to 1.5 ml of the gold nanoparticles along with a 
volume of 30 µl of 500 µM trisodium citrate (pH 3.0). After mixing, the solution was left 
standing for ten minutes before 52.5 µl of 2 M NaCl was added, whereupon the solution was 
left in a rotary mixer for 20 minutes. After this period of time, a further 150 µl of 2 M NaCl 
were added to the solution, and the system returned to the rotary mixer for 40 minutes. 
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In order to remove unbound nanoparticles and DNA, the solution was centrifuged at 8000 
rpm for 30 minutes. The supernatant was decanted, and the red aggregate resuspended in 10 
mM phosphate buffer (pH 7.4) before being centrifuged for a further 30 minutes. This step 
was repeated three times in order to remove as much unbound material as possible. After the 
final rinsing step, the gold nanoparticles were resuspended in 1.5 ml of phosphate buffer. 
 
Successful attachment of the DNA to the gold nanoparticles was initially confirmed by 
agarose gel electrophoresis. Solutions of gold nanoparticles are very unstable, causing them 
to precipitate on electrophoresis. Successful attachment of DNA to gold particles may 
therefore be demonstrated by the movement of properly functionalised particles through an 
agarose gel (Figure 105). 
 
Figure 105 Agarose gel comparing the electrophoretic character of a solution of gold citrate 
nanoparticles (left lane) and a solution of the same nanoparticles functionalised with DNA 
(right lane). The blue colour apparent in the left lane is typical of precipitated gold 
nanoparticles. The stability of the functionalised nanoparticles under these conditions 
confirms the attachment of the DNA. 
 
The addition of DNA to gold nanoparticles may be also be followed quantitatively by 
changes in the UV absorbance spectra of the solutions. Gold nanoparticles have a typical 
peak in absorbance at a wavelength of 520 nm. Functionalisation of the particles with 
dsDNA results in a shift in the position of this peak from 520 to 525 nm (Figure 106). 
 
 
Figure 106 Complete spectra for gold nanoparticles and gold nanoparticles functionalised 
with DNA (left). The peaks between 500 and 550 nm correspond to the gold particles 
themselves, while the appearance of a peak at 260 nm with the functionalised particles 
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reflects the presence of DNA. An enlargement of these spectra, showing a restricted 
wavelength range, shows the shift in the peak of the gold particles from 520 to 525 nm. 
 
Ultraviolet spectroscopy 
Ultraviolet-visible (UV-Vis) spectra were recorded using a Hitachi U-3000 
spectrophotometer at room temperature. A quartz cuvette with a 1 cm path length was used 
for all experiments.  
 
To an initial volume of 570 µl of the gold nanoparticle and DNA solution, the relevant 
ligand was added in 1 µl aliquots and the cuvette shaken gently by hand for a period of one 
minute. After each addition, the UV absorbance of the solution was measured. Spectra were 
exported for analysis using OriginPro™ (OriginLab, ver. 8.0724). 
 
Dynamic light scattering 
Particle size analysis of the nanoparticles was performed in a 1.5 ml plastic UV-visible 
absorbance cuvette using a Malvern Zetasizer Nano-ZS. Particle sizes were obtained for both 
the gold nanoparticles, and gold nanoparticles functionalized with DNA. Measurements for 
the ligands were taken after the addition of 4 µl of 500 µM solutions of the bisacridines 
bisacridine 2 and bisacridine 3, each to an initial volume of 570 µl of the gold nanoparticles. 
Measurements involving SDS were taken after the addition of 12 µl of 20mM SDS to an 
aggregated solution of the gold nanoparticles, containing 4 µl of either of the bisacridine 
ligands. 
 
Transmission electron microscopy 
One drop of a solution of gold nanoparticles functionalised with DNA was added to a copper 
TEM grid incorporating a holey carbon film. A second sample was prepared using a volume 
of 570 µl of a solution of the same gold nanoparticles after the addition of 4 µl of 500 µM 
bisacridine 2. Images were obtained using a FEI Tecnai G2 20 Twin transmission electron 
microscope (John Innes Centre, Norwich, UK) operating at 200.0 kV. 
 
Holliday junction assay 
Firstly, four oligonucleotides capable of forming a cruciform junction were purchased from 
Sigma, UK. Each pair of oligonucleotides was annealed according to the manufacturer’s 
instructions, forming a hemi-junction that incorporated a 4 base pair overhang that could be 
ligated to another complementary DNA sequence (Figure 107).
165
 In order to provide 
structures of sufficient size to visualise via AFM, each hemi-junction was ligated to a longer 
stretch of duplex DNA. A quantity of a plasmid DNA, pcDNA3.1/Hygro (+) (Invitrogen, 
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UK), was transformed and then separated using a QIAGEN plasmid purification kit 
(QIAGEN, UK). The DNA was purified via ethanol precipitation, and the concentration 
confirmed via NanoDrop. The initial concentration of the DNA stock solution was 1.6 
mg/ml.  
 
 
 
Figure 107 Sequences of the four oligonucleotides (top) used to construct a Holliday 
junction. The highlighted area shows the complementary region between each of the pairs of 
oligonucleotides. The lower half of the figure illustrates how the two separate hemi-junctions 
would align after annealing. 
 
The extracted plasmids were digested with the enzyme NdeI (New England Biolabs, UK), 
generating linear DNA. In order to eliminate the accumulation of unwanted ligation 
products, the linear DNA sequences were treated with calf-alkaline phosphatase (Invitrogen, 
UK). This process removed the terminal phosphate groups from the end termini of the DNA, 
which are essential for covalent attachment of one DNA sequence to another. The processed 
DNA was then restricted with the enzyme HindIII (Invitrogen, UK), yielding a 427 base pair 
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DNA duplex with a 4 base pair sticky overhang complementary to that of the oligonucleotide 
hemi-junctions. This fragment was separated from the remaining DNA via agarose gel 
electrophoresis and purified using a QIAGEN gel purification kit (Figure 108). 
 
 
Figure 108 Digestion of pcDNA 3.1/Hygro (+) with enzymes NdeI and HindIII. The agarose 
gel shows the three digestion fragments (lane 3) relative to a 100 base pair DNA ladder 
(New England Biolabs, lane 1). Lane 2 shows an 842 base pair DNA fragment from an 
alternative digest that was included as an additional reference standard. The schematic 
illustration of the plasmid pcDNA 3.1 shows the locations of the restriction sites. 
 
The processed DNA was analysed using AFM in order to ascertain whether or not the 
separation of the 427 base pair fragment from other products of the digestion had been 
effective and that the length of the DNA correlated with the expected size of the fragment 
(Figure 109). This experiment was conducted in the same manner as had previously been 
used when measuring the 771 base pair fragments of DNA from the plasmid φX174, 
substituting the DNA. 
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Figure 109 AFM image of the 427 base pair fragment of pcDNA 3.1/Hygro (+) and the 
corresponding histogram of the contour lengths of isolated DNA strands from the image. The 
scale bar denotes 250 nm. 
 
Assuming that the DNA remains in a B-conformation, with a helical rise of 0.34 nm per base 
pair, the theoretical length of the 427 base pair fragment would be 145 nm. This corresponds 
well with the value of 154 nm obtained by direct measurement of DNA contour lengths from 
AFM images. 
 
 
Figure 110 Agarose gel showing the products of the ligation of the 427 base pair DNA 
fragment and the corresponding oligonucleotides (lane 1) versus a low molecular weight 
DNA ladder (New England Biolabs, lane 2). The enlargement highlights two of the three 
products of the ligation, the third being smaller than the 75 base pair marker on the ladder 
and not visible on the gel. 
 
Each hemi-junction was ligated to the 427 base pair duplex using T4 ligase (New England 
Biolabs, UK). This procedure yielded three potential products, these being two hemi-
junctions, two 427 base pair duplexes, or the desired hemi-junction/427 base pair conjugate 
(Figure 110). The hemi-junction/427 base pair conjugate was separated from the other 
products via agarose gel electrophoresis and purified using a QIAGEN kit. The concentration 
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of the final product in aqueous solution was confirmed via NanoDrop, and was typically in 
the region of 5 ng/µl. 
 
In order to form a Holliday junction, or rather a solution of Holliday junctions that could be 
analysed using AFM, the separate pairs of hemi-junctions were annealed at equimolar ratios 
in TNM buffer for 4 minutes at a temperature of 50°C. Typically, the volumes of material 
used were 1 µl of each HJ hemi-junction (at a concentration of 5 ng/µl) and 3 µl of TNM 
buffer (10 mM tris-HCl, pH 7.9, 50 mM NaCl, 10 mM MgCl2). The annealed material was 
then added to 45 µl of a solution of 10 mM MgCl2 and immediately transferred to freshly 
cleaved mica. AFM imaging was conducted in tapping mode at a scan rate of 2 Hz and a 
resolution of 512 pixels.  
 
Force spectroscopy of the I-motif 
Force spectroscopy was conducted using a NanoWizard 2™ AFM fitted with a liquid cell 
(JPK, DE). Preparation of the substrate was conducted in the same manner, and used the 
same materials, as the force spectroscopy DNA cross-linking assay. The only difference 
between these two protocols was the composition of the DNA sequence, in this case a 
ssDNA sequence of 24 bases with an amine functionality at the 5’ terminus. The sequence of 
this DNA is as follows: 
 
1) 5’ – [NH2] – TAACCCTAACCCTAACCCTAACCC – 3’  
 
Gold coated cantilevers were purchased from Asylum Research (BL-RC150VB) and used as 
received (nominal spring constant 0.027 N/m). Cantilevers were calibrated using the thermal 
tune method (range 0.016 N/m to 0.058 N/m). Experiments were conducted in contact mode, 
at a setpoint of 0.6 nN and a relative setpoint of 0.2 nN. The z-length for all experiments was 
150 nm and the approach and retract speeds set at 0.5 microns per second and a resolution of 
2048 Hz. Force spectra were collected in arrays of 100 x 100 data points over areas of 10 x 
10 microns. Spectra were exported and analysed using JPK’s data processing software (JPK 
instruments, DE, ver. 4.0.0). Data sets were exported and analysed using OriginPro™ 
(OriginLab, ver. 8.0724).  
 
The experiment was repeated under three different sets of conditions, using three different 
buffers to fill the liquid cell. These buffers were 3mM phosphate buffer pH 7, 10 mM 
sodium cacodylate buffer pH 5.5 and 10mM sodium cacodylate buffer pH 7.4 containing 100 
µM AgNO3. 
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A rapid screen for molecules that form duplex to
duplex crosslinks in DNA†
Marı´a J. Marı´n,za Benjamin D. Rackham,zb Andrew N. Round,b Lesley A. Howell,b
David A. Russell*a and Mark Searcey*b
We describe a gold nanoparticle based assay that can rapidly
determine the crosslinking of DNA duplexes by ligands. Such
compounds have potential in targeting highly compacted DNA
such as that found in the nucleosome.
Studies of ligand–DNA interactions tend to focus on naked
structures either through gel techniques1 or, more recently,
through single molecule studies.2 In cells, DNA is tightly
compacted into the nucleosome, where it is closely associated
with the histone proteins and where it is tightly wound so that
one duplex structure lies close to another.3 There are few
studies of ligands binding to nucleosomal DNA, in part due
to the complexity in forming the core particle and also due to
the requirement for techniques such as footprinting4 and
crystallography5 that allow the assessment of the results.
Surrogate techniques, that allow the study of histone–DNA
and DNA–DNA interactions and the effects of these on molecule
binding have not been disclosed and yet have the potential to
change the way ligand–DNA interactions are viewed and new
therapeutics are designed. One simple example is how small
molecules with multiple functions are affected by the presence
of both protein and other DNA strands when binding to a
duplex sequence. There have been several recent descriptions
of multinuclear platinum complexes, one of which has pro-
gressed into clinical trial6 and which could potentially have
crosslinked protein to DNA or DNA duplex to DNA duplex.7
Pyrrolobenzodiazepine dimers such as the clinically tested
SJG-1368 could potentially form crosslinks within the nucleo-
some that run along a minor groove from one duplex strand
to another. These studies suggest that a simple test for this
novel higher order interaction is required. Gold nanoparticles
(ca. 16 nm in diameter) exhibit an intense red colour in aqueous
solution that changes upon aggregation of the particles.9 The
colour change is due to the coupling interactions between the
surface plasmon fields of the particles. Various studies have
focussed on the combination of single stranded DNA with gold
nanoparticles to investigate sequence recognition properties10
and even the ability of small molecules to stabilise the duplex.11
However, to our knowledge, there are no studies of double
stranded DNA (dsDNA) on nanoparticles to investigate duplex to
duplex interactions that may be crucial in nucleosome targeting.
In this paper, we describe a rapid colorimetric technique based on
the aggregation of dsDNA functionalised gold nanoparticles that
allows the identification of ligands that can crosslink two duplex
strands – a DNA to DNA crosslink (Fig. 1a). We have applied this
technique to the identification of a classical bisintercalator that
has previously only been shown to bind in a two base pair
sandwich fashion (bisacridine 1, Fig. 1b)12 and to a second
molecule designed to form DNA to DNA crosslinks (bisacridine
2, Fig. 1b).13 Themonointercalator 9-aminoacridine (9-AA, Fig. 1b)
was used as a control since it does not have the ability to crosslink
the duplex and therefore, it should not produce aggregation of the
dsDNA functionalised gold nanoparticles (Fig. 1a).
Water soluble gold nanoparticles were prepared via the citrate
reduction method14 and were functionalised with thiolated DNA
using a pH-assistedmethod.15 The thiolated DNA was added as a
pre-formed duplex. The dsDNA functionalised nanoparticles
formed a red suspension in phosphate buﬀer (10 mM, pH 7.4)
(Fig. 2) and were stable in the presence of NaCl as compared with
non-functionalised nanoparticles (Fig. S1 in ESI†).
9-Aminoacridine-4-carboxamides, such as compounds 1 and
2, are known DNA intercalating agents. The bisintercalator linked
through an eight methylene chain, compound 1, has previously
been shown to bind to and unwind supercoiled DNA and to have
a potent antiproliferative eﬀect on tumour cells in culture.12 We
have previously shown that the compound with a six methylene
linker is able to crosslink DNA duplexes,16 but the longer chain
allows for bisintercalation as a ‘‘staple’’ like structure similar
to natural products such as echinomycin.17 9-Aminoacridine-4-
carboxamide exhibits some sequence selectivity, with a preference
a School of Chemistry, University of East Anglia, Norwich Research Park,
Norwich NR4 7TJ, UK. E-mail: d.russell@uea.ac.uk
b School of Pharmacy, University of East Anglia, Norwich Research Park,
Norwich NR4 7TJ, UK. E-mail: m.searcey@uea.ac.uk; Fax: +44 (0)1603 592009;
Tel: +44 (0)1603 592026
† Electronic supplementary information (ESI) available: Experimental details for
this work. See DOI: 10.1039/c3cc45600e
‡ These two authors contributed equally to this work.
Received 23rd July 2013,
Accepted 22nd August 2013
DOI: 10.1039/c3cc45600e
www.rsc.org/chemcomm
ChemComm
COMMUNICATION
Pu
bl
ish
ed
 o
n 
22
 A
ug
us
t 2
01
3.
 D
ow
nl
oa
de
d 
by
 U
ni
ve
rs
ity
 o
f E
as
t A
ng
lia
 L
ib
ra
ry
 o
n 
12
/0
1/
20
14
 1
5:
21
:2
3.
 
View Article Online
View Journal  | View Issue
9114 Chem. Commun., 2013, 49, 9113--9115 This journal is c The Royal Society of Chemistry 2013
for GC rich sequences.18 The double stranded oligonucleotide
used to functionalise the gold nanoparticles (50-CTACGTGGACCT-
GGAGAGAGGAAGGAGACTGCCTG) contains multiple sites for
intercalation with compounds 1 and 2. Increasing concentrations
of compound 1 (from 0 to 17.2 mM) were added to a sample of the
dsDNA functionalised gold nanoparticles. The samples were slowly
shaken by hand for 1 min. The UV-Vis extinction spectrum of the
functionalised gold nanoparticle solution was measured before
and after addition of the corresponding compound 1 concen-
tration (Fig. 2a). Upon addition of increasing concentrations of 1,
the surface plasmon absorption band showed a significant red
shift from 525 to 578 nm and a decrease in intensity. Incubation of
the gold nanoparticles with 1 led to a rapid (o1 min) disappear-
ance of the red colour (Fig. 2d). These results suggest that the
bisintercalator 1 is causing aggregation of the dsDNA functiona-
lised gold nanoparticles through duplex to duplex crosslinking. A
similar titration was performed with phosphate buﬀer (PB) and no
colour change was observed (Fig. S2a in ESI†). The increase in the
extinction seen at 400–500 nm in Fig. 2a is due to the addition of
increasing concentrations of 1 (Fig. S2b in ESI†).
The observed colour change could be a consequence of simple
intercalation rather than crosslinking. In order to elucidate
whether crosslinking between 1 and the DNA was taking place,
the dsDNA functionalised gold nanoparticles were incubated
with 9-AA. Titration with 9-AA from 0 to 34.5 mM (i.e. twice the
final concentration of the bisintercalator) led to neither a change
in the UV-Vis extinction spectrum of the nanoparticles (Fig. 2b)
nor in the colour of the solution (Fig. 2d), suggesting that the
aggregation of the nanoparticles in the presence of 1 is not
simply a consequence of intercalation but rather a crosslinking.
The increase in extinction seen at 350–450 nm is due to the
addition of increasing concentrations of 9-AA (Fig. S2c in ESI†).
In a recent study, we described the use of click chemistry to
generate bisintercalators designed to bind to higher order DNA
structures.13 Some of these compounds were designed to direct
the second chromophore away from the duplex, one such mole-
cule being the bisintercalator compound 2. When the dsDNA
functionalised gold nanoparticles were incubated with increasing
concentrations of 2 (0 to 17.2 mM) a red shift (from 525 to 554 nm)
in the surface plasmon absorption band was observed accom-
panied by a decrease in the extinction intensity (Fig. 2c). The
changes in the surface plasmon band led to the disappearance of
the red colour (Fig. 2d). The increase in the extinction seen at
400–500 nm is due to the addition of increasing concentrations
of 2 (Fig. S2d in ESI†). A summary of how the addition of
compound 1, 2 and 9-AA affects the intensity of the extinction
maxima can be seen in Fig. S3 in ESI.†
The surfactant sequestration technique has been utilised in
kinetic studies of drug–DNA interactions in order to assess
dissociation kinetics of ligands from the duplex.19 Surfactant
sequestration was applied to demonstrate the reversibility of the
ligand–DNA binding and, therefore, the reversibility of the aggre-
gation of the dsDNA functionalised gold nanoparticles. In an
initial step, dsDNA functionalised gold nanoparticles were treated
with 1 (3.5 mM) to induce aggregation of the particles. A red shift
in the surface plasmon absorption band of the nanoparticles from
525 to 560 nm (Fig. 3a) and a change in the colour of the solution
(Fig. 3b) were observed upon addition of 1. Increasing concentra-
tions of sodium dodecylsulfate (SDS) (from 34.8 to 442.9 mM)
were added to the solution of gold nanoparticles containing 1.
Fig. 1 (a) Schematic representation of: (i) the aggregation of the dsDNA
functionalised gold nanoparticles in the presence of a bisintercalator and (ii)
non-aggregation of the dsDNA functionalised gold nanoparticles in the presence
of the monointercalator; (b) chemical structure of compound 1, compound 2 and
9-aminoacridine.
Fig. 2 UV-Vis extinction spectrum of dsDNA functionalised gold nanoparticles
(PB 10 mM, pH 7.4) after addition of increasing concentrations of: (a) 1; (b) 9-AA;
and (c) 2 and (d) Eppendorf tubes containing dsDNA functionalised gold
nanoparticles after addition of: (1) no compound; (2) 1 (17.2 mM); (3) 9-AA
(34.5 mM); and (4) 2 (17.2 mM). All of the samples were shaken by hand for 1 min
prior to measurement.
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The samples were shaken by hand for 1 min and the UV-Vis
extinction spectrum was recorded (Fig. 3a). After addition of SDS
(442.9 mM), the extinction maximum shifted back to 525 nm
(Fig. 3a) and the colour of the solution turned to the initial deep
red (Fig. 3c). These results clearly demonstrate the reversibility of
the DNA-compound 1 crosslinking reaction. Addition of increas-
ing concentrations of SDS to a solution of DNA functionalised
gold nanoparticles without compound 1 had no effect on the
surface plasmon absorption band of the solution (Fig. S4 in ESI†).
The reversibility process was also confirmed by dynamic light
scattering that showed an increase in the hydrodynamic diameter
of the dsDNA functionalised gold nanoparticles after addition of
compound 1. The diameter of the aggregated particles decreased
when SDS was added to the solution containing 1, i.e., when the
aggregation was reversed (Table S1 in ESI†).
Further verification of the reversibility of the crosslinking
between the DNA and compound 1 came from the titration of a
solution of dsDNA functionalised gold nanoparticles containing
1 (3.5 mM, aggregated nanoparticles) with non-immobilised calf
thymus DNA (CT-DNA). When the CT-DNA is in excess, it
competes with the gold nanoparticles for ligand binding and
should lead to disaggregation as 1 is sequestered onto the non-
immobilised DNA. Upon addition of CT-DNA (97 mM base pairs),
the surface plasmon absorption band shifted back to 525 nm
and the extinction intensity increased (Fig. S5a in ESI†) confirm-
ing the reversibility of the ligand–DNA crosslinking. Addition of
the same concentrations of CT-DNA to a solution of dsDNA
functionalised nanoparticles without 1 produced no changes in
the surface plasmon absorption band (Fig. S5b in ESI†).
Transmission electron microscopy (TEM) was used to further
confirm the crosslinking between dsDNA functionalised gold
nanoparticles and compound 1. TEM images of the dsDNA
functionalised particles showed dispersed gold nanoparticles
(Fig. 4a). In the presence of compound 1 the nanoparticles
aggregated forming large clusters as observed in Fig. 4b.
The ability of small molecules to crosslink duplex DNA (from
strand to strand) is well documented and studied – it forms the
basis for the clinically used antitumour agents such as cyclophos-
phamide – whereas duplex to duplex crosslinking is largely
unexplored and remains difficult to visualise by macroscopic
means, such as gel electrophoresis. As the move towards persona-
lised medicine and gene targeting continues, the ability to target
DNA that is compacted into the nucleosome and to study its
susceptibility to drugs and ligands is an imperative. In this paper,
we have shown that a compound previously demonstrated to bind
to one duplex structure is also able to form duplex to duplex
crosslinks. We have also demonstrated that it is possible to design
molecules with rigid linkers that can reach across from one DNA
strand to another, a potential benefit in a compact structure in the
cell. The use of gold nanoparticle conjugates to demonstrate
duplex to duplex crosslinking is a rapid colorimetric approach to
detection which could be extended to other molecules.
We thank the School of Chemistry (UEA) for the post-doctoral
fellowship of M.J.M. and the School of Pharmacy (UEA) for a
studentship for B.D.R. The authors are grateful to Dr Kim Find
(John Innes Centre, Norwich) for assistance with the TEM.
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Fig. 3 (a) UV-Vis extinction spectrum of dsDNA functionalised gold nanoparticles
(PB 10 mM, pH 7.4): (1) alone; (2) after addition of 1 (3.5 mM); and (3) after
addition of 1 (3.5 mM) and SDS (442.9 mM). (b) and (c) Eppendorf tubes containing
dsDNA functionalised gold nanoparticles (PB 10 mM, pH 7.4): (1) alone; (2) after
addition of 1 (3.5 mM); and (3) after addition of 1 (3.5 mM) and SDS (442.9 mM). All
of the samples were shaken by hand for 1 min prior to measurement.
Fig. 4 TEM images of dsDNA functionalised gold nanoparticles (a) before and
(b) after addition of 1 (3.5 mM). Scale bars: (a) 20 nm and (b) 100 nm.
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Non-covalent duplex to duplex crosslinking of DNA in
solution revealed by single molecule force
spectroscopy†
Benjamin D. Rackham, Lesley A. Howell, Andrew N. Round* and Mark Searcey*
Small molecules that interact with DNA, disrupting the binding of transcription factors or crosslinking
DNA into larger structures, have signiﬁcant potential as cancer therapies and in nanotechnology. Bisinter-
calators, including natural products such as echinomycin and rationally designed molecules such as the
bis-9-aminoacridine-4-carboxamides, are key examples. There is little knowledge of the propensity of
these molecules to crosslink duplex DNA. Here we use single molecule force spectroscopy to assay the
crosslinking capabilities of bisintercalators. We show that bis-9-aminoacridine-4-carboxamides with both
rigid and ﬂexible linkers are able to crosslink duplex strands of DNA, and estimate the equilibrium free
energy of a 9-aminoacridine-4-carboxamide bisintercalator from DNA at 5.03 kJ mol−1. Unexpectedly,
we ﬁnd that echinomycin and its synthetic analogue TANDEM are capable of sequence-speciﬁc cross-
linking of the terminal base pairs of two duplex DNA strands. In the crowded environment of the nucleo-
some, small molecules that crosslink neighbouring DNA strands may be expected to have signiﬁcant
eﬀects on transcription, while a small molecule that facilitates sequence-speciﬁc blunt-end ligation of
DNA may ﬁnd applications in the developing ﬁeld of DNA nanotechnology.
Introduction
DNA binding molecules are used extensively in the treatment
of cancer and yet molecules that can bind to and crosslink
multiple strands of DNA are relatively unexplored. The nitro-
gen mustards exert their eﬀects through the formation of inter-
strand covalent crosslinks on a single duplex strand that
inhibit DNA processing in proliferative cells.1 Adriamycin (doxo-
rubicin) is a natural product that forms a non-covalent inter-
action with DNA in which a planar aromatic chromophore is
inserted between the base pairs, forming a complex that inhi-
bits the enzyme topoisomerase II.2 This is an example of a
monointercalating compound. Echinomycin is a bisintercala-
tor, in which two chromophores are inserted into the helix,3
again leading to inhibition of DNA processing and cell death.
Although it has advanced into clinical trials, echinomycin is
not clinically utilised.
In a cell, DNA is tightly compacted into the nucleosome
and it is likely bifunctional molecules that can bind in the
nucleus will interact with more than one strand of DNA.
Several years ago, a gel based technique was used to demon-
strate that luzopeptin A had the ability to form duplex to
duplex crosslinks through bisintercalation,4 although this con-
clusion was challenged.5 Intercalators have also been specifi-
cally designed to favour crosslinking.6 These threading
acridines are also potent cytotoxins and it is possible that the
ability to crosslink duplex strands in the nucleosome, prevent-
ing unpacking during replication, is contributing to this
activity.
The sequence recognition properties of DNA also make it a
powerful tool for the preparation of devices on the nanoscale.
This has been demonstrated by disclosures of “smiley” faces,
DNA walkers and nanoscale frameworks to study reactivity.7–9
DNA has also been exploited for its ability to act as a molecular
wire, with the insertion of ruthenium complexes into
sequences up to 100 base pairs in length.10 Nanoscale struc-
tures often rely on large circular plasmid DNA that is then
stitched together using smaller sequences that are designed to
make the plasmid fold into unusual shapes.7 Smaller oligo-
nucleotides could be built up to longer stretches using enzyme
based ligation, although the eﬃciency of this process is depen-
dent on the size of the ligation site.11
The eﬀects of small molecules on the assembly of DNA
structures in the nanotechnology arena have been less well
studied. Small molecules can crosslink four-way junctions,
bind to three-way junctions and even promote the assembly of
†Electronic supplementary information (ESI) available. See DOI: 10.1039/
c3ob42009d
School of Pharmacy, University of East Anglia, Norwich Research Park, Norwich
NR4 7TJ, UK. E-mail: m.searcey@uea.ac.uk, a.round@uea.ac.uk;
Fax: +44 (0)1603 592009; Tel: +44 (0)1603 592026
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higher order DNA structures at room temperature.12–14 If (i) it
is possible to crosslink duplex DNA in solution and (ii) the
binding site is properly defined, the potential to build up DNA
nanostructures arises.4,15 However, to build linear DNA struc-
tures would require an end-to-end non-covalent ligation,
which is hard to demonstrate with these compounds.
The 9-aminoacridine-4-carboxamide bisintercalators demon-
strate little sequence selectivity, with a reported preference
for 5′-GC sequences.16,17 By contrast, the binding modes of the
natural product echinomycin and the synthetic analogue of
triostin-A, TANDEM, are more clearly defined. NMR and crys-
tallographic studies demonstrate that both echinomycin and
TANDEM adopt a staple-like conformation on binding to
DNA.18,19 Echinomycin has a pronounced sequence selectivity
for a four base pair sequence with a central CpG step, whereas
TANDEM prefers to bind to a sequence with a central TpA.20,21
Other than by crystallography, the phenomenon of duplex
to duplex crosslinks is diﬃcult to study.22 The use of an
atomic force microscope (AFM) in force spectroscopy mode
allows the study of molecular interactions at a single molecule
level.23–25 By tethering oligonucleotides to the cantilever probe
and to a gold-coated surface, it is possible to study the inter-
actions between the two DNA strands. Here, we report on our
force spectroscopy study of the crosslinking abilities of several
bisintercalators. We find that in the absence of ligand, the
DNA strands do not interact, whereas in the presence of a
bisintercalator such as a bisacridine, we observe the cross-
linking of the two DNA strands. In the presence of echinomy-
cin and TANDEM, this crosslinking interaction is dependent
upon the identity of the terminal nucleotide; when the final
base is changed to fit the sequence selectivity of the ligand, we
observe events that indicate the rupture of end-to-end cross-
linking interactions. Thus we demonstrate that bisintercalators
based upon 9-aminoacridine-4-carboxamides can crosslink
one duplex DNA strand to another, and show that echinomycin
and TANDEM non-covalently link two DNA strands in a
sequence specific manner.
Results and discussion
The synthesis of bisacridine 1 was recently described.26 Model-
ling (data not shown) suggests that the two chromophores are
unable to stack well on each other due to the rigid linker
between them, suggesting a possible mode of intercalation
with DNA that diﬀers from the classical ‘Type I’ intercalation
interaction. We assessed the ability of bisacridine 1 to cross-
link DNA duplexes. Crosslinking of duplex DNA strands by
bisintercalators has previously been proposed by the group of
Henderson as an explanation for the observation of compact,
coiled and crossed DNA structures in AFM images.27 When
we use AFM to image duplex DNA to which bisacridine 1
has been added, we observe increases (from 14–19% to 30%;
see ESI†) in the proportion of DNA strands that overlie
each other and that adopt more compact, coiled confor-
mations, in comparison to the same DNA sequences imaged
with the monointercalator ethidium bromide, the rigidly-linked
bisintercalator echinomycin and without any intercalator
(Fig. 1). The proportion of coils and crossovers in the DNA-
only control reflects the way the DNA is adsorbed to the mica
surface.
In order to establish that bisintercalator 1 crosslinks DNA,
we use force spectroscopy, following the experimental setup
represented in Fig. 2a. With DNA covalently bound to both
probe and substrate surfaces, an interaction between the
opposing duplex DNA strands is recorded as a peak in the
force vs. distance plot (Fig. 2b), at a force representing the
resistance of the bond to stretching and at a distance reflecting
the separation of probe and surface at which the interaction is
ruptured. Fig. 2c shows the distribution of forces arising from
rupture events in this experiment when bisacridine 1 is added
into solution while DNA-functionalised probe and substrate
surfaces are cyclically brought together and separated. In more
than 4% of these cycles a rupture event is recorded on separ-
ation. In the absence of the bisintercalator less than 0.3% of
cycles show rupture events. A low level of non-specific events
between probe and surface is expected in such an experiment.
Similarly, no cross-linking is observed on the introduction of a
monointercalator (9-aminoacridine, ethidium bromide – see
Table 1). By contrast, addition of bisintercalator 2, a flexibly
linked bisintercalator, gives rise to an increase in the number
of observed rupture events (Fig. 2d) in a similar way to that
seen for bisintercalator 1. Table 1 presents the frequencies of
rupture events observed, as well as the mean forces and
lengths recorded for the crosslinking interactions. The relative
frequencies of unbinding events for the systems described
above demonstrate that the two bisintercalators do crosslink
Fig. 1 AFM images of (a) 1341 bp dsDNA control, (b) DNA + echinomycin,
(c) DNA + ethidium bromide, (d) DNA + bisacridine 1. In all cases the scale bar
denotes 250 nm.
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duplex DNA strands, in agreement with the AFM image analy-
sis presented above.
Unexpectedly, we observed a smaller but significant
number of crosslinking interactions between the two
G/C-terminated surfaces when echinomycin was present in
solution (Fig. 3). Echinomycin has a rigid structure linking the
two chromophores, imposing a staple-like conformation on
the molecule and strongly favouring Type 1 intercalation. Such
a conformation does not allow crosslinking unless the interca-
lated sites are the terminal sequences of two diﬀerent strands.
Fig. 2 (a) (left) Schematic illustration of the experimental setup: AFM cantilever and opposing substrate showing no interaction (top) and a positive interaction
(bottom). The legend denotes (1) 11-mercaptoundecanoic acid, (2) PEG, (3) DNA, (4) bisintercalator. (right) Predicted binding arrangements and theoretical lengths
of the bound complexes and enlargement of the terminal base pairs of each of the two DNA sequences. The only diﬀerence is the composition of the terminal base
pair, being either GC or AT. (b) Typical force-extension curves for the interaction between bisintercalator 1 and GC-terminated DNA. (c) Distribution of forces for the
interaction between bisintercalator 1 and GC-terminated DNA at a retract velocity of 0.5 μm s−1. (d) Distribution of forces for the interaction between bisintercalator
2 and GC-terminated DNA at a retract velocity of 0.5 μm s−1.
Table 1 Comparison of most probable contour lengths and rupture forces for each intercalator (at a retract velocity of 0.5 μm s−1). Frequencies were calculated as
a function of the total number of observed events relative to the total number of collected force curves. Values in brackets are standard errors for the length and
force columns, and total number of force–distance cycles in the number of observed events column
Terminal
base pair Ligand
Rupture
length/nm
Rupture
force/pN
Number of events with
Kuhn length ≥0.6 nm
Number of observed
eFJC events
GC Bisacridine 1 51.6 (2.0) 49.7 (3.2) 113 438 (10 000)
AT Bisacridine 1 44.4 (1.8) 52.3 (3.2) 257 551 (20 000)
GC Bisacridine 2 43.2 (2.6) 55.0 (3.7) 123 502 (20 000)
AT Bisacridine 2 46.0 (2.2) 57.3 (3.7) 135 427 (20 000)
GC 9-Amino acridine — — 1 45 (20 000)
GC Ethidium bromide — — 8 16 (15 817)
GC — — — 11 56 (20 000)
GC Echinomycin 43.5 (3.5) 50.5 (1.7) 47 367 (25 127)
AT Echinomycin — — 1 12 (20 000)
GC TANDEM — — 1 8 (20 355)
AT TANDEM 42.9 (4.0) 40.4 (2.4) 23 92 (20 000)
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Echinomycin has a pronounced preference for a CpG binding
sequence, and the DNA oligos used in this experiment would
form a GC pair if their termini were brought together (5′-TG
linking to 5′-CA, giving a TGCA sequence). We tested whether
we were observing Type 1 intercalation crosslinking the two
DNA strands by varying the terminal base pairing. With A/T
termini, crosslinking by echinomycin was abolished (Fig. 3,
Table 1). While the sequence formed by the two joined strands
is not the most favoured binding site for echinomycin,20 pre-
vious work found binding by echinomycin to this sequence.28
This suggests that crosslinking is occurring via Type 1 inter-
calation between the two terminal base pairs. We also tested
a synthetic analogue of Triostin A, TANDEM, with a similarly
constrained rigid linker structure between its chromophores
but a strong preference for binding to AT sequences. In this
case we find crosslinking between AT-terminated strands
(5′-TA linking to 5′-TA, giving a TATA sequence) and none
between GC-terminated strands (Fig. 3, Table 1). Since the
terminal bases are the only diﬀerence between the two
sequences used, these results taken together suggest that echi-
nomycin and TANDEM are indeed binding in a staple-like
manner at the end of the sequence, crosslinking the blunt
ends of the DNA duplexes. It is notable that we do not observe
crosslinking by echinomycin in the AFM images (Fig. 1b),
which in this case would be manifest as longer polymers
where two or more sequences are joined at their terminal
ends. We attribute this to two factors: the lower concentration
of free ends in much longer polymers and their concomitant
decrease in likelihood of meeting in dilute solution, and the
lower rate of end-to-end crosslinking observed in the force
spectroscopy data compared to the bisacridines (Table 1).
In order to understand something about the energetics of
the crosslinking interactions, it is necessary to construct a
dynamic force spectrum and apply a suitable model in order
to extract the parameters koﬀ and xβ, the intrinsic unbinding
rate of the bond and the distance to the transition state,
respectively. Recently Friddle and Noy introduced a new
model29,30 that describes both the equilibrium (at low loading
rates) and non-equilibrium (at high loading rates) regimes of
the dynamic force spectrum. In cases where the equilibrium
regime is reached in the force spectrum, a third parameter, the
equilibrium force feq (the minimum force required to move the
binding pair apart by the distance xβ, beyond which they can
no longer instantaneously rebind) may be obtained and from
it ΔGu, the equilibrium free energy, for the bond. We describe
our implementation of the Friddle–Noy model in ESI.† Before
applying the model we follow Akhremitchev’s method31 of
using the fitted Kuhn lengths to distinguish between single
and multiple polymer stretches, selecting only single polymer
stretches (those with Kuhn lengths greater than 0.6 nm) for
further analysis. When we apply the Friddle–Noy model to
the dynamic force spectrum for the crosslinking interaction
Fig. 3 Comparative force curves and histograms of rupture force for echinomycin (top) and TANDEM (bottom). The central column applies to binding activity with
the AT terminated DNA, and the right hand column with the GC terminated DNA.
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between A/T-terminated DNA and bisacridine 2 for loading
rates in the range 70–39 000 pN s−1 we get the results depicted
in Fig. 4 and Table 2. The dynamic force spectrum shows a
clear transition from non-equilibrium to equilibrium regime,
giving rise to estimates for the values of xβ and koﬀ of
0.13 nm and 22.4 s−1 respectively, and a value of 25.5 pN
for feq, leading to a equilibrium free energy, ΔGu, value of
5.03 kJ mol−1. This value is lower than the range of free ener-
gies of association reported for type I intercalation by echino-
mycin (32 kJ mol−1)32 and other intercalators (16–44 kJ mol−1),33
likely reflecting the constraints imposed on the binding con-
formation by the bridging of the linker between two DNA
strands. For the crosslinking interactions of bisacridine 1,
echinomycin and TANDEM, and for bisacridine 2 with the
G/C-terminated DNA, the recorded rupture events did not
reach far enough into the low loading rate regime for reliable
values of feq and ΔGu to be estimated. The values of xβ and koﬀ
for each of these interactions are presented in Table 2. In all
the bisintercalators studied, the values of xβ and koﬀ fall within
the ranges 0.13 to 0.16 nm and 7.3 to 22.4 s−1 respectively,
suggesting that the crosslinking interactions being explored
for the two bisacridines, for echinomycin and for TANDEM are
similar to each other, as well as to other high-aﬃnity non-
covalent interactions such as the digoxigenin–antidigoxigenin
complex.34 In particular, a value of xβ of around 1 Ångström
typically signifies the measurement of a single bond, whereas
values below 0.1 Å usually result from the measurement of
multiple bonds breaking.29
There have been few previous single molecule force spec-
troscopy studies of the interaction between acridine intercala-
tors and DNA. Liu et al.25 investigated the dynamic force
spectrum of the interaction between acridine tethered to an
AFM probe and duplex DNA tethered to a substrate. The
dynamic force spectrum presented by Liu et al. covers a
similar range of loading rates to the work presented here.
Using the Bell–Evans model35 they found two distinct linear
regimes in the force vs. ln(loading rate) plot, leading them to
propose the existence of two energy barriers to the disassocia-
tion of the acridine–DNA bond. The second barrier, associated
with higher forces and loading rates, is characterised by xβ and
koﬀ values similar to those found in this study (0.28 nm and
21.7 s−1 respectively). The Bell–Evans model and the Friddle–
Noy model suggest very diﬀerent origins for the observation of
diﬀerent linear regimes in the dynamic force spectrum. In the
Bell–Evans model, each distinct linear regime is attributed to a
diﬀerent energy barrier in the rupture of the bond. In the
Friddle–Noy model, a single energy barrier is generally
assumed and a maximum of two distinct linear regimes may
be observed: an asymptotically flat regime at low loading rates
tending towards the value of feq, the minimum equilibrium
unbinding force, and a regime at higher loading rates that rep-
resents the single energy barrier in much the same way as the
Bell–Evans model. Thus, while in the present work we use the
Friddle–Noy method to find feq from the low loading rate
regime, the Bell–Evans model requires the assertion of a
second, long range (xβ = 1.18 nm), interaction to fit Liu et al.’s
data. To the best of our knowledge there are no other reports
of such a long range interaction in the unbinding of acridine
intercalators from DNA. In the dynamic force spectra for the
other bisintercalators studied, in which the low loading rate
regime is under-represented, the data is best fit by a single
energy barrier.
Fig. 4 (a) Scatter plot showing the distribution of rupture forces relative to critical loading rate (left). (b) Linear plot of the relationship between rupture force and
critical loading rate, from which xβ, koﬀ and feq are determined.
Table 2 Table of values for xβ and koﬀ for the four bisintercalators used in this
study
Ligand/terminal BP xβ/nm (±SE) koﬀ/s
−1 (±SE) feq/pN (±SE)
Bisacridine 1/AT 0.137 (0.26) 9.52 (1.92) —
Bisacridine 1/GC 0.148 (0.22) 9.02 (1.1) —
Bisacridine 2/AT 0.130 (0.80) 22.45 (18.9) 25.5 (6.8)
Bisacridine 2/GC 0.154 (0.12) 10.31 (0.96) —
Echinomycin/GC 0.149 (0.10) 7.88 (0.65) —
TANDEM/AT 0.137 (0.16) 7.32 (0.65) —
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Experimental
Intercalating ligands
The acridine ligands and TANDEM were synthesised as pre-
viously described.26,36,37 Echinomycin and 9-amino acridine
(Sigma, UK) and ethidium bromide (Fisher Scientific, UK) were
purchased and used as received. Solutions were prepared
in pH 7 phosphate buﬀer (Fisher Scientific UK, Cat. no.
B/4765/77), filtered using syringe filters with a 0.2 µm PTFE
membrane and used immediately. Scheme 1 shows the struc-
tures of all intercalators used in this study.
AFM imaging
φX174 RF I plasmid DNA (1 mg mL−1) was obtained from New
England Biolabs (UK) and restricted using the enzyme BsaAI
(NEB, UK). Fragments were separated via agarose gel electro-
phoresis. The band corresponding to a 1341 bp fragment was
excised and then purified using a QIA Quick Kit (QIAGEN, UK)
following the supplier’s instructions. The final concentration
of the DNA fragment in 10 mM Tris HCl (pH 8.5) was deter-
mined via NanoDrop instrument (ThermoScientific, UK), and
the solution stored at −20 °C until used.
Experimental samples were prepared by the addition of
15 µL of an appropriate concentration of the ligand (10 µM
echinomycin (in 0.1% DMSO) or bisacridine 1, 20 µM ethi-
dium bromide (in water), in order to maintain the same ratio
of intercalator chromophores to DNA base pairs) to 10 µL of a
solution of the 1341 bp fragment of φX174 DNA (concentration
0.34 ng µL−1). This ratio corresponds to an intercalator to
base pair ratio of approximately 25 : 1, within the range of
ratios explored previously using this technique.27 Controls
were prepared using water in place of the ligand. Following an
incubation period of 1 h, 25 µL of 10 mM MgCl2 were added,
giving a final system volume of 50 µL. The system was then
transferred to freshly cleaved mica, mounted on a metallic
AFM disc. After a period of 10 min to allow incubated DNA
strands to adhere to the mica, the disc was rinsed using Nano-
pure™ water and dried under nitrogen.
Imaging was conducted in tapping-mode in air using a CPII
atomic force microscope (Veeco Instruments, USA), equipped
with a small area scanner. Commercially available cantilevers
were used, with images captured in height mode at a scan rate
of 2 Hz in a 512 × 512 pixel format over areas of 2 × 2 µm. The
set-point was increased until contact with the surface was lost
and then gradually decreased until a surface trace was again
visible. Collected images were processed and examined using
commercially available image editing software and adjusted as
required for brightness and contrast.
Single molecule force spectroscopy
Two pairs of 33 base pair oligonucleotides were purchased
from Sigma (UK). The sequences of the oligonucleotides yield-
ing the GC termination are (1) 5′-NH2-CTACGTGGACCTG-
GAGAGAGGAAGGAGACTGCCTG-3′ (2) 5′-CAGGCAGTCTCCTT-
CCTCTCTCCAGGTCCACGTAG-3′ and those yielding the AT
termination are (1) 5′-NH2-CTACGTGGACCTGGAGAGAGGAAG-
GAGACTGCCTA-3′ (2) 5′-TAGGCAGTCTCCTTCCTCTCTCCAG-
GTCCACTGAG-3′. The oligonucleotides were annealed accord-
ing to the protocol provided by the manufacturer and purified
using a Qiagen (UK) nucleotide clean-up kit. A 15.4 nm, 3000 Da
PEG (Iris Biotech, DE) was coupled to the oligonucleotide via a
hydroxysuccinimide functionality and a thiol termination was
added to the oligonucleotide and PEG conjugate by the
addition of propanedithiol using a published protocol.38 The
final solution was diluted to a concentration of 60 ng µL−1
with pH 7 phosphate buﬀer (Fisher Scientific, UK) and stored
at −20 °C until used.
Substrate gold deposition was performed using an Auto306
vacuum coater (Edwards) onto freshly cleaved mica. Depo-
sition was stopped once the gold layer had reached a thickness
of 50 nm. Coated mica was then glued to microscope slides
using a thin layer of Araldite™ glue, and stored at room temp-
erature until used. The gold surface was exposed for use by
peeling with adhesive tape.
Gold-coated cantilevers (serial code BL-RC150VB, typical
spring constant 0.027 N m−1) were purchased from Asylum
Research (UK) and used as received. Functionalisation was per-
formed by depositing a 5 µL droplet of the PEG and DNA con-
jugate on an exposed gold surface, and by immersing a clean
cantilever in a droplet of the same solution. The substrates
and the cantilevers were placed in a humidity chamber at 6 °C
for 24 h.39 The reaction was terminated by rinsing with Nano-
pure™ water. Passivation of substrates and cantilevers was
performed immediately using a 10 mM solution of 11-
mercaptoundecanoic acid in a 50% solution of DMSO in
water for 1 h. Passivation was terminated by rinsing with
Nanopure™ water.Scheme 1 Structures of the intercalators used in this study.
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Force spectroscopy was conducted using a NanoWizard 3™
AFM fitted with a liquid cell (JPK, DE). Either pH 7 phosphate
buﬀer (Fisher Scientific, UK) or the appropriate concentration
of a ligand (100 nM for bisintercalators and 200 nM for mono-
intercalators) in either water (acridines) or 0.1% DMSO (echi-
nomycin, TANDEM) was introduced to the cell. Cantilevers, as
described above, were calibrated using the thermal tune
method. Experiments were conducted in contact mode, at a
setpoint of 0.6 nN and a relative setpoint of 0.2 nN. The
z-length for all experiments was 150 nm and the approach and
retract speeds set at 0.5 microns per second and a resolution
of 2048 Hz. For the dynamic force spectroscopy study, retrac-
tion speeds were varied from 0.05 to 4 microns per second,
and the resolution adjusted as required. Force spectra were
collected in arrays of 100 × 100 data points over areas of
10 × 10 microns. Force spectra were exported and analysed
using JPK’s data processing software (JPK instruments, DE,
ver. 4.2.23). Observed events were fitted with an extended
freely-jointed chain model and the compiled data was analysed
using OriginPro™ (OriginLab, ver. 8.0724).
Conclusions
We have developed a highly sensitive probe for examining the
crosslinking properties of bisintercalators. Besides crystallo-
graphy, a method for unambiguously identifying crosslinking
of duplex DNA by intercalators has been lacking, leading to
the current situation where the interactions we report here
have not been observed before. This situation is now chan-
ging,40 opening a new avenue in exploration of the properties
of bisintercalators. Echinomycin and TANDEM are known to
bind to DNA in a staple-like conformation and to have
sequence selectivity for a CpG and TpA respectively in the
centre of the four base pair binding site. We have now demon-
strated using single molecule force spectroscopy that these
properties can be exploited to join DNA sequences in an end-
to-end fashion. The diﬀerences in binding exhibited by the
two compounds are entirely consistent with the changes in
sequence at the ends of the two oligonucleotides. The binding
mode for echinomycin and its analogue TANDEM diﬀer from
the acridine bisintercalators examined here in that, while the
latter may form end-to-end crosslinks as well, they are also
able to form duplex-to-duplex crosslinks of the type previously
shown and described as type II bisintercalation (see Fig. 5),
and this second binding mode is likely to be more common.
In the environment of the nucleosome, the close proximity
of multiple strands of DNA is likely to facilitate the cross-
linking of duplexes upon exposure to the acridine bisintercala-
tors and this mechanism may represent a significant factor in
the activity of these molecules. The novel end-to-end linking
mechanism disclosed here for echinomycin and TANDEM,
conversely, may have little opportunity to manifest itself
in nucleo due to the relative paucity of free ends of DNA.
However, the ability to assemble DNA strands in this end-to-
end, sequence-specific fashion has implications for the use of
rationally designed DNA sequences in nanoscale self-assembly.
The application of small molecules that promote the for-
mation of higher order structures in DNA (including intercala-
tors41) may be combined with those that non-covalently ligate
sequences in order to build structures that are accessible from
the “bottom up” of small oligonucleotide sequences rather
than the “top-down” approach using large plasmid structures.
The discovery of further small molecules that specifically
target DNA ends in a sequence specific fashion is a major goal
for future research.
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Appendix 2 
 
 
Figure 1 – Ethidium bromide, 9-amino acridine, doxorubicin 
 
 
Figure 2 – Echinomycin, TANDEM 
 
 
Figure 3 – Bisacridine 1, bisacridine 2 
 
 
Figure 4 – Bisacridine 3, bisacridine 4 
